As filed with the Securities and Exchange Commission on August 14, 2014
Registration No. 333 - 197845
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________
FORM S-1
Amendment No. 1
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
_________________________________
Nxt-ID, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 7381 | 46-0678374 | ||
(State
or other jurisdiction of incorporation or organization) |
(Primary
Standard Industrial Classification Code Number) |
(I.R.S.
Employer Identification Number) |
One Reservoir Corporate Centre
4 Research Drive, Suite 402
Shelton, CT 06484
(203) 242-3076
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
National Corporate Research, Ltd.
615 South DuPont Highway
Dover, DE 19901
(800) 483-1140
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies of communications, including communications sent to agent for service, should be sent to:
David E. Danovitch, Esq. Joseph E. Segilia, Esq. Zachary D. Blumenthal, Esq. Robinson Brog Leinwand Greene Genovese & Gluck P.C. 875 Third Avenue, 9th Floor New York, New York 10022 Tel: (212) 603-6300 Fax: (212) 956-2164 |
Jonathan R. Zimmerman James R. DeBuse Faegre
Baker Daniels LLP Tel: (612) 766-7000 Fax: (612) 766-1600 |
Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ | Smaller reporting company | ☒ |
CALCULATION OF REGISTRATION FEE
Title of Each Class Of Securities to be Registered | Proposed Maximum Aggregate Offering Price (1)(2) | Amount of Registration Fee | ||||||
Common stock, $0.0001 par value per share | $ | 8,050,000 | $ | 1,036.84 | ||||
Warrants to purchase common stock (3) | $ | 0 | $ | 0 | ||||
Common stock underlying warrants (4) | $ | 10,140,000 | (5) | $ | 1,306.03 | |||
TOTAL | 18,190,000 | 2,342.87 |
(1) | This amount represents the proposed maximum aggregate offering price of the securities registered hereunder that may be sold by the registrant. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. |
(2) | Includes additional shares of common stock and warrants to purchase shares of common stock that the underwriters have the option to purchase to cover over-allotments, if any. |
(3) | In accordance with Rule 457(g) under the Securities Act, no separate registration fee is required with respect to the warrants registered hereby. The warrants registered hereby include warrants issued to the underwriters in connection with this offering. |
(4) | Estimated solely for the purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The warrants are exercisable at a per share exercise price equal to 120% of the public offering price. The proposed maximum aggregate offering price of the warrants is $ , which is equal to 120% of $ . These shares registered hereby include the shares of common stock issuable upon exercise of the underwriters’ warrants. |
(5) | There will be issued warrants to purchase shares of common stock. The warrants are exercisable at a per share price equal to 120% of the common stock public offering price. |
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the commission, acting pursuant to said Section 8(a), may determine.
The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
PRELIMINARY PROSPECTUS | SUBJECT TO COMPLETION | DATED AUGUST 14, 2014 |
Shares of Common Stock
Warrants to Purchase Shares of Common Stock
We are offering shares of our common stock, par value $0.0001 per share, and warrants to purchase shares of common stock of Nxt-ID, Inc. The warrant to purchase of a share of our common stock will have an exercise price of $ per share (120% of the public offering price of the common stock). The warrants are exercisable immediately and will expire five years from the date of issuance. Our common stock is presently traded on the OTC Bulletin Board (the “OTC Bulletin Board”) under the symbol NXTD. On August 12, 2014, the last sale price of our shares as reported by the OTC Bulletin Board was $3.46 per share. In conjunction with this offering, we intend to apply to list our common stock and warrants on the Nasdaq Capital Market under the symbols “NXTD” and “NXTDW”, respectively.
Prior to this offering, there has been no public market for our warrants in the United States. It is currently estimated that the initial public offering price will be $0.01 per warrant.
We are an “emerging growth company” as the term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have elected to comply with certain reduced public company reporting requirements.
Investing in our common stock involves risks. See “Risk Factors” beginning on page 5.
Per Share | Per Warrant | Total | ||||||||||
Initial price to public | $ | $ | $ | |||||||||
Underwriting discounts and commissions (1) | $ | $ | $ | |||||||||
Proceeds before expenses to Nxt-ID, Inc. | $ | $ | $ |
(1) | In addition to the underwriting discounts and commissions, we have agreed to pay up to $150,000 of the fees and expenses of the underwriters in connection with this offering, which includes the fees and expenses of the underwriter’s counsel. See “Underwriting” for more information. |
We have granted the underwriters a 45-day option to purchase up to an additional shares of our common stock and/or warrants to purchase up to an additional shares of our common stock solely to cover over-allotments, if any, within 45 days of the date of this prospectus.
In connection with this offering, we have also agreed to issue the underwriters warrants to purchase shares of our common stock in an amount up to 5% of the shares of common stock sold in this offering. If the underwriters exercise these warrants, each share of common stock may be purchased at (120% of the price of the shares of common stock sold in this offering). This prospectus covers these underwriter warrants and the shares of common stock issuable upon exercise of the underwriters’ warrants.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters expect to deliver the shares on or about , 2014.
Northland Capital Markets |
The Benchmark Company |
Newport Coast Securities Inc.
The date of this prospectus is , 2014.
1 |
This summary highlights selected information contained elsewhere in this prospectus. This summary does not contain all the information that you should consider before investing in the common stock. You should carefully read the entire prospectus, including “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statements, before making an investment decision. All references to “we,” “us,” “our,” and the “company” mean Nxt-ID, Inc.
Our Company
We are an early stage technology company that is focused on products, solutions, and services that have a need for biometric identification and secure access control. We have three distinct lines of business that we are currently pursuing: mobile commerce (“m-commerce”), law enforcement and biometric access control applications. Our initial efforts have primarily focused on the development of our secure products for the growing m- commerce market, most immediately, a secure mobile electronic smart wallet. Wocket™ is a smart wallet, the next evolution in smart devices following the smart phone and smart watch, designed to protect your identity and replace all the cards in your wallet, with no smart phone required. Wocket™ works anywhere credit cards are accepted and only works with your biometric stamp of approval. Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
Wocket™ prototype
Our plan also anticipates that we will use our core biometric facial and voice recognition algorithms to develop security applications (both cloud based and locally hosted) that can be used for corporations (including industrial uses such as enterprise computer networks) as well as individuals (including consumer uses such as smart phones, tablets or personal computers). Finally, our plan calls for a suite of high level security products and facial recognition applications that can be utilized by law enforcement, the defense industry, and the U.S. Department of Homeland Security.
We believe that our MobileBioTM products, together with our biometric security solutions, will provide distinct advantages within these markets by improving mobile security. Currently most mobile devices continue to be protected simply by questions that a user asks, and PIN numbers. This security methodology is easily duplicated on another device, and can be easily spoofed or hacked. Nxt-ID’s biometric security paradigm is Dynamic Pairing Codes (DPC). DPC are a new, proprietary method to secure users, devices, accounts, locations and servers over any communication media by sharing key identifiers, including biometric-enabled identifiers, between end-points by passing dynamic pairing codes (random numbers) between end-points to establish sessions and/or transactions without exposing identifiers or keys. The recent high-level breaches of personal credit card data raises serious concerns among consumers about the safety of their money. These consumers are also resistant to letting technology companies learn even more about their personal purchasing habits.
We also plan to service the access control and law enforcement facial recognition markets with our existing 3D facial recognition technology products beginning with U.S. federal and state governmental agencies. These products, whose underlying technologies have been licensed by us, provide customers with the capability to enroll subjects in a 3D database and use that database for verification of identities. During 2012, we acquired 100% of the membership interests in 3D-ID, LLC, an entity affiliated with our founders as a means toward advancing our business plan.
2 |
Market Overview
The 2013 Federal Reserve Payments Study reported that there were 775.4 million general-purpose cards in force nationally in 2012. Of these cards, only 47.1 million were estimated to have security chips on them.
Each year approximately 12 million people in the United States are victims of identity theft and 44% of known causes of identity theft can be traced to a lost or stolen wallet or purse.
We believe that given the aforementioned statistics that credit and debit card fraud will continue to be of concern to holders, as the number of credit card holders/users continues to grow and with it the number of credit card transactions. We believe there is a significant segment of this market that at least initially also will be reluctant to use their smartphone for mobile payments due to a variety of reasons including: limited battery life; dependency on wireless network coverage; and well publicized security threats.
We believe that Wocket™ can significantly reduce the incidence of identity theft by concealing the cardholders personal information on a tamper proof secure chip on the Wocket that can only be accessed by a voice biometric or PIN. Furthermore, the Wocket Card does not retain any information after the card has been swiped so, unlike the loss or theft of a wallet, the loss or theft of a Wocket or Wocket Card does not lead to a breach of personal information.
Recent Developments
Between June 12, 2014 and June 17, 2014, the Company completed a private offering of warrants to purchase common stock (the “Offering”) with a group of accredited investors, who had previously participated in the Company’s private offering that had occurred between December 30, 2013 and January 13, 2014 (the “Purchasers”) for total net proceeds to the Company of $4,000. Pursuant to a securities purchase agreement with the Purchasers (the “Purchase Agreement”), the Company issued to the Purchasers warrants (the “Warrants”) to purchase an aggregate of 400,000 shares (the “Warrant Shares”) of our Common Stock at an exercise price of $3.00 per share. The Warrants are exercisable for a period of five years from the original issue date. The exercise price for the Warrants is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes. If exercised, the Warrants will provide the Company with gross proceeds of approximately $1.2 million. The Company determined that the effect of the issuance of the warrants was to induce the Purchasers to exercise warrants previously issued to them in the Offering and thus accounted for the issuance as an inducement.
On May 28, 2014, we formally launched the Wocket at a hosted event. Since the May 28 launch, we have begun accepting advance orders for our Wocket. As a result, we have commenced purchasing inventory for manufacturing. The Wocket is being manufactured in the United States by a well-established third-party electronic assembly house and we are also in the process of building out our fulfillment and customer support center. As of the date of this prospectus, we anticipate beginning to fulfill our initial orders by the end of the 3rd Quarter of 2014.
During the three months ended June 30, 2014 the Company received $1,200,000 in connection with the exercise of 400,000 warrants into 400,000 shares of common stock at an exercise price of $3.00 per share. Upon exercise, pursuant to the Purchase Agreement, the Company’s Founders agreed to cancel a corresponding number of shares to be cancelled for each Warrant Share issued. As a result, the Founders returned to the Company and the Company retired 400,000 shares of common stock.
3 |
The Offering
Common stock offered by us: | shares of common stock. |
Warrants offered by us: | The warrants will have a per share exercise price of $ (120% of the public offering price of the common stock). The warrants are exercisable immediately and will expire five (5) years from the date of issuance. This prospectus also relates to the offering of shares of common stock issuable upon the exercise of the warrants. See “Description of Warrants.” |
Over-allotment option: | We have agreed to allow the underwriters to purchase up to an additional shares from us and warrants to purchase up to shares of our common stock, at the respective public offering price less underwriting discounts and commissions, within forty-five (45) days from the date of this prospectus. |
Common stock outstanding after this offering: | shares (or shares, if the underwriters exercise their option to purchase additional shares in full). |
Use of proceeds: | We estimate that the net proceeds from our sale of shares of our common stock and warrants to purchase shares of our common stock in this offering will be approximately $ million, or approximately $ million if the underwriters exercise their option to purchase additional shares and related warrants in full, based on the combined public offering price of $ per share, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. |
We expect to use $ of the net proceeds from this offering for general corporate purposes including working capital, product development and marketing activities. | |
Dividend Policy | We do not anticipate paying any cash dividends on our common stock. See “Dividend Policy.” |
Risk factors: | Investing in our common stock involves a high degree of risk. Before buying any shares, you should read the discussion of material risks of investing in our common stock in “Risk Factors” beginning on page 5. |
Trading symbol: | NXTD. In conjunction with this offering, we intend to apply to list our common stock and warrants on the Nasdaq Capital Market under the symbols “NXTD” and “NXTDW”, respectively. |
The number of shares of our common stock outstanding after this offering is based on 22,030,843 shares outstanding as of August 12, 2014, and excludes warrants to purchase 1,396,139 shares of common stock at an exercise price of $3.00.
Unless otherwise indicated, this prospectus reflects and assumes no exercise by the underwriters of the over-allotment option.
Corporate Information
Our principal executive offices are located at One Reservoir Corporate Centre, 4 Research Drive, Suite 402, Shelton, CT 06484, and our telephone number is (203) 242-3076. Our website address is www.nxt-id.com. The information contained therein or connected thereto shall not be deemed to be incorporated into this prospectus or the registration statement of which it forms a part. The information on our website is not part of this prospectus.
We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act. We will remain an emerging growth company for up to five years, or until the earliest of (i) the last day of the first fiscal year in which our annual gross revenue exceed $1 billion, (ii) the date that we become a ‘‘large accelerated filer’’ as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter or (iii) the date on which we have issued more than $1 billion in non-convertible debt during the preceding three-year period. Pursuant to Section 102 of the JOBS Act, we have provided reduced executive compensation disclosure and have omitted a compensation discussion and analysis from this prospectus. Pursuant to Section 107 of the JOBS Act, we have elected to utilize the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”), for complying with new or revised accounting standards. |
4 |
An investment in our common stock involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information included in this report, before making an investment decision. If any of the following risks actually occurs, our business, financial condition or results of operations could suffer. In that case, the trading price of our shares of common stock could decline, and you may lose all or part of your investment. You should read the section entitled “Special Note Regarding Forward Looking Statements” above for a discussion of what types of statements are forward-looking statements, as well as the significance of such statements in the context of this report.
Risks Relating to our Business
Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a going concern.
The Company is an early stage entity and has incurred net losses of $1,544,534 for the year ended December 31, 2013 and $3,822,887 for the six months ended June 30, 2014. As of December 31, 2013, the Company had cash and a stockholders’ deficiency of $303,626 and ($1,831,393), respectively. As of June 30, 2014, the Company had cash and stockholders’ equity of $588,179 and $513,779, respectively. At December 31, 2013 and June 30, 2014, the Company had working capital (deficiency) of $($1,839,127) and $490,570, respectively. Primarily as a result of our losses and limited cash balances, our independent registered public accounting firm has included in its report for the year ended December 31, 2013, an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is contingent upon, among other factors, ability to raise additional cash from equity financings, secure debt financing, and/or generate revenue from the sales of our products. We cannot provide any assurance that we will be able to raise additional capital. If we are unable to secure additional capital, we may be required to curtail our research and development initiatives and take additional measures to reduce costs in order to conserve our cash in amounts sufficient to sustain operations and meet our obligations.
We are uncertain of our ability to continue as a going concern, indicating the possibility that we may not be able to operate in the future.
To date, we have completed only the initial stages of our business plan and we can provide no assurance that we will be able to generate a sufficient amount of revenue, if at all, from our business in order to achieve profitability. It is not possible for us to predict at this time the potential success of our business. The revenue and income potential of our proposed business and operations are currently unknown. If we cannot continue as a viable entity, you may lose some or all of your investment in our Company.
Because we are an early stage company, we expect to incur significant additional operating losses.
The Company is an early stage entity. The amount of future losses and when, if ever, we will achieve profitability are uncertain. Our current products have not generated significant commercial revenue for our Company and there can be no guarantee that we can generate sufficient revenues from the commercial sale of our products in the near future to fund our ongoing capital needs.
We have a limited operating history upon which you can gauge our ability to obtain profitability.
We have a limited operating history and our business and prospects must be considered in light of the risks and uncertainties to which early stage companies are exposed. We cannot provide assurances that our business strategy will be successful or that we will successfully address those risks and the risks described herein. Most important, if we are unable to secure future capital, we may be unable to continue our operations. We may incur losses on a quarterly or annual basis for a number of reasons, some of which may be outside our control.
If we cannot obtain additional capital required to finance our research and development efforts, our business may suffer and you may lose the value of your investment.
We may require additional funds to further execute our business plan and expand our business. If we are unable to obtain additional capital when needed, we may have to restructure our business or delay or abandon our development and expansion plans. If this occurs, you may lose part or all of your investment.
5 |
We will have ongoing capital needs as we expand our business. If we raise additional funds through the sale of equity or convertible securities, your ownership percentage of our common stock will be reduced. In addition, these transactions may dilute the value of our common stock. We may have to issue securities that have rights, preferences and privileges senior to our common stock. The terms of any additional indebtedness may include restrictive financial and operating covenants that would limit our ability to compete and expand. There can be no assurance that we will be able to obtain the additional financing we may need to fund our business, or that such financing will be available on terms acceptable to us.
We face intense competition in our market, especially from larger, well-established companies, and we may lack sufficient financial or other resources to maintain or improve our competitive position.
A number of other companies engage in the business of developing applications for facial recognition for access control. The market for biometric security products is intensely competitive, and we expect competition to increase in the future from established competitors and new market entrants. Our current competitors include both emerging or developmental stage companies such as ourselves as well as larger companies. Many of our existing competitors have, and some of our potential competitors could have, substantial competitive advantages such as:
● | Greater name recognition and longer operating histories; |
● | Larger sales and marketing budgets and resources; |
● | Broader distribution and established relationships with distribution partners and end-customers; |
● | Greater customer support resources; |
● | Greater resources to make acquisitions; |
● | Larger and more mature intellectual property portfolios; and |
● | Substantially greater financial, technical, and other resources. |
In addition, some of our larger competitors have substantially broader product offerings and leverage their relationships based on other products or incorporate functionality into existing products to gain business in a manner that discourages users from purchasing our products, including through selling at zero or negative margins, product bundling, or closed technology platforms. Conditions in our market could change rapidly and significantly as a result of technological advancements, partnering by our competitors or continuing market consolidation. New start-up companies that innovate and large competitors that are making significant investments in research and development may invent similar or superior products and technologies that compete with our products and technology. Our current and potential competitors may also establish cooperative relationships among themselves or with third parties that may further enhance their resources.
Our markets are subject to technological change and our success depends on our ability to develop and introduce new products.
Each of the governmental and commercial markets for our products is characterized by:
● | Changing technologies; |
● | Changing customer needs; |
● | Frequent new product introductions and enhancements; |
● | Increased integration with other functions; and |
● | Product obsolescence. |
Our success will be dependent in part on the design and development of new products. To develop new products and designs for our target markets, we must develop, gain access to and use leading technologies in a cost-effective and timely manner and continue to expand our technical and design expertise. The product development process is time-consuming and costly, and there can be no assurance that product development will be successfully completed, that necessary regulatory clearances or approvals will be granted on a timely basis, or at all, or that the potential products will achieve market acceptance. Our failure to develop, obtain necessary regulatory clearances or approvals for, or successfully market potential new products could have a material adverse effect on our business, financial condition and results of operations.
Claims by others that we infringe their intellectual property rights could increase our expenses and delay the development of our business. As a result, our business and financial condition could be harmed.
Our industries are characterized by the existence of a large number of patents as well as frequent claims and related litigation regarding patent and other intellectual property rights. We cannot be certain that our products do not and will not infringe issued patents, patents that may be issued in the future, or other intellectual property rights of others.
We do not have the resources to conduct exhaustive patent searches to determine whether the technology used in our products infringes patents held by third parties. In addition, product development is inherently uncertain in a rapidly evolving technological environment in which there may be numerous patent applications pending, many of which are confidential when filed, with regard to similar technologies.
6 |
We may face claims by third parties that our products or technology infringe their patents or other intellectual property rights. Any claim of infringement could cause us to incur substantial costs defending against the claim, even if the claim is invalid, and could distract the attention of our management. If any of our products are found to violate third-party proprietary rights, we may be required to pay substantial damages. In addition, we may be required to re-engineer our products or obtain licenses from third parties to continue to offer our products. Any efforts to re-engineer our products or obtain licenses on commercially reasonable terms may not be successful, which would prevent us from selling our products, and, in any case, could substantially increase our costs and have a material adverse effect on our business, financial condition and results of operations.
We may not be able to protect our intellectual property rights adequately.
Our ability to compete for government contracts is affected, in part, by our ability to protect our intellectual property rights. We rely on a combination of patents, trademarks, copyrights, trade secrets, confidentiality procedures and non-disclosure and licensing arrangements to protect our intellectual property rights. Despite these efforts, we cannot be certain that the steps we take to protect our proprietary information will be adequate to prevent misappropriation of our technology or protect that proprietary information. The validity and breadth of claims in technology patents involve complex legal and factual questions and, therefore, may be highly uncertain. Nor can we assure you that, if challenged, our patents will be found to be valid or enforceable, or that the patents of others will not have an adverse effect on our ability to do business. In addition, the enforcement of laws protecting intellectual property may be inadequate to protect our technology and proprietary information.
We may not have the resources to assert or protect our rights to our patents and other intellectual property. Any litigation or proceedings relating to our intellectual property, whether or not meritorious, will be costly and may divert the efforts and attention of our management and technical personnel.
We also rely on other unpatented proprietary technology, trade secrets and know-how and no assurance can be given that others will not independently develop substantially equivalent proprietary technology, techniques or processes, that such technology or know-how will not be disclosed or that we can meaningfully protect our rights to such unpatented proprietary technology, trade secrets, or know-how. Although intend to enter into non-disclosure agreements with our employees and consultants, there can be no assurance that such non-disclosure agreements will provide adequate protection for our trade secrets or other proprietary know-how.
Our success will depend, in part, on our ability to obtain new patents.
To date, we have licensed sixteen (16) United States patents and our success will depend, in part, on our ability to obtain patent and trade secret protection for proprietary technology that we currently possess or that we may develop in the future. No assurance can be given that any pending or future patent applications will issue as patents, that the scope of any patent protection obtained will be sufficient to exclude competitors or provide competitive advantages to us, that any of our patents will be held valid if subsequently challenged or that others will not claim rights in or ownership of the patents and other proprietary rights held by us.
Furthermore, there can be no assurance that our competitors have not or will not independently develop technology, processes or products that are substantially similar or superior to ours, or that they will not duplicate any of our products or design around any patents issued or that may be issued in the future to us. In addition, whether or not patents are issued to us, others may hold or receive patents which contain claims having a scope that covers products or processes developed by us.
We may not have the resources to adequately defend any patent infringement litigation or proceedings. Any such litigation or proceedings, whether or not determined in our favor or settled by us, is costly and may divert the efforts and attention of our management and technical personnel. In addition, we may be required to obtain licenses to patents or proprietary rights from third parties. There can be no assurance that such licenses will be available on acceptable terms if at all. If we do not obtain required licenses, we could encounter delays in product development or find that the development, manufacture or sale of products requiring such licenses could be foreclosed. Accordingly, challenges to our intellectual property, whether or not ultimately successful, could have a material adverse effect on our business and results of operations.
7 |
We rely on a third party for licenses relating to a critical component of our technology. The failure of such licensor would materially and adversely affect our business and product offerings.
We currently license technology for a critical component of our current product offerings from a third party. The third party’s independent registered public accounting firm included an explanatory paragraph in its audit report as it relates to the third party’s ability to continue as a going concern in its recent financial statement. In the event that our licensor were to fail, it could impact our license arrangement and impede our ability to further commercialize our technology. In the event we were to lose our license or our license were to be renegotiated as a result of our licensor’s failure, our ability to manage our business would suffer and it would significantly harm our business, operating results and financial condition.
Our future success depends on the continued service of management, engineering and sales personnel and our ability to identify, hire and retain additional personnel.
Our success depends, to a significant extent, upon the efforts and abilities of members of senior management. We have entered into an employment agreement with our Chief Executive Officer, but have not entered into an employment agreement with our Chief Technology Officer and have no current plans to use employment agreements as a tool to attract and retain new hires that we may make of key personnel in the future. The loss of the services of one or more of our senior management or other key employees could adversely affect our business. We do not currently maintain key person life insurance on any of our officers, employees or consultants, but are in the process of attempting to obtain such insurance on our senior most personnel. There is no guarantee we will be able to obtain such insurance or if we are able to obtain such insurance to do so on acceptable terms to us.
There is intense competition for qualified employees in our industry, particularly for highly skilled design, applications, engineering and sales people. We may not be able to continue to attract and retain developers, managers, or other qualified personnel necessary for the development of our business or to replace qualified individuals who may leave us at any time in the future. Our anticipated growth is expected to place increased demands on our resources, and will likely require the addition of new management and engineering staff as well as the development of additional expertise by existing management employees. If we lose the services of or fail to recruit engineers or other technical and management personnel, our business could be harmed.
The requirements of being a public company may strain our resources and divert management’s attention.
As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (“Exchange Act”), the Sarbanes-Oxley Act, the Dodd-Frank Act and other applicable securities rules and regulations. Compliance with these rules and regulations will increase our legal and financial compliance costs, make some activities more difficult, time-consuming, or costly, and increase demand on our systems and resources. The Exchange Act requires, among other things, that we file annual and current reports with respect to our business and operating results.
As a result of disclosure of information in this prospectus and in filings required of a public company, our business and financial condition is more visible, which we believe may result in threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business and operating results could be harmed, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert resources of our management and harm our business and operating results.
8 |
Periods of rapid growth and expansion could place a significant strain on our resources, including our employee base, which could negatively impact our operating results.
We may experience periods of rapid growth and expansion, which may place significant strain and demands on our management, our operational and financial resources, customer operations, research and development, marketing and sales, administrative, and other resources. To manage our possible future growth effectively, we will be required to continue to improve our management, operational and financial systems. Future growth would also require us to successfully hire, train, motivate and manage our employees. In addition, our continued growth and the evolution of our business plan will require significant additional management, technical and administrative resources. If we are unable to manage our growth successfully we may not be able to effectively manage the growth and evolution of our current business and our operating results could suffer.
We depend on contract manufacturers, and our production and products could be harmed if it is unable to meet our volume and quality requirements and alternative sources are not available.
We rely on contract manufacturers to provide manufacturing services for our products. If these services become unavailable, we would be required to identify and enter into an agreement with a new contract manufacturer or take the manufacturing in-house. The loss of our contract manufacturers could significantly disrupt production as well as increase the cost of production, thereby increasing the prices of our products. These changes could have a material adverse effect on our business and results of operations.
Our insiders and affiliated parties beneficially own a significant portion of our stock.
As of the date of hereof, our executive officers, directors, and affiliated parties beneficially own approximately 85% of our common stock. As a result, our executive officers, directors and affiliated parties will have significant influence to:
● | Elect or defeat the election of our directors; |
● | Amend or prevent amendment of our certificate of incorporation or bylaws; |
● | Effect or prevent a merger, sale of assets or other corporate transaction; and |
● | Affect the outcome of any other matter submitted to the stockholders for vote. |
In addition, any sale of a significant amount of our common stock held by our directors and executive officers, or the possibility of such sales, could adversely affect the market price of our common stock. Management’s stock ownership may discourage a potential acquirer from making a tender offer or otherwise attempting to obtain control of us, which in turn could reduce our stock price or prevent our stockholders from realizing any gains from our common stock.
We are presently a small company with limited resources and personnel to establish a comprehensive system of internal controls. If we fail to maintain an effective system of internal controls, we would not be able to accurately report our financial results or prevent fraud. As a result, current and potential stockholders could lose confidence in our financial reporting, which would harm our business and the trading price of our stock.
Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, our brand and operating results would be harmed. We may in the future discover areas of our internal controls that need improvement. For example, because of size and limited resources, our external auditors may determine that we lack the personnel and infrastructure necessary to properly carry out an independent audit function. Although we believe that we have adequate internal controls for a company with our size and resources, we are not certain that the measures that we have in place will ensure that we implement and maintain adequate controls over our financial processes and reporting in the future. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, would harm our operating results or cause us to fail to meet our reporting obligations. Inferior internal controls would also cause investors to lose confidence in our reported financial information, which would have a negative effect on our company and, if a public market develops for our securities, the trading price of our stock.
9 |
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. generally accepted accounting principles. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis.
If we do not effectively manage changes in our business, these changes could place a significant strain on our management and operations.
Our ability to grow successfully requires an effective planning and management process. The expansion and growth of our business could place a significant strain on our management systems, infrastructure and other resources. To manage our growth successfully, we must continue to improve and expand our systems and infrastructure in a timely and efficient manner. Our controls, systems, procedures and resources may not be adequate to support a changing and growing company. If our management fails to respond effectively to changes and growth in our business, including acquisitions, this could have a material adverse effect on the Company’s business, financial condition, results of operations and future prospects.
We are an emerging growth company within the meaning of the Securities Act, and if we decide to take advantage of certain exemptions from various reporting requirements applicable to emerging growth companies, our common stock could be less attractive to investors.
We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act, or the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. We could be an emerging growth company for up to five years, although we could lose that status sooner if our revenues exceed $1 billion, if we issue more than $1 billion in non-convertible debt in a three year period, or if the market value of our common stock held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter, in which case we would no longer be an emerging growth company as of the following December 31. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.
Under the JOBS Act, emerging growth companies may also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.
Risks Related To Our Biometric Recognition Applications and Related Products
Our biometric products and technologies may not be accepted by the intended commercial consumers of our products, which could harm our future financial performance.
There can be no assurance that our biometric systems will achieve wide acceptance by commercial consumers of such security-based products, and market acceptance generally. The degree of market acceptance for products and services based on our technology will also depend upon a number of factors, including the receipt and timing of regulatory approvals, if any, and the establishment and demonstration of the ability of our proposed device to provide the level of security in an efficient manner and at a reasonable cost. Our failure to develop a commercial product to compete successfully with existing security technologies could delay, limit or prevent market acceptance. Moreover, the market for new biometric-based security systems is largely undeveloped, and we believe that the overall demand for mobile biometric-based security systems technology will depend significantly upon public perception of the need for such a level of security. There can be no assurance that the public will believe that our level of security is necessary or that private-industry will actively pursue our technology as a means to solve their security issues. Long-term market acceptance of our products and services will depend, in part, on the capabilities, operating features and price of our products and technologies as compared to those of other available products and services. As a result, there can be no assurance that currently available products, or products under development for commercialization, will be able to achieve market penetration, revenue growth or profitability.
10 |
Our biometric applications may become obsolete if we do not effectively respond to rapid technological change on a timely basis.
The biometric identification and personal identification industries are characterized by rapid technological change, frequent new product innovations, changes in customer requirements and expectations and evolving industry standards. If we are unable to keep pace with these changes, our business may be harmed. Products using new technologies, or emerging industry standards, could make our technologies less attractive. If addition, we may face unforeseen problems when developing our products, which could harm our business. Furthermore, our competitors may have access to technologies not available to us, which may enable them to produce products of greater interest to consumers or at a more competitive cost.
Our biometric applications are new and our business model is evolving. Because of the new and evolving nature of biometric technology, it is difficult to predict the size of this specialized market, the rate at which the market for our biometric applications will grow or be accepted, if at all, or whether other biometric technologies will render our applications less competitive or obsolete. If the market for our biometric applications fails to develop or grows slower than anticipated, we would be significantly and materially adversely affected.
If our products and services do not achieve market acceptance, we may never have significant revenues or any profits.
If we are unable to operate our business as contemplated by our business model or if the assumptions underlying our business model prove to be unfounded, we could fail to achieve our revenue and earnings goals within the time we have projected, or at all, which would have a detrimental effect on our business. As a result, the value of your investment could be significantly reduced or completely lost.
We may in the future experience competition from other biometric application developers.
Competition in the development of biometric recognition is expected to become more intense. Competitors range from university-based research and development graphics labs to development-stage companies and major domestic and international companies. Many of these entities have financial, technical, marketing, sales, distribution and other resources significantly greater than those of our company. There can be no assurance that we can continue to develop our biometric technologies or that present or future competitors will not develop technologies that render our biometric applications obsolete or less marketable or that we will be able to introduce new products and product enhancements that are competitive with other products marketed by industry participants.
We may fail to create new applications for our products and enter new markets, which would have an adverse effect on our operations, financial condition and prospects.
Our future success depends in part on our ability to develop and market our technology for applications other than those currently intended. If we fail in these goals, our business strategy and ability to generate revenues and cash flow would be significantly impaired. We intend to expend significant resources to develop new technology, but the successful development of new technology cannot be predicted and we cannot guarantee we will succeed in these goals.
Our products may have defects, which could damage our reputation, decrease market acceptance of our products, cause us to lose customers and revenue and result in costly litigation or liability.
Our products may contain defects for many reasons, including defective design or manufacture, defective material or software interoperability issues. Products as complex as those we offer, frequently develop or contain undetected defects or errors. Despite testing defects or errors may arise in our existing or new products, which could result in loss of revenue, market share, failure to achieve market acceptance, diversion of development resources, injury to our reputation, and increased service and maintenance cost. Defects or errors in our products and solutions might discourage customers from purchasing future products. Often, these defects are not detected until after the products have been shipped. If any of our products contain defects or perceived defects or have reliability, quality or compatibility problems or perceived problems, our reputation might be damaged significantly, we could lose or experience a delay in market acceptance of the affected product or products and might be unable to retain existing customers or attract new customers. In addition, these defects could interrupt or delay sales. In the event of an actual or perceived defect or other problem, we may need to invest significant capital, technical, managerial and other resources to investigate and correct the potential defect or problem and potentially divert these resources from other development efforts. If we are unable to provide a solution to the potential defect or problem that is acceptable to our customers, we may be required to incur substantial product recall, repair and replacement and even litigation costs. These costs could have a material adverse effect on our business and operating results.
11 |
We will provide warranties on certain product sales and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires us to make estimates of product return rates and expected costs to repair or to replace the products under warranty. We will establish warranty reserves based on our best estimates of warranty costs for each product line combined with liability estimates based on the prior twelve months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from our estimates, adjustments to recognize additional cost of sales may be required in future periods. In addition, because our customers rely on secure authentication and identification of cardholder to prevent unauthorized access to programs, PC’s, networks, or facilities, a malfunction of or design defect in its products (or even a perceived defect) could result in legal or warranty claims against us for damages resulting from security breaches. If such claims are adversely decided against us, the potential liability could be substantial and have a material adverse effect on our business and operating results. Furthermore, the possible publicity associated with any such claim, whether or not decided against us, could adversely affect our reputation. In addition, a well-publicized security breach involving smart card-based or other security systems could adversely affect the market’s perception of products like ours in general, or our products in particular, regardless of whether the breach is actual or attributable to our products. Any of the foregoing events could cause demand for our products to decline, which would cause its business and operating results to suffer.
Risks Related to Our Securities and this Offering
The market price for our common shares is particularly volatile given our status as a relatively unknown company with a small and thinly traded public float, and lack of profits, which could lead to wide fluctuations in our share price. You may be unable to sell your common shares at or above your purchase price, which may result in substantial losses to you.
The market for our common shares is characterized by significant price volatility when compared to the shares of larger, more established companies that trade on a national securities exchange and have large public floats, and we expect that our share price will continue to be more volatile than the shares of such larger, more established companies for the indefinite future. The volatility in our share price is attributable to a number of factors. First, as noted above, our common shares are, compared to the shares of such larger, more established companies, sporadically and thinly traded. The price for our shares could, for example, decline precipitously in the event that a large number of our common shares are sold on the market without commensurate demand. Secondly, we are a speculative or “risky” investment due to our lack of profits to date. As a consequence of this enhanced risk, more risk-adverse investors may, under the fear of losing all or most of their investment in the event of negative news or lack of progress, be more inclined to sell their shares on the market more quickly and at greater discounts than would be the case with the stock of a larger, more established company that trades on a national securities exchange and has a large public float. Many of these factors are beyond our control and may decrease the market price of our common shares, regardless of our operating performance.
No liquid market currently exists for our common stock or warrants, and an active, liquid trading market for our common stock or warrants may not develop, which may cause our common stock to trade at a discount from the initial offering price and make it difficult for you to sell the common stock you purchase.
Our common stock is currently quoted on the OTC Bulletin Board. Although we intend to apply to list the common stock and warrants on the Nasdaq Capital Market, NASDAQ may decline our application to be listed on such exchange. Further, even if NASDAQ approves the common stock and warrants for listing, there can be no assurance that there will be an active market for our shares of common stock and warrants either now or in the future. If an active and liquid trading market does not develop or if developed cannot be sustained, you may have difficulty selling any of our common stock that you purchase. The initial public offering price for the shares and related warrants will be determined by negotiations between us and the underwriters and may not be indicative of prices that will prevail in the open market following this offering. The market price of our common stock may decline below the initial offering price, and you may not be able to sell your shares of our common stock at or above the price you paid in this offering, or at all.
If and when a larger trading market for our common stock develops, the market price of our common stock is still likely to be highly volatile and subject to wide fluctuations, and you may be unable to resell your shares at or above the price at which you acquired them.
The market price of our common stock is likely to be highly volatile and could be subject to wide fluctuations in response to a number of factors that are beyond our control, including, but not limited to:
· | Variations in our revenues and operating expenses; | |
· | Actual or anticipated changes in the estimates of our operating results or changes in stock market analyst recommendations regarding our common stock, other comparable companies or our industry generally; | |
· | Market conditions in our industry, the industries of our customers and the economy as a whole; | |
· | Actual or expected changes in our growth rates or our competitors’ growth rates; | |
· | Developments in the financial markets and worldwide or regional economies; | |
· | Announcements of innovations or new products or services by us or our competitors; | |
· | Announcements by the government relating to regulations that govern our industry; | |
· | Sales of our common stock or other securities by us or in the open market; and | |
· | Changes in the market valuations of other comparable companies. |
12 |
In addition, if the market for technology stocks or the stock market in general experiences loss of investor confidence, the trading price of our common stock could decline for reasons unrelated to our business, financial condition or operating results. The trading price of our shares might also decline in reaction to events that affect other companies in our industry, even if these events do not directly affect us. Each of these factors, among others, could harm the value of your investment in our common stock. In the past, following periods of volatility in the market, securities class-action litigation has often been instituted against companies. Such litigation, if instituted against us, could result in substantial costs and diversion of management’s attention and resources, which could materially and adversely affect our business, operating results and financial condition.
We do not anticipate paying dividends in the foreseeable future; you should not buy our stock if you expect dividends.
The payment of dividends on our common stock will depend on earnings, financial condition and other business and economic factors affecting us at such time as our board of directors may consider relevant. If we do not pay dividends, our common stock may be less valuable because a return on your investment will only occur if our stock price appreciates.
We currently intend to retain our future earnings to support operations and to finance expansion and, therefore, we do not anticipate paying any cash dividends on our common stock in the foreseeable future.
Investors will incur immediate and substantial dilution as a result of this offering.
Investors purchasing shares of our common stock in this offering will incur immediate and substantial dilution in net tangible book value per share. Assuming a public offering price of $ per share, purchasers of our common stock will effectively incur dilution of $ per share in the net tangible book value of their purchased shares. In addition, purchasers of common stock in this offering will have contributed approximately % of the aggregate price paid by all purchasers of our stock but will own only approximately % of our common stock outstanding after this offering. Furthermore, you may experience further dilution to the extent that shares of our common stock are issued upon the exercise of outstanding stock options and warrants. See “Dilution”.
You may experience additional dilution in the future.
We may acquire other technologies or finance strategic alliances by issuing equity, which may result in additional dilution to our stockholders.
We have broad discretion in the use of the net proceeds from this offering and may not use them effectively.
Our management will have broad discretion in the application of the net proceeds from this offering, including for any of the purposes described in the section of this prospectus entitled “Use of Proceeds.” The failure by our management to apply these funds effectively could harm our business. Pending their use, we may invest the net proceeds from this offering in short-term, investment-grade, interest-bearing securities. These investments may not yield a favorable return to our stockholders.
We could issue “blank check” preferred stock without stockholder approval with the effect of diluting then current stockholder interests and impairing their voting rights, and provisions in our charter documents could discourage a takeover that stockholders may consider favorable.
Our certificate of incorporation authorizes the issuance of up to 10,000,000 shares of “blank check” preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors. Our board of directors is empowered, without stockholder approval, to issue a series of preferred stock with dividend, liquidation, conversion, voting or other rights which could dilute the interest of, or impair the voting power of, our common stockholders. The issuance of a series of preferred stock could be used as a method of discouraging, delaying or preventing a change in control. For example, it would be possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of our company.
FINRA sales practice requirements may limit a stockholder’s ability to buy and sell our stock.
FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will not be suitable for certain customers. FINRA requirements will likely make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may have the effect of reducing the level of trading activity in our common stock. As a result, fewer broker-dealers may be willing to make a market in our common stock, reducing a stockholder’s ability to resell shares of our common stock.
13 |
Unless or until we list our common stock on NASDAQ, our common stock will be deemed a “penny stock,” which makes it more difficult for our investors to sell their shares.
Unless or until our common stock lists on the Nasdaq Capital Market, our common stock is subject to the “penny stock” rules adopted under Section 15(g) of the Exchange Act. The penny stock rules generally apply to companies whose common stock is not listed on a national securities exchange and trades at less than $5.00 per share, other than companies that have had average revenue of at least $6,000,000 for the last three years or that have tangible net worth of at least $5,000,000 ($2,000,000 if the company has been operating for three or more years). These rules require, among other things, that brokers who trade penny stock to persons other than “established customers” complete certain documentation, make suitability inquiries of investors and provide investors with certain information concerning trading in the security, including a risk disclosure document and quote information under certain circumstances. Many brokers have decided not to trade penny stocks because of the requirements of the penny stock rules and, as a result, the number of broker-dealers willing to act as market makers in such securities is limited. If we remain subject to the penny stock rules for any significant period, it could have an adverse effect on the market, if any, for our securities. If our securities are subject to the penny stock rules, investors will find it more difficult to dispose of our securities.
We may not be able to access the equity or credit markets.
We face the risk that we may not be able to access various capital sources including investors, lenders, or suppliers. Failure to access the equity or credit markets from any of these sources could have a material adverse effect on the Company’s business, financial condition, results of operations, and future prospects.
Persistent global economic trends could adversely affect our business, liquidity and financial results.
Although improving, persistent global economic conditions, particularly the scarcity of capital available to smaller businesses, could adversely affect us, primarily through limiting our access to capital and disrupting our clients’ businesses. In addition, continuation or worsening of general market conditions in economies important to our businesses may adversely affect our clients’ level of spending and ability to obtain financing, leading to us being unable to generate the levels of sales that we require. Current and continued disruption of financial markets could have a material adverse effect on the Company’s business, financial condition, results of operations and future prospects.
We may seek or need to raise additional funds. Our ability to obtain financing for general corporate and commercial purposes or acquisitions depends on operating and financial performance, and is also subject to prevailing economic conditions and to financial, business and other factors beyond our control. The global credit markets and the financial services industry have been experiencing a period of unprecedented turmoil characterized by the bankruptcy, failure or sale of various financial institutions. An unprecedented level of intervention from the U.S. and other governments has been seen. As a result of such disruption, our ability to raise capital may be severely restricted and the cost of raising capital through such markets or privately may increase significantly at a time when we would like, or need, to do so. Either of these events could have an impact on our flexibility to fund our business operations, make capital expenditures, pursue additional expansion or acquisition opportunities, or make another discretionary use of cash and could adversely impact our financial results.
Although recent trends point to continuing improvements, there is still lingering volatility and uncertainty. A change or disruption in the global financial markets for any reason may cause consumers, businesses and governments to defer purchases in response to tighter credit, decreased cash availability and declining consumer confidence. Accordingly, demand for our products could decrease and differ materially from their current expectations. Further, some of our customers may require substantial financing in order to fund their operations and make purchases from us. The inability of these customers to obtain sufficient credit to finance purchases of our products and meet their payment obligations to us or possible insolvencies of our customers could result in decreased customer demand, an impaired ability for us to collect on outstanding accounts receivable, significant delays in accounts receivable payments, and significant write-offs of accounts receivable, each of which could adversely impact our financial results.
14 |
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains forward looking statements that involve risks and uncertainties, principally in the sections entitled “Description of Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” All statements other than statements of historical fact contained in this prospectus, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under “Risk Factors” or elsewhere in this Report, which may cause our or our industry’s actual results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements included in this document are based on information available to us on the date hereof, and we assumes no obligation to update any such forward-looking statements.
You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this prospectus. Before you invest in our securities, you should be aware that the occurrence of the events described in the section entitled “Risk Factors” and elsewhere in this Report could negatively affect our business, operating results, financial condition and stock price. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this Report to conform our statements to actual results or changed expectations.
15 |
We plan to retain any earnings for the foreseeable future for our operations. We have never paid any dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future. Any future determination to pay cash dividends will be at the discretion of our Board of Directors and will depend on our financial condition, operating results, capital requirements and such other factors as our Board of Directors deems relevant. In addition, our credit facility restricts our ability to pay dividends.
16 |
We estimate that the net proceeds from the sale of common stock and warrants to purchase common stock offered by us will be approximately $ million, or approximately $ million if the underwriters exercise in full their over-allotment option, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.
We currently intend to use the net proceeds to us from this offering for general corporate purposes, including working capital, product development and marketing activities.
Our management will have broad discretion in the application of the net proceeds from this offering, and investors will be relying on the judgment of our management with regard to the use of these net proceeds. Pending the use of the net proceeds from this offering as described above, we intend to invest the net proceeds in short-term, investment-grade, interest-bearing instruments.
17 |
The
as adjusted net tangible book value of our common stock as of June 30, 2014, was $513,779, or approximately $0.02 per share
based upon 22,028,285 shares of common stock outstanding on such date. As adjusted
net tangible book value per share represents the amount of our total tangible assets
reduced by the amount of our total liabilities, divided by the total number of
shares of common stock outstanding after giving effect to the sale of
shares of the common stock and warrants
to purchase common stock we are offering based upon an assumed combined public offering
price of $ per share and related warrant,
the closing price of our common stock on OTC Bulletin Board on ,
2014, and after deducting underwriting discounts and commissions and estimated offering
expenses of approximately $ million. If
you participate in this offering, your interest will be diluted to the extent of the difference between the offering price per
share and the as adjusted net tangible book value per share of our common stock immediately after completion after this offering.
This represents an immediate increase in as adjusted net tangible book value of $
per share to our existing stockholders and an immediate dilution of $ per
share to investors participating in this offering. The
following table illustrates this dilution on a per share basis to new investors: Each
$1.00 increase (decrease) in the assumed combined public offering price of $ per
share would increase (decrease) the net tangible book value, as adjusted to give effect to this offering, by $
per share and the dilution to new investors by $ per share, assuming that the
number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated
underwriting discounts and commissions. If the underwriters exercise their over-allotment option in full, the net tangible book
value per share of our common stock, as adjusted to give effect to this offering, would be $
per share, and the dilution as adjusted net tangible book value per share to investors in this offering would be $
per share of our common stock. The
table below summarizes as of June 30, 2014, on an as adjusted basis described above, the number of shares of our common stock,
the total consideration and the average price per share (i) paid to us by our existing stockholders and (ii) to be paid
by new investors purchasing shares in our common stock in this offering at an assumed combined public offering price of $
per share and related warrant, the closing price of our common stock on OTC Bulletin Board on ,
2014, before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. The
total number of shares of our common stock reflected in the discussion and tables above is based on
shares of our common stock outstanding, as of June 30, 2014, and excludes: The following table sets forth our cash and cash equivalents
and capitalization as of June 30, 2014: The
information below is illustrative only and our capitalization following the completion of this offering will be adjusted based
on the actual public price. You should read this table together with the sections entitled “Use of Proceeds” and “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” as well as our financial statements and the related
notes, which appear elsewhere in this prospectus. MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS The
following discussion and analysis of the results of operations and financial condition for the three and six months ended
June 30, 2014 and 2013 and fiscal years ended December 31, 2013 and 2012, and should be read in conjunction with our
financial statements, and the notes to those financial statements that are included elsewhere in this
Registration Statement. Overview Nxt-ID,
Inc. (the “Company”) is a Delaware corporation formed on February 8, 2012.
We were initially known as Trylon Governmental Systems, Inc. We changed our name to Nxt-ID,
Inc. on June 25, 2012 to reflect our primary focus on our growing biometric identification,
m-commerce and secure mobile platforms. On or about June 25, 2012,
the Company acquired 100% of the membership interests in 3D-ID LLC (“3D-ID”), a limited liability company formed
in Florida in February 2011 and owned by the Company’s founders. By acquiring 3D-ID,
the Company gained the rights to a portfolio of patented technology in the field of three-dimensional facial recognition and imaging
including 3D facial recognition products for access control, law enforcement and travel and immigration. 3D-ID was an early
stage company engaged in the design, research and development, integration, analysis, modeling, system networking, sales and support
of intelligent surveillance, three-dimensional facial recognition and three-dimensional imaging devices and systems primarily
for identification and access control in the security industries. Since the Company’s acquisition of 3D-ID was a transaction
between entities under common control in accordance with Accounting Standards Codification (“ASC”) 805, “Business
Combinations”, Nxt-ID recognized the net assets of 3D-ID at their carrying amounts in the accounts of Nxt-ID on the date
that 3D-ID was organized, February 14, 2011. We are an early stage technology
company that is focused on developing and marketing products, solutions, and services for organizations that have a need for biometric
secure access control. We have three distinct lines of business that we believe will form our company: law enforcement, m-commerce,
and biometric access control applications. Our initial efforts are focused on our secure products offering for law enforcement,
the Department of Defense, and Homeland Security through our 3D FaceMatch® biometric identification systems. In parallel we
are developing a secure biometric electronic smart wallet for the growing m-commerce market. We believe that this constitutes
unique technology because it takes a very different approach relative to the current offerings: instead of replacing the wallet
through a smartphone, our aim is to improve it. We believe that our Wocket™ will reduce the number of cards carried
in a consumer’s wallet while supporting virtually every payment method currently available at point of sale at retailers
around the world, including magnetic stripe, barcodes and Quick Response (QR) Codes and in the near future near field communications,
all within a secure biometric vault. We have also recently launched a new biometric authentication product named Voicematch®.
This product is a new method of recognizing both speakers and specific words they use providing innovative multi-factor recognition
that is efficient enough to run on low-power devices. Using our biometrics technologies,
we plan to address the growing m-commerce market with our innovative MobileBioÔ
suite of biometric solutions that secure mobile platforms. Currently, most mobile devices continue to be protected
simply by questions that a user asks and PIN numbers. This security methodology is easily duplicated on another device and can
be easily spoofed or hacked. Nxt-ID’s biometric security paradigm is Dynamic
Pairing Codes (DPCs). DPCs are a new, proprietary method to secure users, devices, accounts, locations and servers over any communication
media by sharing key identifiers, including biometric-enabled identifiers, between end-points by passing dynamic pairing codes
(random numbers) between end-points to establish sessions and/or transactions without exposing identifiers or keys. Our plan also
anticipates that we will use our core biometric algorithms to develop a security application that can be used for corporations
(industrial uses, such as enterprise computer networks), as well as individuals (consumer uses, such as smart phones, tablets,
or personal computers). In August 2013, we commenced
a pilot program with the Palm Bay, Florida Police Department to evaluate the potential implementation of our 3D FaceMatch®
biometric facial recognition identification systems. The pilot program is expected to expand to include other law enforcement
agencies connected to 3D-ID’s BioCloud™ to improve identification of previously enrolled (booked) individuals from
multiple law enforcement agencies searching from a common 3D database. We have also hired a former law enforcement officer to
assist with the marketing of these products. We were also invited and have recently demonstrated our products to the Department
of Defense. In addition, we recently
announced a three year distribution and supply agreement for the distribution of the Company’s 3D facial recognition systems
in India and Sri Lanka on an exclusive basis and in the Middle East and Singapore on a non-exclusive basis. To date, our operations have
been funded through sales of our common stock, an initial sale of our 3D facial recognition access control and identification
products, advances from an officer, a loan from Connecticut Innovations, Inc., a quasi-state owned venture capital fund and exercises
of common stock purchase warrants. Our financial statements contemplate the continuation of our business as a going concern. However,
we are subject to the risks and uncertainties associated with an emerging business, as noted above we have no established source
of capital, and we have incurred recurring losses from operations since inception. Results
of Operations Three and six months ended June 30, 2014 compared
with the three and six months ended June 30, 2013 Revenue. There
were no revenues during the three and six months ended June 30, 2014 or the three and six months ended June 30, 2013. In
May 2014, the Company started taking advance orders for the Wocket™ and deliveries are expected to commence in September
2014. Operating Expenses. Operating
expenses for the three months ended June 30, 2014 totaled $1,049,675 and consisted of research and development expenses of $259,847,
selling expenses of $319,073 and general and administrative costs of $470,755. The research and development expenses primarily
related to salaries and consulting services of approximately $179,632, as well as expenses of $75,326 for the development of the
Company’s biometric wallet. Selling expenses consisted of $314,072 primarily for marketing consultants of $132,658 and advertising
and promotion for the pre-orders for the Wocket™ of $166,509. General and administrative
expenses for the period consisted of salaries of $86,097, legal, audit and accounting fees of approximately $88,475 and consulting
fees for public relations of approximately $165,908. Also included is $110,000 in non-cash stock compensation to consultants and
board members. Operating expenses for the
three months ended June 30, 2013 totaled $152,249 and consisted primarily of research and development expenses of $84,225 and
general and administrative costs of $67,535. The research and development expenses mainly related to consulting services for the
design and development of the Company’s biometric wallet. General and administrative expenses for the period consisted of
salaries and payments to consultants for financial consulting and public relations. The increase in expenditure for the three
months ended June 30, 2014 over the same period ended June 30, 2013 is due to the increased level of research and development
activity relating to the development of the Company’s biometric wallet, improving and updating the Company’s 3D facial
recognition system, increased professional fees relating to consultants, increased expenses related to being publicly listed and
increased rent expenses. Operating expenses for the
six months ended June 30, 2014 totaled $1,559,806 and consisted of research and development expenses of $424,126, selling expenses
of $377,603 and general and administrative costs of $758,077. The research and development expenses primarily related to salaries
and consulting services of approximately $341,630, as well as materials of approximately $97,669 necessary for the design, development
and manufacturing of the Company’s biometric wallet, and the reversal of an accrued royalty expense no longer owed by the
Company in the amount of $35,000. Selling expenses consisted of $372,603 primarily for marketing consultants of $177,161 and advertising
and promotion for the pre-orders for the Wocket™ of $166,509. General and administrative
expenses for the period consisted of salaries of $185,597, legal, audit and accounting fees of approximately $159,475 and consulting
fees for public relations of approximately $249,749. Also included is $144,000 in non-cash stock compensation to consultants and
board members. Operating expenses for the
six months ended June 30, 2013 totaled $593,500 and consisted of research and development expenses of $262,007, selling costs
of $5,489 and general and administrative costs of $326,004. The research and development expenses mainly related to the design
and development of the Company’s biometric wallet, including payments of $125,000 to a subcontractor to provide manufacturing
samples of the reprogrammable magnetic stripe for the Wocket™. General and administrative expenses for the period totaled
$326,004. Of this amount, $75,500 was for salaries and $80,000 was for non-cash stock compensation to a board member and to consultants
for marketing and public relations. The increase in expenditure for the six months ended June 30, 2014 over the same period ended
June 30, 2013 is due to the increased level of research and development activity relating to the development of the Company’s
biometric wallet, improving and updating the Company’s 3D facial recognition system, increased professional fees relating
to consultants, increased expenses related to being publicly listed, the addition of sales staff for pre-sales of the Company’s
products and increased rent expenses. Net Loss. The
net loss for the three months ended June 30, 2014 was $2,227,435 including inducement fee in connection with warrant exercise
of $1,177,760. The net loss for the three months ended June 30, 2013 was $156,749, including $4,500 in interest expense for the
loan to the Company from Connecticut Innovations. The net loss for the six months ended June 30, 2014 was $3,822,887, including
$30,744 in interest expense from the loan to the Company from Connecticut Innovations, and an inducement fee in connection with
warrant exercise of $1,177,760. Also included is the unrealized loss on change in fair value of derivatives liabilities that were
initially recorded in connection with the issuance of a convertible note payable and warrants issued in the Company’s private
placement in January 2014. During the six months ended June 30, 2014, the Company recorded an unrealized loss on the change in
fair value of the derivative liabilities of $1,054,577. During the period, the note payable was converted into common stock and
the Company successfully modified the terms of the warrants with each of the holders. As a result, no derivative liabilities exist
as of June 30, 2014. The net loss for the six months ended June 30, 2013 was $601,750, including $8,250 in interest expense for
the loan to the Company from Connecticut Innovations. Year
ended December 31, 2013, compared with the year ended December 31, 2012. Revenue. There
were no revenues during the year ended December 31, 2013. In November 2012, the Company made its initial sale of its 3D facial
recognition access control and identification products and software to an overseas law enforcement agency for approximately $250,000. Operating
Expenses. Operating expenses for the year ended December 31, 2013, totaled $1,435,099 and consisted of research and development
of $518,614, selling expenses of $81,323 and general and administrative costs of $835,162. The research and development expenses
related to salaries and consulting services for the design and development and prototype of the Company’s biometric wallet
of approximately $493,614 and a non-cash incentive stock based compensation to non-executive employees of $25,000. Selling expenses
consisted of $80,835 for consultants and $488 for travel. General and administrative expenses for the period consisted of salaries
and payments to consultants for financial consulting and public relations. This included $286,240 in non-cash stock compensation
to consultants and board members. For
the year ended December 31, 2012, operating expenses totaled $396,888 and consisted of research and development of
$114,269, sales commissions to an overseas distributor of $62,500 and general and administrative costs of $220,119. The research
and development was spent on the completion of a new 3D facial recognition camera and integration with analytical software which
resulted in the sale in November 2012 and preliminary design of the WocketTM. General and administrative costs consisted
of management salaries of $87,500, consulting fees of $60,000, legal and professional fees of $20,800, royalties of $25,000 and
other travel and office expenses. The
increase in expenditures for the year ended December 31, 2013 over the same period ended December 31, 2012 is due to the increased
level of research and development activity relating to the development of the Company’s biometric wallet and improving and
updating the Company’s 3D facial recognition systems and an increase in consulting and professional fees relating to the
public listing of the Company. Net
Loss. The net loss for the year ended December 31, 2013, was $1,544,534, including $17,250 in interest expense for the
loan to the Company from Connecticut Innovations, Inc. (“CI”) and $18,211 in amortization of debt discount. Also included
is the unrealized loss in fair value of the conversion feature of the CI note in the amount of $73,974. The net loss for the year
ended December 31, 2012, was $194,215. Liquidity
and Capital Resources Cash and Working Capital.
We have incurred operating losses of $1,559,806 and $1,049,675 for the six and three months ended June 30, 2014, respectively.
We have incurred net losses of $3,822,887 and $2,227,435 for the six and three months ended June 30, 2014, respectively. As of
June 30, 2014, the Company had cash and stockholder’s equity of $588,179 and $513,779, respectively. As of June 30, 2014
the Company had working capital of $490,570. Cash Used in Operating
Activities . Our primary ongoing uses of operating cash relate to payments to subcontractors and vendors for research
and development, salaries and related expenses and professional fees. The timing of such payments is generally even throughout
the year. Our vendors and subcontractors generally provide us with normal trade payment terms. During the six months ended June
30, 2014, net cash used in operating activities amounted to $1,664,554 comprised of net loss of $3,822,887, positive adjustments
to reconcile net loss to net cash used in operating activities of $2,404,352 and changes in operating assets and liabilities of
negative $246,019, compared to net cash used in operating activities for the six months ended June 30, 2013 of $304,435 comprised
of a net loss of $601,750, positive adjustments to reconcile net loss to net cash used in operating activities of $80,198 and
changes in operating assets and liabilities of $217,117. Cash Used in Investing Activities .
During the six months ended June 30, 2014, net cash used in investing activities amounted to $20,887 comprised of the purchases
of equipment of $16,735 and changes in restricted cash of $4,152. During the six
months ended June 30, 2013, the Company used no cash for investing activities. Cash Provided
by Financing Activities . During the six months ended June 30, 2014, the Company received net proceeds of $1,969,994
from the issuance of common stock and warrants and the exercise of warrants . During the six months
ended June 30, 2013, the Company received $246,000 from the issuance of common stock and the second and final tranche of
a loan from Connecticut Innovations in the amount of $75,000. The Company also received an aggregate of $64,000 in
cash advances from an officer of the Company and made aggregate repayments of $60,000. The advances are non-interest bearing
and short-term in nature. Sources of Liquidity .
We are an early stage entity and incurred net losses of $3,822,887 during the six months ended June 30, 2014, which included an
aggregate $2,404,352 of non-cash charges. As of June 30, 2014, the Company had working capital and stockholders’ equity
of $490,570 and $513,779, respectively. In order to execute the Company's
long-term strategic plan to develop and commercialize its core products, the Company will need to raise additional funds through
public or private equity offerings, debt financings, or other means. The Company can give no assurance that additional funds will
be available on reasonable terms, or available at all, or that it will generate sufficient revenue to alleviate the going concern.
These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability
to execute its business plan is dependent upon its ability to raise additional equity, secure debt financing, and/or generate
revenue. Should the Company not be successful in obtaining the necessary financing, or generate sufficient revenue to fund its
operations, the Company would need to curtail certain of its operational activities. The accompanying financial statements do
not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Off
Balance Sheet Arrangements We
do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured
finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements
or other contractually narrow or limited purposes. In addition, we do not have any undisclosed borrowings or debt, and we have
not entered into any synthetic leases. We are, therefore, not materially exposed to any financing, liquidity, market or credit
risk that could arise if we had engaged in such relationships. Subsequent
Events The
Company evaluates events that have occurred after the balance sheet date but before the condensed consolidated financial statements
are issued. Between
June 12, 2014 and June 17, 2014, the Company completed a
private offering of warrants to purchase common stock (the “Offering”) with a group of accredited investors,
who had previously participated in the Company’s private offering that had occurred between December 30, 2013 and
January 13, 2014 (the “Purchasers”) for total net proceeds to the Company of $4,000. Pursuant to a securities
purchase agreement with the Purchasers (the “Purchase Agreement”), the Company issued to the Purchasers warrants
(the “Warrants”) to purchase an aggregate of 400,000 shares (the “Warrant Shares”) of our Common
Stock at an exercise price of $3.00 per share. The Warrants are exercisable for a period of five years from the
original issue date. The exercise price for the Warrants is subject to adjustment upon certain events, such as stock splits,
combinations, dividends, distributions, reclassifications, mergers or other corporate changes. If exercised, the
Warrants will provide the Company with gross proceeds of approximately $1.2 million. The Company determined that the
effect of the issuance of the warrants was to induce the Purchasers to exercise warrants previously issued to them in the
Offering and thus accounted for the issuance as an inducement. During
the three months ended June 30, 2014 the Company received $1,200,000 in connection with the exercise of 400,000 warrants into
400,000 shares of common stock at an exercise price of $3.00 per share. Upon exercise, pursuant to the Purchase Agreement, the
Company’s Founders agreed to cancel a corresponding number of shares to be cancelled for each Warrant Share issued. As a
result, the Founders returned
to the Company and the Company retired 400,000 shares of common stock. Critical
Accounting Policies The
following discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements,
which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain
accounting policies and estimates are particularly important to the understanding of our financial position and results of operations
and require the application of significant judgment by our management or can be materially affected by changes from period to
period in economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree
of uncertainty. In applying these policies, our management uses their judgment to determine the appropriate assumptions to be
used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans
and projected financial results, our observance of trends in the industry and information available from other outside sources,
as appropriate. Please see Note 3 to our consolidated financial statements for a more complete description of our significant
accounting policies. We
intend to utilize the extended transition period provided in Securities Act Section 7(a)(2)(B) as allowed by Section 107(b)(1)
of the JOBS Act for the adoption of new or revised accounting standards as applicable to emerging growth companies. As part of
the election, we will not be required to comply with any new or revised financial accounting standard until such time that a company
that does not qualify as an “issuer” (as defined under Section 2(a) of the Sarbanes-Oxley Act of 2002) is required
to comply with such new or revised accounting standards. As
an emerging growth company within the meaning of the rules under the Securities Act, and we will utilize certain exemptions from
various reporting requirements that are applicable to public companies that are not emerging growth companies. For example, we
will not have to provide an auditor’s attestation report on our internal controls in future annual reports on Form 10-K
as otherwise required by Section 404(b) of the Sarbanes-Oxley Act. In addition, Section 107 of the JOBS Act provides that an emerging
growth company can utilize the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with
new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until
those standards would otherwise apply to private companies. We have elected to utilize this extended transition period. Our financial
statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards as
they become applicable to public companies. Basis
of Presentation. The Company’s consolidated financial statements have been prepared in conformity with accounting principles
generally accepted in the United States which contemplate continuation of the Company as a going concern. However, the Company
is subject to the risks and uncertainties associated with a new business, has no established source of revenue, and has incurred
significant losses from operations since inception. The Company’s operations are dependent upon it raising additional capital.
These matters raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial
statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts
and classification of liabilities that could result from the outcome of this uncertainty. Principles
of Consolidation. The consolidated financial statements include the accounts of Nxt-ID and its wholly-owned subsidiary, 3D-ID.
Intercompany balances and transactions have been eliminated upon consolidation. Research
and Development. Research and development costs consist of expenditures incurred during the course of planned research and
investigation aimed at the discovery of new knowledge, which will be useful in developing new products or processes. The Company
expenses all research and development costs as incurred. Convertible
Instruments. The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from
equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to bifurcate
conversion options from their host instruments and account for them as free standing derivative financial instruments according
to certain criteria. The criteria includes circumstances in which (i) the economic characteristics and risks of the embedded derivative
instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (ii) the hybrid
instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under
otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and
(iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.
The derivative is subsequently marked to market at each reporting date based on current fair value, with the changes in fair value
reported in the results of operations. Conversion
options that contain variable settlement features such as provisions to adjust the conversion price upon subsequent issuances
of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract generally result
in their bifurcation from the host instrument. The
Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should
not be bifurcated from their host instruments in accordance with ASC 470-20 “Debt with Conversion and Other Options”.
The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in
debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the
note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized
over the term of the related debt. Derivative
Financial Instruments. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign
currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain
features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the
derivative instrument is initially recorded at its fair value and is then re-valued at the reporting date, with changes in the
fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company
uses the Black-Scholes option valuation model to value the derivative instruments at inception and on subsequent valuation dates.
The conversion feature embedded within Company’s convertible note payable does not have fixed settlement provisions as the
conversion price varies based on the trading price of the Company’s common stock and the potential number of common shares
to be issued upon conversion is indeterminable up to a maximum of 120,000 shares of common stock. In addition, the warrants issued
in connection with the Offering (as defined in Note 8) do not have fixed settlement as their exercise prices may be lowered if
the Company conducts an offering in the future at a price per share below the exercise price of the warrants. Accordingly, the
conversion feature and warrants have been recognized as derivative instruments. Although the Company determined the conversion
feature and warrants both include an implied downside protection feature, it performed a Monte-Carlo simulation and concluded
that the difference in value between the Monte-Carlo simulation and the Black-Scholes valuation model is de minimis and the use
of the Black-Scholes valuation model is considered to be a reasonable method to value each instrument. The classification of derivative
instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each
reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether
or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Debt
Discount and Amortization of Debt Discount. Debt discount represents the fair value of embedded conversion options of various
convertible debt instruments and attached convertible equity instruments issued in connection with debt instruments. The debt
discount is amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt, using the straight-line method
which approximates the interest method. The amortization of debt discount is included as a component of other expenses in the
accompanying statements of operations. MARKET
PRICE OF AND DIVIDENDS ON OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS Market
Information Our
common stock trades on the OTC Bulletin Board under the symbol NXTD. The OTC Bulletin Board is a quotation service that displays real-time
quotes, last-sale prices, and volume information in over-the-counter (“OTC”) equity securities. An OTC Bulletin Board equity
security generally is any equity that is not listed or traded on a national securities exchange. In conjunction with this
offering, we have applied to list the common stock and warrants on the Nasdaq Capital Market under the symbols
“NXTD” and “NXTDW”, respectively. Price
Range of Common Stock The
following table shows, for the periods indicated, the high and low bid prices per share of our common stock as reported by the
OTC Bulletin Board quotation service. These bid prices represent prices quoted by broker-dealers on the OTC Bulletin Board quotation service. The quotations
reflect inter-dealer prices, without retail mark-up, mark-down or commissions, and may not represent actual transactions. ________________________________ Holders
of Common Stock As of August 12, 2014, there
were approximately 67 stockholders of record. Because shares of our common stock are held by depositaries, brokers and other
nominees, the number of beneficial holders of our shares as of May 23, 2014 was 1,628. On August 12, 2014, the last reported
sale price per share for our common stock as reported by the OTC Bulletin Board quotation service was $3.49 per
share. Dividends We
have not declared or paid any cash dividends on our common stock, and we do not anticipate declaring or paying cash dividends
for the foreseeable future. We are not subject to any legal restrictions respecting the payment of dividends, except that we may
not pay dividends if the payment would render us insolvent. Any future determination as to the payment of cash dividends on our
common stock will be at our board of directors’ discretion and will depend on our financial condition, operating results,
capital requirements and other factors that our board of directors considers to be relevant. Equity
Compensation Plan Information as of December 31, 2013 ________________________________ Our Company We
are an early stage technology company that is focused on products, solutions, and services that have a need for biometric secure
access control. We have three distinct lines of business that we are currently pursuing: mobile commerce (“m-commerce”),
law enforcement and biometric access control applications. Our initial efforts have primarily focused on the development of our
secure products for the growing m- commerce market, most immediately, a secure mobile electronic smart wallet. Wocket™
is a smart wallet, the next evolution in smart devices following the smart phone and smart watch, designed to protect your identity
and replace all the cards in your wallet, with no smart phone required. Wocket™ works anywhere credit cards are accepted
and only works with your biometric stamp of approval. Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency,
medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records,
coupons, etc. and 100 voice commands can also be stored on Wocket™. Our plan also
anticipates that we will use our core biometric facial and voice recognition algorithms to develop security applications (both
cloud based and locally hosted) that can be used for corporations (industrial uses, such as enterprise computer networks) as well
as individuals (consumer uses, such as smart phones, tablets or personal computers). Finally, our plan calls for a suite of high
level security products and facial recognition applications that can be utilized by law enforcement, the defense industry, and
the U.S. Department of Homeland Security. We
believe that our MobileBioTM products, together with our biometric security solutions, will provide distinct
advantages within these markets by improving mobile security. Currently most mobile
devices continue to be protected simply by questions that a user asks, and PIN numbers. This security methodology is
easily duplicated on another device, and can be easily spoofed or hacked. Nxt-ID’s
biometric security paradigm is Dynamic Pairing Codes (DPC). DPC are a new, proprietary method to secure users, devices,
accounts, locations and servers over any communication media by sharing key identifiers, including biometric-enabled
identifiers, between end-points by passing dynamic pairing codes (random numbers) between end-points to establish sessions
and/or transactions without exposing identifiers or keys. The recent high-level breaches of personal credit card data raises
serious concerns among consumers about the safety of their money. These consumers are also resistant to letting technology
companies learn even more about their personal purchasing habits. The
Company also plans to service the access control and law enforcement facial recognition markets with our existing 3D facial recognition
technology products beginning with U.S. federal and state governmental agencies. These products, whose underlying technologies
have been licensed by the Company, provide customers with the capability to enroll subjects in a 3D database and use that database
for verification of identities. During 2012, the Company acquired 100% of the membership interests in an entity affiliated with
its founders as a means toward advancing its business plan. Wocket™ We
believe that many credit card holders either do not possess a smartphone or will be reluctant to use their smartphone for mobile
payments. Nxt-ID has developed a separate physical electronic smart wallet that is intended to hold information from credit cards,
debit cards, loyalty cards, identification cards, and virtually any magnetic stripe card to allow the owner of the card to configure
a single, dynamic, electronic card to replicate any of the copied cards and thereby reduce the number of physical cards carried
in a wallet. As designed, users will simply scan in each card, slide through each of the scanned “soft-cards” via
a touch screen display and select the card the user wishes to program. The resultant electronic card can then be swiped just like
a regular credit, debit, or virtually any other card. The system consists of 2 devices: an electronic smart wallet “wocket”
and a dynamic smart card. The electronic smart wallet will be secured by biometric identification and will also have a range of
accessories that allow the user to carry a driver’s license and cash in the same device, replacing the wallet altogether.
We have completed the design stage of the Wocket™ and prototypes are currently being fabricated. Wocket™ prototype Our
current plans call for us to commence manufacturing the product in late September 2014. MobileBio
VoiceMatch® Voicematch®
is a new method of recognizing both speakers and specific words providing innovative multi-factor recognition. Voice
authentication is a more natural biometric method of authentication than fingerprint that allows an individual access to
multiple devices. Voicematch is efficient enough to run on low-power devices and runs or will run on
mobile platforms such as Android and iOS, as well as laptops and desktops. The product helps to address the growing BYOD
(Bring your own device) problem for corporations by positively identifying the individual using the mobile device. Voicematch
is a potential original equipment manufacturer (“OEM”) product for Smartphone manufacturers. The product will
also be sold as a standard development kit (“SDK”) to provide corporations the opportunity to add a further
layer of biometric protection to their websites and smartphone applications for their customers. The
Company’s business plan anticipates that sales will commence in the first half of 2015, although no assurance can be
provided of this. FaceMatch® FaceMatch®
is intended to serve as a modular facial recognition system for smartphones, tablets, laptop and desktop computers. FaceMatch®,
depending on the number of cameras available and level of security desired, will use 2D, partial 3D or 3D facial recognition algorithms
to allow the user access to their device. As being developed, the software is intended to be hosted on the device or through a
cloud computing solution. The software will also be designed to be available as an “app” on the iPhone and Android
platforms, although there are presently no definitive agreements in place with either of the sponsors of those platforms. The
FaceMatch® app will not retain any personal information on the user. The FaceMatch® app is near the completion of its
development for desktop and laptop use. The development work for the FaceMatch® app for tablet and smartphone use has not
yet begun but will use the same basic technology. Our current plans assume that sales from this product will commence during the
4th Quarter of 2014, although no assurances can be provided of this. Through
the acquisition of 3D-ID LLC, the Company acquired 3D FaceMatch® and 3D SketchArtist™ facial recognition products which
are available for sale. These products are primarily designed for access control, law enforcement and travel and immigration
in contrast to the MobileBio™ products which are designed for individual security on mobile devices. 3D
FaceMatch® Biometric Identity Systems The
ActiveID Biometric Identity System is a completely modular and field proven identity management platform providing fusion of 3D
facial recognition, 2D facial recognition and optional fingerprint biometrics. Available as a standalone solution or readily integrated
into national scale systems for travel and immigration, access control and law enforcement, ActiveID products feature patented
FaceMatch® 3D facial recognition. A
complete ActiveID solution includes: 1) one or more Enrollment Systems including integrated lighting for high-quality mug shot
or passport imagery; 2) databases containing enrolled 3D facial templates, 2D images, application-tailored personal data, and
optional fingerprints; and 3) one or more Verifier and/or Identifier stations to determine identities. Duplicate ID/imposter searches
can be performed at any step. Except
for the Biometric Camera hardware, all products consist of software running on industry-standard encrypted networks, databases,
and computers. All software is easily customized to support specific process needs, and several pre-configured solutions are available
including prisoner management, facility access control, and fused face/fingerprint verification. 3D
SketchArtist™ 3D
SketchArtist™ is a 3D software face composite sketch tool that makes sketching a face simple, fast, and realistic. Using
patented 3D morphing technology, law enforcement professionals can now sketch an accurate composite with 3D life-like features.
3D SketchArtist™ transforms ordinary sketches into rapidly evolving mock-ups that can be modified with a simple click of
the mouse. Facial features, poses, expressions, and even lighting can be modified to reflect a witness description in mere seconds.
3D SketchArtist™ is user-friendly so that anyone can use it to render accurate composites of a suspect, quickly and easily.
What once could only be performed by professional sketch artists can now be performed with minimal training. Our Corporate
History We
were incorporated in the state of Delaware on February 8, 2012. We are a technology company with particular core competencies
in biometrics that is targeting the growing m-commerce market with our innovative MobileBio™ suite
of biometric solutions that are intended to secure mobile platforms. Our MobileBio™ solutions are intended to provide
distinct advantages within these markets by filling a gap left by traditional biometric solutions that either are physically integrated
and thus, not flexible or versatile, or provide poor interoperability between different mobile devices and insecure remote services.
The Company also plans to serve the access control and law enforcement facial recognition markets. Effective
June 25, 2012, the Company acquired 100% of the membership interests in 3D-ID,
LLC (“3D-ID”), a limited liability company formed in Florida in February 2011 and owned by the Company’s
founders. Since this was a transaction between entities under common control, in accordance with Accounting Standards Codification
(“ASC”) 805, “Business Combinations”, Nxt-ID recognized the net assets of 3D-ID at their carrying amounts
in the accounts of Nxt-ID on the date that 3D-ID was organized, February 14, 2011. Our corporate headquarters are in Shelton,
CT. Gino
Pereira and David Tunnell, the founders of Nxt-ID, were an integral part of the senior management teams at Technest Holdings,
an OTC Bulletin Board public company, and its subsidiary Genex Technologies. Genex Technologies was founded in 1995 to develop
and commercialize the unique Rainbow® method of capturing 3D data. Since its founding Genex has developed into one of the
market leaders in advanced imaging, including 3D and 360-degree technologies. Genex
has developed innovative technologies and products for all aspects of imaging, including capture, processing, display, and enhancement.
Genex’s products range from 3D cameras to surveillance algorithms to integrated facial recognition systems. Genex
and Technest have won awards from the Department of Defense, National Institutes of Health (“NIH”), National Institute
of Standards and Technology (“NIST”) and National Science Foundation (“NSF”) amounting to over $30 million
in support of this technology. Nxt-ID
has licensed all the Technest/Genex technology (exclusively in Federal, State and Municipal applications) through the acquisition
of 3D-ID to provide a product portfolio and a strong technical foundation for its further development efforts. In
addition, Nxt-ID has also licensed on a non exclusive basis, distribution, manufacturing rights and know-how from Geometrix, a
leading 3D imaging company using a different technical approach to Technest. This technology performed very favorably at the Face
Recognition Vendor Test conducted by NIST. Nxt-ID
also has key scientific and engineering personnel that have had key roles in the development of these technologies and have an
important intellectual knowledge base that the Company intends to leverage. Our Industry The 2013 Federal Reserve Payments Study reported that there
were 775.4 million general-purpose cards in force nationally in 2012. Of these cards, only 47.1 million were estimated to have
security chips on them. Some
experts believe that in the foreseeable future most people will have embraced and fully adopted the use of smart-device swiping
for purchases they make, nearly eliminating the need for cash or credit cards. These experts feel that the explosive growth in
the use of smartphones and other mobile devices, combined with the convenience, security, and other affordances of mobile payments
systems, makes these systems an obvious choice to replace established modes of payment in day-to-day commerce. Others
who do not agree with this scenario say cash and credit cards will remain the dominant method of carrying out transactions in
advanced countries because the security implications raise too many concerns among consumers about the safety of their money.
These consumers are also resistant to letting technology companies learn even more about their personal purchasing habits. We
believe that credit and debit card fraud will continue to be of concern to holders, even if the number of credit card holders/users
continues to grow and with it the number of credit card transactions. We believe there is a significant segment of this market
that either does not possess a smartphone or will be reluctant to use their smartphone for mobile payments due to a variety of
reasons including: limited battery life; dependency on wireless network coverage; and well publicized security threats. Rather
than depend solely on a smart phone, Nxt-ID’s business plan is to develop a next generation electronic smart wallet. We
believe that this constitutes unique technology because it takes a very different approach relative to the current offerings:
instead of replacing the wallet, our aim is to improve it. We believe that our Wocket™ will reduce the number of
cards to be carried in a consumer’s wallet while capable of supporting most payment methods currently available at Point-of-Sale
(POS) retailers around the world including magnetic stripe, bar codes and QR codes in the near future, Near Field Communications
(NFC) all within a secure biometric vault. We believe that we can encourage individuals who are reluctant to use a smartphone
for mobile payments to utilize an electronic wallet based on the security offerings that we plan to embed in this product. Each
year approximately 12 million people in the United States are victims of identity theft and 44% of known causes of identity theft
can be traced to a lost or stolen wallet or purse. We believe that Wocket™ can
significantly reduce the incidence of identity theft by concealing the cardholders personal information on a tamper proof secure
chip on the Wocket that can only be accessed by a voice biometric or PIN. Furthermore, the Wocket Card does not retain any information
after the card has been swiped so, unlike the loss or theft of a wallet, the loss or theft of a Wocket or Wocket Card does not
lead to a breach of personal information. The
mobile phone worldwide market is presently approximately 1.8 billion units per year. Of that amount smart phones represent a large
and growing segment of the market. Smart phones also typically serve as portable media players and camera phones with high-resolution
touchscreen displays and web browsers that can access and properly display standard web pages, GPS navigation, Wi-Fi and mobile
broadband access. We
believe that our MobileBio™ cell phone facial and voice recognition opportunity, once developed, will address a worldwide
market of smart phones sales, which we believe is continuing to grow. We anticipate partnering with application providers on smartphones
that have an interest in additional security for their particular application by using 3D facial and/or voice recognition on their
smartphone to gain access to a particular application; for example, touchless payment applications, banking applications and securities
trading applications. Other
Uses for Facial Recognition Technology Biometric
identifiers have long been used by governments and commercial enterprises to verify a person’s identity. Signatures
are an example of a behavioral biometric that has been used for centuries. With the advent of the photograph, the first paper-based
physiological biometric technique was developed to verify a person’s identity. Photographs on passports and drivers licenses
are obvious examples of early biometric features added to government-issued identity documents. On
the other hand, law enforcement agencies have routinely used fingerprints to positively identify suspects of a crime. In the 1990s,
the use of fingerprints for criminal systems entered the digital age when the FBI awarded a contract to a team of Martin Marietta,
Sagem Morpho, and Calspan (later known as the Lockheed Martin team) to build an electronic storage and search system that incorporated
fingerprint files (or Integrated Automated Fingerprint Identification System - IAFIS), replacing the paper files. By capturing
biometric information electronically and storing the files within a secure network for over 10 years, the U.S. government has
been creating the foundation for greater use of biometrics in government and commercial activities. However,
terrorists and other criminals are now more capable of subverting traditional paper-based security measures through improved forgery
and information-sharing technology and techniques. Furthermore, the evolution of the internet and the subsequent deviation from
paper-based data storage and processes to electronic-based systems has opened the door to increased identity theft and other fraudulent
activities within the commercial world. In
order to address deficiencies in current security systems used, we intend to market products that can be used by both government
and commercial consumers as a viable, more powerful alternative to security measures currently being used by them. Nxt-ID believes
that its products will contain the necessary security solutions to cover both consumer preferences with MobileBio FaceMatch®
and the Wocket™ and government and commercial needs with its 3D facial recognition access control products. Our
Competition The
markets for our products are extremely competitive and are characterized by rapid technological change as a result of technical
developments exploited by our competitors, changing technical needs of customers, and frequent introductions of new features.
We expect competition to increase as other companies introduce products that are competitively priced, that may have increased
performance or functionality, or that incorporate technological advances not yet developed or implemented by us. Some of our present
and potential competitors may have financial, marketing, and research resources substantially greater than ours. Competitors
in the digital wallet marketplace include: Google
Wallet – A mobile payment system developed by Google that allows its users to store debit cards, credit cards, loyalty
cards, and gift cards among other things, as well as redeeming sales promotions on their mobile phone. Paypal
– A mobile service that can send money between other PayPal users and friends, track your balances, check in to pay
from ones phone, and order ahead at restaurants. Square
wallet – Links user credit card to its app, but instead of paying directly with the credit card, it requires the use
of merchant cards, which limits its usage to only certain merchants. Because it is location based, the store knows you’re
ordering something and will charge it to the card linked on your Square account. Isis
– A mobile app that lets a user store virtual versions of nearly everything in ones wallet, on ones smartphone. It uses
NFC technology for contactless payments. Lemon
Wallet – A mobile app that allows users to store debit, credit, ID, insurance member and loyalty cards. The app turns
that information into a barcode to be scanned by merchants. Users can also connect payment cards to their bank allowing users
to check their balance and make transactions from within the app. This company was recently acquired by Lifelock. All
of the above products rely on the use of a smartphone. The fundamental competitive advantage of the Wocket is that it is not smartphone
dependent and is as simple to use as the swipe of a credit card. It will work in situations where there is no cell phone signal
or internet connectivity. In addition the Wocket features biometric and other security features not available on a smartphone. There
are a number of suppliers of biometric products that deliver to the market place presently. One of the largest suppliers is L1
Identity Solutions, which has primarily concentrated its prior efforts in the government and corporate sectors. L1 is a vertically
integrated biometric solutions provider with a large established base of business and it has well developed government marketing
channels. The Company was sold to Safran in 2010. Another established supplier is Cognitec, a German facial recognition company,
with worldwide distribution. Google
and Apple are developing facial recognition applications for smartphones. The Google app can currently be fooled by using a photograph
of the user. Apple is using a 2D to 3D conversion model which holds better promise but this is already a heavily patented area. Rather
than competing directly against these well-established entities, Nxt-ID’s plans to develop and foster market niches that
would serve affordable lower priced retail consumer, small business biometric applications and end users not necessarily involved
in large enterprise activities. We believe that our MobileBio™ technology that we are developing is the key to differentiating
our solutions to the end user by providing what we maintain is a true end-to-end security offering using our patent-pending dynamic
pairing codes that dynamically utilize identifiers that uniquely identify the user, device, manufacturer, account, location, and
session or transaction, the combination of which changes periodically in real-time among all points along the communication path
so that communication and data is protected 100% of the time. The biosensors that we are developing are intended to integrate
with multiple devices, apps, users, operating systems, firmware, remote services and virtually any “entities” so that
intercommunications with all entities, local or remote, are protected. One of the major areas of concern with facial recognition
is user privacy with most companies utilizing private data for other marketing purposes. The Nxt-ID apps will not sell or share
any personal information on the user. Nxt-ID
plans to offer what we believe to be unique features that will include cloud-based identity and authentication MobileBio™
management services that secure biometric authentication across mobile devices, as well as a new, innovative Facial Recognition
technology and a physical alternative to current e-wallets that are embedded in smartphones. The
value proposition that we plan to offer customers with our versatile, simple MobileBio™ technology is complete interoperability
of sensors with mobile applications and cloud-based services, which will secure the mobile money/m-commerce market by filling
a versatility and flexibility gap in lacking with current solutions. In
order to compete effectively in this environment, our plan is to continually develop and market new and enhanced products at competitive
prices, and have the resources to invest in significant research and development activities. There is a risk that we may not be
able to make the technological advances necessary to compete successfully. Existing and new competitors may enter or expand their
efforts in our markets, or develop new products to compete against ours. Our competitors may develop new technologies or enhancements
to existing products or introduce new products that will offer superior price or performance features. New products or technologies
may render our products obsolete. Many of our primary competitors are well-established companies that have substantially greater
financial, managerial, technical, marketing, personnel and other resources than we do. Our Business
Strategy Against
the backdrop of challenges with identification of individuals, more and more mobile phones are being used as a source of payment
for goods and services. Our business is premised on the belief that worldwide mobile payment volume will continue to grow rapidly
in the upcoming years. Many global companies have announced plans for mobile payments including AT&T, Sprint, Verizon, T-Mobile,
Google, Visa, MasterCard, American Express, Discover, Bank of America, Barclays, RIM and others. The risks and concerns
of fraud accompanying the introduction of these potential applications are financially enormous and could hamper the growth of
this budding industry. As a result of these concerns, the Company believes that the “m-commerce/mobile money” market
is positioned to grow rapidly. We
intend to initially market the Wocket™ to colleges. Students are traditionally early technology adopters and the college
environment has a need for simplification of the methods for students to both make payments and gain access to restricted environments
on campus through easy to use improved security. Thereafter
we will expand our reach through distinct channel partners that have a large body of members or subscribers that have a need for
secure transactions and identity protection. Concurrently, we will market the Wocket™ directly to consumers through internet
marketing. Worldwide,
government agencies, financial, corporate and industrial entities are investing a considerable amount of resources into improving
security systems as a result of ongoing security breaches which accompany acts of terrorism, financial and resource thefts that
dangerously expose flaws and weaknesses in today’s safety mechanisms. Badge or password-based authentication procedures
are too easy to hack. Biometrics represents a viable and robust alternative but also has potential for drawbacks as well; for
example, iris scanning, while very reliable is considered too intrusive; fingerprints are socially accepted, but not applicable
to non-consenting individuals and have proven to be fooled. Alternatively, facial recognition represents a good compromise between
what’s socially acceptable and what’s reliable, even when operating under controlled conditions. We believe that facial
recognition has emerged as one of the fastest growing technologies among the biometric technologies accepted worldwide. Facial
recognition is applicable to both verification and identification. In addition, it is the only biometric system that can routinely
be used in a covert manner for surveillance of uncooperative individuals as a person’s face is easily captured at a distance
by video technology with or without consent. Based
on our anecdotal analysis of certain macro trends, we believe that the world-wide facial recognition market for all applications
of the technology grow for the foreseeable future as consumers come to understand and adapt biometric technologies as a preferred
manner for security, particularly mobile security. We believe that 3D facial recognition technology will gain traction for access
control and is already being used by organizations with a high traffic volume to quickly, easily and securely authenticate users.
Currently, 2D facial recognition is used primarily by law enforcement officials to identify someone by comparing their 2D image
against a large database of pictures, whereas 3D facial recognition is designed primarily for verification - to confirm that someone
is exactly whom they say they are. 3D face readers can also be used with PINs, access control cards and other biometric factors
for multifactor authentication. 3D face recognition is as fast and accurate as fingerprint technology and is ideal in situations
where workers’ hands are full or dirty, or where employees wear gloves or other applications where fingerprints would be
inconvenient or difficult to obtain. Nxt-ID
plans call for the positioning of its products to have applications in markets as diverse as Military and Homeland Defense, Law
Enforcement, Commercial and Consumer. For
sales to the Department of Defense, Nxt-ID is partnered with established Prime Contractors that have or are bidding for Contact
vehicles through which sales may be made. Our current Partners include Battelle Memorial Institute and Verizon Federal Systems. We
currently plan for our sales to Law Enforcement Agencies to be made through distributors. Our management has several key relationships
from past engagements that it is pursuing. We
intend to market the MobileBio VoiceMatch and FaceMatch® product to application providers on iPhone and Android devices that
have a need to increased security because of the nature of the application. To make potential buyers aware of the product the
Company will use social networks, such as Twitter, Facebook and YouTube as well as traditional PR. Our Intellectual
Property Our
ability to compete effectively depends to a significant extent on our ability to protect our proprietary information. We currently
rely and will continue to rely primarily on patents and trade secret laws and confidentiality procedures to protect our intellectual
property rights. We have filed two patents based on the Wocket™ and Dynamic Pairing Codes (DPC) a proprietary method used
by the Company to secure users, devices, accounts, locations and servers over any communication media by sharing key identifiers,
including biometric-enabled identifiers, between end-points by passing dynamic pairing codes (random numbers) between end-points
to establish sessions and/or transactions without exposing identifiers or keys. We are currently in the process of applying for
our third patent on multi-factor voice authentication. Subsequent
to the acquisition of 3D-ID, we licensed sixteen (16) U.S. patents. We enter into confidentiality agreements with our consultants
and key employees, and maintain control over access to and distribution of our technology, software and other proprietary information.
The steps we have taken to protect our technology may be inadequate to prevent others from using what we regard as our technology
to compete with us. We
do not generally conduct exhaustive patent searches to determine whether the technology used in our products infringes patents
held by third parties. In addition, product development is inherently uncertain in a rapidly evolving technological environment
in which there may be numerous patent applications pending, many of which are confidential when filed, with regard to similar
technologies. We
may face claims by third parties that our products or technology infringe their patents or other intellectual property rights
in the future. Any claim of infringement could cause us to incur substantial costs defending against the claim, even if the claim
is invalid, and could distract the attention of our management. If any of our products are found to violate third-party proprietary
rights, we may be required to pay substantial damages. In addition, we may be required to re-engineer our products or seek to
obtain licenses from third parties to continue to offer our products. Any efforts to re-engineer our products or obtain licenses
on commercially reasonable terms may not be successful, which would prevent us from selling our products, and in any case, could
substantially increase our costs and have a material adverse effect on our business, financial condition and results of operations. Licensed
Patents Employees As
of August 1, 2014, we had a total of 10 full-time employees, 8 in product engineering and 2 in administration and
finance. None of our employees is represented by a collective bargaining agreement, nor have we experienced any work
stoppage. We consider our relations with our employees to be good. Our future success depends on our continuing ability to
attract and retain highly qualified engineers, graphic designers, computer scientists, sales and marketing and senior
management personnel. In addition, we have independent contractors whose services we are using on an as-needed basis to
assist with the engineering and design of our products. DIRECTORS
AND EXECUTIVE OFFICERS Our
directors, executive officers and key employees are listed below. The number of directors is determined by our board of directors.
All directors hold office until the next annual meeting of the board or until their successors have been duly elected and qualified.
Officers are elected by the board of directors and their terms of office are, except to the extent governed by employment contract,
at the discretion of the board of directors. Gino
M. Pereira, one of our co-founders, has served as the Chief Executive Officer, Chief Financial Officer and director, from
the date of inception of the Company. Mr. Pereira has over 30 years of executive, operational and financial experience with technology
companies in the United States, Europe and the Far East. He has also helped to develop several technology start-ups as well as
served in an executive capacity in a large multinational public company. Mr. Pereira was Chief Financial Officer and later Chief
Executive Officer of Technest Holdings Inc., a publicly quoted defense contracting company, from 2004 to 2011. Technest Holdings
operated subsidiaries EOIR Technologies, Inc. and Genex Technologies, Inc. Mr. Pereira is a Fellow of the Chartered Association
of Certified Accountants (UK) and has an MBA, with a specialty in finance, from the Manchester Business School in England. Mr.
Pereira brings to the Board significant expertise in the biometric and software recognition industries, as well as experience
in international business technology and extensive management and operating experience. Having founded and/or operated companies
in similar or related industries during the past 15 years, provides the board with unparalleled knowledge of the Company and its
operations and an understanding of the markets the Company plans to operate in. David
Tunnell, one of our co-founders, has served as the Chief Technology Officer, from the date of inception of the Company. Mr.
Tunnell is an expert in biometrics and is the inventor of a variety of miniature technologies for remote distributed sensors.
Mr. Tunnell has over 23 years of experience in developing high-technology solutions for the US Government. He was the divisional
director of 3D identification products at Technest Holdings Inc., from 2003 to 2011. Prior to that he was at the National Security
Agency (NSA) serving in operations, support, and development and later at L3 Communications where he served as Director of Engineering,
overseeing the development of SIGINT solutions and served as the primary interface with customers, bridging the gap between customer
requirements and system design and engineering. He also managed technical personnel, budgets, schedules, and technical direction.
Mr. Tunnell earned a Masters in Technical Management (MSTM) from Johns Hopkins University and a BSEE from the University of Tennessee. Major
General David R. Gust, USA, Ret. has served as a director of the Company from the date of inception of the Company. General
Gust presently does consulting work for his own company, David R. Gust & Associates, LLC. Between April 2007 and May 2009,
General Gust was the President of USfalcon, a privately-held company working with the U.S. Defense sector, primarily in information
technology. Previously, General Gust had served as the Manager for Federal Telecommunications for Bechtel National, Inc. from
November 2004 to March 2007. Prior to that, he was the President and Chief Executive Officer of Technical and Management Services
Corporation from 2000 to 2004. General Gust retired from the United States Army in 2000 after completing a career of 34 years
of service. His
General Officer assignments included the Program Executive Officer, Communications Systems (PEO-Comm Systems), Program Executive
Officer, Intelligence, Electronic Warfare and Sensors (PEO-IEW&S) and at Army Materiel Command, as Deputy Chief of Staff for
Research, Development and Acquisition (DCSRDA). His
final assignment at the Army Materiel Command included serving as the Chairman of the Source Selection Advisory Council for the
Tactical Unmanned Aerial Vehicle procurement and supervising preparation of the acquisition procurement package for the Stryker
combat vehicle. General Gust received his B.S. in Electrical Engineering from the University of Denver and Master’s Degrees
in Systems Management and National Security and Strategy from the University of Southern California and the United States Naval
War College, respectively. General
Gust brings to the Board valuable business expertise, particularly expertise in defense and Homeland security market segments
due to his significant experience as a director of a publicly held companies and his substantial experience gained as a member
of the US Armed Services. Michael
J. D’Almada-Remedios, PhD had served as a director of the Company since September 26, 2013. Dr. Remedios’
background includes a successful track record for product innovation and development, outsourcing, global platform integration,
massive-scale/hyper-growth operations, and building/developing teams from 50 to over 500 people. His key accomplishments at each
company consistently show impressive gains in sales, profitability and global expansion into new markets. Between
January 2011 and September 2013 he was Chief Information Officer for Arbonne International, a billion dollar global cosmetics
company. From February 2009 to December 2010 he was a Vice-President at Expedia, Inc. and was responsible for all technologies,
product development and technical operations for hotels.com and Venere brands, including “One H”, the global integration
of business and technology for hotels.com and Expedia, Inc. Prior
to February 2009, Dr. Remedios was Chief Technology Officer for Realtor.com and Shopping.com, a subsidiary of eBay, Inc. At eBay
he was a member of the eBay Inc. Technology Board for eBay, PayPal and Skype. He was also a key member of the eBay Inc. workgroups
for defining and driving the next-generation consumer experience “Finding 2.0”, “on-eBay” and the Advertising
and Distributed Commerce Network offering “off-eBay”. Earlier
in his career, he was the Global Chief Information Officer for the Travelocity group of companies and President and Chief Operating
Officer of Bluelight.com, a subsidiary of Kmart. Dr. Remedios began his career as Vice President and Manager, Systems Integration
& Development at Wells Fargo Bank, Consumer Banking Group. Dr.
Remedios recently joined software company, Swarm-Mobile. He has a PhD in Computer Control and Fluid Dynamics from the University
of Nottingham in England and a B.Sc. in Physics and Computer Science from Kings College, University of London in England. Dr. Remedios
brings to the Board valuable business experience, particularly expertise in eCommerce and hyper growth companies. Daniel
Sharkey’s background includes 36 years of broad experience with finance and business development for technology companies.
His key accomplishments in his prior engagements focused on expanding technology companies into new marketplaces and plotting
and implementing successful, long-term growth strategies. Between
2007 and 2014, Mr. Sharkey was Executive Vice President of Business Development for ATMI, a publicly traded semi-conductor company.
Mr. Sharkey originally joined ATMI as Chief Financial Officer in 1990. ATMI was sold to Entegris in 2014 for $1.15 billion. From
1987 to 1990, before joining ATMI, Mr. Sharkey was Vice President of Finance for Adage, a publicly traded computer graphics manufacturer.
From 1983 to 1987, Mr. Sharkey served as Corporate Controller for CGX Corporation, a venture capital backed, privately held, computer
graphics manufacturer that merged with Adage in 1987. Mr. Sharkey was a Certified Public Accountant for KPMG from 1978 to 1983. Mr.
Sharkey earned a Bachelor of Arts degree in Economics and Accounting from the College of the Holy Cross in Worcester, Massachusetts. Mr.
Sharkey’s extensive experience in the technology industry and advising companies, and years of executive management, give
him the qualifications and skills to serve as a director of our Company. Board
Committees Our Board
of Directors currently has the following committees: Audit –
Daniel Sharkey*, David R. Gust, Michael J. D’Almada-Remedios, PhD Compensation – David R. Gust*, Daniel Sharkey, Michael J. D’Almada-Remedios, PhD Nominating
and Governance – David R. Gust*, Daniel Sharkey, Michael J. D’Almada-Remedios, PhD * --Indicates
Committee Chair Daniel
Sharkey is an audit committee financial expert serving on our Board of Directors. We are not currently required to have an audit
committee since our common stock is not currently listed on a national securities exchange. In conjunction with this offering,
we have applied to list the common stock on the Nasdaq Capital Market, which will require the successful satisfaction of the NASDAQ
listing rules, including having audit, compensation and governance committees comprise solely of independent directors including
having a member of the audit committee be audit committee financial expert. Involvement
in Certain Legal Proceedings To
the best of our knowledge, none of our directors or executive officers has, during the past ten years: Except
as set forth in our discussion below in “Certain Relationships and Related Transactions,” none of our directors or
executive officers has been involved in any transactions with us or any of our directors, executive officers, affiliates or associates
which are required to be disclosed pursuant to the rules and regulations of the Commission. Family
Relationships There
are no relationships between any of the officers or directors of the Company. Director
Independence Because
we are applying to list our common stock on NASDAQ, we have used the definition of
“independence” of The NASDAQ Stock Market to make this determination. NASDAQ Listing Rule 5605(a)(2) provides
that an “independent director” is a person other than an officer or employee of the Company or any other
individual having a relationship which, in the opinion of the Company’s board of directors, would interfere with the
exercise of independent judgment in carrying out the responsibilities of a director. The NASDAQ listing rules provide that a
director cannot be considered independent if: Based
on the above qualifications, we have determined that Major General David R. Gust, USA, Ret., Michael J.
D’Almada-Remedios, PhD, and Daniel Sharkey are independent directors. We have an audit committee,
compensation committee, and a nominating/governance committee. Summary
Compensation Table for Fiscal Years 2013 and 2012 The
following summary compensation table sets forth all compensation awarded to, earned by, or paid to the named executive officers
paid by us during the years ended December 31, 2013, and 2012 in all capacities for the accounts of our executives, including
the Chief Executive Officer and Chief Financial Officer. 2013 2012 150,000 87,500 – – 150,000 87,500 2013 2012 120,000 80,000 – 120,000 80,000 Employment
Agreements Effective
October 1, 2012, we entered into an employment agreement with Gino Pereira, our Chief Executive Officer, which was amended
effective March 14, 2013. The employment agreement has an initial term of 3 years beginning on October 1, 2012. In addition
the employment agreement provides Mr. Pereira with a base salary of $150,000 per year, increasing to $300,000 per year upon
the completion of the Company’s Wocket™ prototype (which occurred subsequent to year-end). The amended
employment agreement also provides for: We do not have an employment agreement with David Tunnell, our Chief Technology Officer. Outstanding
Equity Awards at 2013 Fiscal Year End The
following table provides information relating to the vested and unvested option and stock awards held by the named executives
as of December 30, 2013. Each award to each named executive is shown separately, with a footnote describing the award’s
vesting schedule. Director
Compensation for Fiscal 2013 Our
non-employee directors receive $20,000 annually for serving on our Board, which is paid quarterly in stock. The following table
reflects all compensation awarded to, earned by or paid to the Company’s directors for the fiscal year ended December 31,
2013. SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The
following table sets forth certain information regarding the beneficial ownership of our Common Stock as of August 12, 2014 by
(a) each stockholder who is known to us to own beneficially 5% or more of our outstanding Common Stock; (b) all directors;(c)
our executive officers, and (d) all executive officers and directors as a group. Except as otherwise indicated, all persons listed
below have (i) sole voting power and investment power with respect to their shares of Common Stock, except to the extent that
authority is shared by spouses under applicable law, and (ii) record and beneficial ownership with respect to their shares of
Common Stock. For
purposes of this table, a person or group of persons is deemed to have “beneficial ownership” of any shares of common
stock that such person has the right to acquire within 60 days of August 12, 2014. For purposes of computing the percentage of
outstanding shares of our common stock held by each person or group of persons named above, any shares that such person or persons
has the right to acquire within 60 days of August 12, 2014 is deemed to be outstanding, but is not deemed to be outstanding for
the purpose of computing the percentage ownership of any other person. The inclusion herein of any shares listed as beneficially
owned does not constitute an admission of beneficial ownership.
Unless otherwise identified, the address of our directors and officers is c/o Nxt-ID, Inc., One Reservoir Corporate Centre, 4
Research Drive, Suite 402, Shelton, CT 06484. CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS Except
as described below, during the past three years, there have been no transactions, whether directly or indirectly, between our
company and any of our officers, directors, beneficial owners of more than 5% of our outstanding common stock or their family
members, that exceeded $120,000. Effective
June 25, 2012, the Company acquired certain 100% of the membership interests in
3D-ID, LLC (“3D-ID”), a limited liability company formed in Florida in February 2011 and owned by the Company’s
founders. Since this was a transaction between entities under common control, in accordance with Accounting Standards Codification
(“ASC”) 805, “Business Combinations”, Nxt-ID recognized the net assets of 3D-ID at their carrying amounts
in the accounts of Nxt-ID on the date that 3D-ID was organized, February 14, 2011. Our corporate headquarters are in Shelton,
CT. During the year ended December 31,
2013, the Company received an aggregate of $64,000 of cash advances from an officer of the Company and made aggregate repayments
of $64,000. The advances were non-interest bearing and short-term in nature. No such advances were made during the six months
ended June 30, 2014. The
founders of Nxt-ID were an integral part of the senior management teams at Technest Holdings, an OTC Bulletin Board public company,
and its subsidiary Genex Technologies. Genex Technologies was founded in 1995 to develop and commercialize the unique Rainbow®
method of capturing 3D data. Since its founding Genex has developed into one of the market leaders in advanced imaging, including
3D and 360-degree technologies. Genex
has developed innovative technologies and products for all aspects of imaging, including capture, processing, display, and enhancement.
Genex’s products range from 3D cameras to surveillance algorithms to integrated facial recognition systems. Genex
and Technest have won awards from the Department of Defense, NIH, NIST and NSF amounting to over $30 million in support of this
technology. On August 19, 2011, the Company signed a licensing
agreement with Technest Holdings, Inc. and Genex Technologies, Inc., which granted 3D-ID a perpetual sub-licensable, exclusive,
worldwide license to use their intellectual property in U.S. Federal and State markets, and a non-exclusive license in all other
markets. The Company’s Chief Executive Officer (“CEO”) is a stockholder of and was the former CEO of Technest
Holdings, Inc. In consideration of the license of rights affected by this Agreement, 3D-ID is obligated to pay Technest a royalty
equal to 5% of net sales. To date, no royalties have been paid. Since the Technest patents do not constitute part of the Company’s
core intellectual property in its present or anticipated future product offerings it has decided to forgo the exclusive rights
to the Technest patents. As a result the Company reversed an accrual of $35,000 which represented a minimum royalty to maintain
certain exclusive rights. The Company retains a perpetual non-exclusive worldwide license to these patents. We
are offering shares of our common stock, par value $0.0001 per share, together with warrants to purchase shares of common stock
in this offering. Each share of common stock sold in this offering will be sold with a warrant to purchase of a share of common
stock at an exercise price of $ per share (120% of the public offering price of the common stock). The warrants are exercisable
for a period of five years beginning on the closing date of this offering. Subject
to compliance with any applicable securities laws, any portion of a warrant may be transferred by the warrant holder upon
surrender of the warrant. We intend to list the warrants on the Nasdaq Capital Market, but there is currently no
established trading market for the warrants. We do not intend to make a market in the warrants and do not expect that one
will develop. Therefore, the warrant holders may have to hold the warrants they purchase in this offering, until such time,
if any, as they wish to exercise them. The warrant holders do not have the rights or privileges of holders of common stock
and any voting rights until they exercise their warrants and receive shares of common stock. After the issuance of shares of
common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held on record on all
matters to be voted on by stockholders. Pursuant
to the terms of the warrants, warrant holders are not permitted to exercise the warrants for an amount of common stock that would
result in a holder owning more than 9.99% of our common stock outstanding after the exercise. We
will not be required to issue any fractional shares of our common stock upon the exercise of a warrant. Instead, the Company may
elect to either pay cash equal to the product of such fraction multiplied by the closing price of one warrant share on the date
of exercise or have the number of shares of common stock exercised will be rounded up to the nearest whole number. The
exercise price and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances
including in the event of our recapitalization, reorganization, merger or consolidation. We
will attempt to maintain the effectiveness of a current prospectus covering the common stock issuable upon exercise of the warrants
until the expiration of the warrants. However, we cannot assure you that we will be able to do so and we may not be able to maintain
our eligibility to use such current prospectus. If the prospectus relating to the common stock issuable upon the exercise of the
warrants is not current or if we are not eligible to use such current prospectus or if the common stock is not qualified or exempt
from qualification in the jurisdictions in which the holders of the warrants reside, the warrants may have no value. The
warrants may initially be represented in one or more permanent global certificates in fully registered form and will be deposited
with a custodian for, and registered in the name of a nominee of the Depository Trust Company, New York, New York, as depositary. Introduction In
the discussion that follows, we have summarized selected provisions of our certificate of incorporation, bylaws and the Delaware
General Corporation Law (the “DGCL”) relating to our capital stock. This summary is not complete. This discussion
is subject to the relevant provisions of Delaware law and is qualified in its entirety by reference to our certificate of incorporation
and our bylaws. You should read the provisions of our certificate of incorporation and our bylaws as currently in effect for provisions
that may be important to you. Authorized
Capital Stock The
Company is authorized to issue 110,000,000 shares of its capital stock consisting of (a) 100,000,000 shares of common stock, par
value $0.0001 per share and (b) 10,000,000 shares of “blank check” preferred stock. As of August 12, 2014, 22,030,843
shares of our common stock were issued and outstanding. Common
Stock Each
share of common stock entitles the holder to one vote, either in person or by proxy, at meetings of stockholders. The holders
are not permitted to vote their shares cumulatively. Accordingly, the stockholders of our common stock who hold, in the aggregate,
more than fifty percent of the total voting rights can elect all of our directors and, in such event, the holders of the remaining
minority shares will not be able to elect any of such directors. The vote of the holders of a majority of the issued and outstanding
shares of common stock entitled to vote thereon is sufficient to authorize, affirm, ratify or consent to such act or action, except
as otherwise provided by law. Holders
of common stock are entitled to receive ratably such dividends, if any, as may be declared by our Board of Directors out of funds
legally available. We have not paid any dividends since our inception, and we presently anticipate that all earnings, if any,
will be retained for development of our business. Any future disposition of dividends will be at the discretion of our Board of
Directors and will depend upon, among other things, our future earnings, operating and financial condition, capital requirements,
and other factors. Holders
of our common stock have no preemptive rights or other subscription rights, conversion rights, redemption or sinking fund provisions.
Upon our liquidation, dissolution or winding up, the holders of our common stock will be entitled to share ratably in the net
assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities. There are
no provisions in our certificate of incorporation or our by-laws that would prevent or delay change in our control. Preferred
Stock We
are authorized to issue up to 10,000,000 shares of “blank check” preferred stock, $0.0001 par value per share, none
of which is presently issued or outstanding. Our Board of Directors is authorized to issue such shares of preferred stock with
designations, rights and preferences as it may determine from time to time. Accordingly, our Board of Directors is empowered,
without stockholder approval, to issue shares of preferred stock with dividend, liquidation, conversion, or other rights that
could adversely affect the rights of the holders of our common stock. Dividends Since
inception we have not paid any dividends on our common stock. We currently do not anticipate paying any cash dividends in the
foreseeable future on our common stock. Although we intend to retain our earnings, if any, to finance the exploration and growth
of our business, our board of directors will have the discretion to declare and pay dividends in the future. Payment of dividends
in the future will depend upon our earnings, capital requirements, and other factors, which our board of directors may deem relevant. Warrants As
of August 12, 2014, we had 1,350,000 warrants to purchase 1,350,000 shares of our common stock at an exercise price of $3.00 outstanding.
These warrants are exercisable through January 13, 2019. The exercise price of the warrants are subject to adjustment upon certain
events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate change and
dilutive issuances. As
of August 12, 2014, we had 4,600 warrants to purchase 4,600 shares of our common stock at an exercise price of $1.00 outstanding.
These warrants are exercisable through May 10, 2016. The exercise price of the warrants are subject to adjustment upon certain
events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate changes. Options
and Other Stock Awards On
January 3, 2013, the Company’s shareholders authorized the Nxt-ID, Inc. 2013 Long-Term Stock Incentive Plan. The maximum
aggregate number of shares of Common Stock that may be issued under the Plan, including Stock Options, Stock Awards, and Stock
Appreciation Rights is limited to 10% of the shares of Common Stock outstanding on the first trading day of any fiscal year, less
shares or awards previously issued under the plan, or 2,044,949 for fiscal 2014. Currently, we have not issued any stock options
under the plan. We have issued 155,180 shares under the Long Term Incentive Plan. Registration
Rights Between
June 12, 2014 and June 17, 2014, the Company completed a private offering (the “Offering”) with a group
of accredited investors, who had previously participated in the Company’s private offering that had occurred
between December 30, 2013 and January 13, 2014 (the “Purchasers”) for total net proceeds to the Company of
$4,000. Pursuant to a securities purchase agreement with the Purchasers (the “Purchase Agreement”), the Company
issued to the Purchasers warrants (the “Warrants”) to purchase an aggregate of 400,000 shares (the
“Warrant Shares”) of our Common Stock at an exercise price of $3.00 per share. The Warrants are exercisable for a
period of five years from the original issue date. The exercise price for the Warrants is subject to adjustment upon certain
events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate change. If
exercised, the Warrants will provide the Company with gross proceeds of approximately $1.2 million. The Company
determined that the effect of the issuance of the warrants was to induce the Purchasers to exercise warrants previously
issued to them in the Offering and thus accounted for the issuance as an inducement. In
connection with the sale of the Warrants, the Company entered into a registration rights agreement (the “Registration
Rights Agreement”) with the Purchasers, pursuant to which the Company agreed to register the Shares and the shares of
our Common Stock underlying the Warrants (the “Registrable Securities”) on a Form S-1 registration statement (the
“Registration Statement”) to be filed with the SEC 90 days following the completion of an underwritten public
offering (the “Filing Date”) and to cause the Registration Statement to be declared effective under the
Securities Act within 90 days following the Filing Date (the “Required Filing Date”). If
the Registration Statement is not filed by the Filing Date or declared effective by the Required Effective Date, the Company is
required to pay partial liquidated damages to each Purchaser in the amount equal to 2% for the purchase price paid for the Warrants
then owned by such Purchaser for each 30-day period for which the Company is non-compliant. Limitation
on Directors’ Liability Delaware
law authorizes Delaware corporations to limit or eliminate the personal liability of their directors to them and their stockholders
for monetary damages for breach of a director’s fiduciary duty of care. The duty of care requires that, when acting on behalf
of the corporation, directors must exercise an informed business judgment based on all material information reasonably available
to them. Absent the limitations Delaware law authorizes, directors of Delaware corporations are accountable to those corporations
and their stockholders for monetary damages for conduct constituting gross negligence in the exercise of their duty of care. Delaware
law enables Delaware corporations to limit available relief to equitable remedies such as injunction or rescission. Our certificate
of incorporation limits the liability of our directors to us and our stockholders to the fullest extent Delaware law permits.
Specifically, no director will be personally liable for monetary damages for any breach of the director’s fiduciary duty
as a director, except for liability: This
provision could have the effect of reducing the likelihood of derivative litigation against our directors and may discourage or
deter our stockholders or management from bringing a lawsuit against our directors for breach of their duty of care, even though
such an action, if successful, might otherwise have benefited us and our stockholders. Our bylaws provide indemnification to our
officers and directors and other specified persons with respect to their conduct in various capacities. See “Indemnification
of Directors and Officers.” Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or person controlling
the Company pursuant to the foregoing provisions, the Company has been informed that in the opinion of the SEC such indemnification
is against public policy as expressed in the Act and is therefore unenforceable. Anti-Takeover
Effects of Provisions of the DGCL and our Certificate of Incorporation and Bylaws Provisions
of the DGCL and our certificate of incorporation and bylaws could make it more difficult to acquire us by means of a tender offer,
a proxy contest or otherwise, or to remove incumbent officers and directors. These provisions, summarized below, are expected
to discourage certain types of coercive takeover practices and takeover bids that our board of directors may consider inadequate
and to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the
benefits of increased protection of our ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire
or restructure us outweigh the disadvantages of discouraging takeover or acquisition proposals because, among other things, negotiation
of these proposals could result in improved terms for our stockholders. Delaware
Anti-Takeover Statute. We were subject to Section 203 of the DGCL, an anti-takeover statute. In general, Section 203
of the DGCL prohibits a publicly-held Delaware corporation from engaging in a “business combination” with an “interested
stockholder” for a period of three years following the time the person became an interested stockholder, unless the business
combination or the acquisition of shares that resulted in a stockholder becoming an interested stockholder is approved in a prescribed
manner. Generally, a “business combination” includes a merger, asset or stock sale, or other transaction resulting
in a financial benefit to the interested stockholder. Generally, an “interested stockholder” is a person who, together
with affiliates and associates, owns (or within three years prior to the determination of interested stockholder status did own)
15% or more of a corporation’s voting stock. The existence of this provision would be expected to have an anti-takeover
effect with respect to transactions not approved in advance by the board of directors, including discouraging attempts that might
result in a premium over the market price for the shares of common stock held by stockholders. As
of August 12, 2014, we are not subject to Section 203 of the DGCL because we do not have a class of voting stock that is listed
on a national securities exchange or held of record by more than 2,000 stockholders and we have not elected by a provision in
our original certificate of incorporation to be governed by Section 203. Unless we adopt an amendment of our certificate of incorporation
by action of our stockholders expressly electing not to be governed by Section 203, we would generally become subject to Section
203 of the DGCL at such time that we have a class of voting stock that is either listed on a national securities exchange or held
of record by more than 2,000 stockholders, except that the restrictions contained in Section 203 would not apply if the business
combination is with an interested stockholder who became an interested stockholder before the time that we have a class of voting
stock that is either listed on a national securities exchange or held of record by more than 2,000 stockholders. Amendments
to Our Certificate of Incorporation. Under the DGCL, the affirmative vote of a majority of the outstanding shares entitled
to vote thereon and a majority of the outstanding stock of each class entitled to vote thereon is required to amend a corporation’s
certificate of incorporation. Under the DGCL, the holders of the outstanding shares of a class of our capital stock shall be entitled
to vote as a class upon a proposed amendment, whether or not entitled to vote thereon by the certificate of incorporation, if
the amendment would: If
any proposed amendment would alter or change the powers, preferences or special rights of one or more series of any class of our
capital stock so as to affect them adversely, but shall not so affect the entire class, then only the shares of the series so
affected by the amendment shall be considered a separate class for the purposes of this provision. Vacancies
in the Board of Directors. Our bylaws provide that, subject to limitations, any vacancy occurring in our board of directors
for any reason may be filled by a majority of the remaining members of our board of directors then in office, even if such majority
is less than a quorum. Each director so elected shall hold office until the expiration of the term of the other directors. Each
such directors shall hold office until his or her successor is elected and qualified, or until the earlier of his or her death,
resignation or removal. Special
Meetings of Stockholders. Under our bylaws, special meetings of stockholders may be called at any time by our President
whenever so directed in writing by a majority of the entire board of directors. Special meetings can also be called whenever one-third
of the number of shares of our capital stock entitled to vote at such meeting shall, in writing, request one. Under the DGCL,
written notice of any special meeting must be given not less than 10 nor more than 60 days before the date of the special meeting
to each stockholder entitled to vote at such meeting. No
Cumulative Voting. The DGCL provides that stockholders are denied the right to cumulate votes in the election of directors
unless our certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation does not provide
for cumulative voting. Listing Our
common stock is listed on the OTC Bulletin Board under the symbol “NXTD.” In conjunction with this offering, we intend to
apply to list our common stock and warrants on the Nasdaq Capital Market under the symbols “NXTD” and
“NXTDW”, respectively. Transfer
Agent The transfer agent
and registrar for our common stock and the warrants to be issued to the public in this offering is VStock Transfer, LLC. The
transfer agent’s address is 18 Lafayette Place, Woodmere, NY 11598, and its telephone number is (212) 828-8436. SHARES
ELIGIBLE FOR FUTURE SALE As
of August 12, 2014, we had 22,030,843 shares of common stock outstanding, not including shares issuable upon exercise of our warrants.
All shares sold in this offering will be freely tradable without restriction or further registration under the Securities Act,
unless they are purchased by our “affiliates,” as that term is defined in Rule 144 promulgated under the Securities
Act. The
outstanding shares of our common stock not included in this prospectus will be available for sale in the public market as follows: Public
Float Of
our outstanding shares, as of August 12, 2014 approximately 18,738,530 shares are beneficially owned by executive officers, directors
and affiliates (excluding shares of our common stock which may be acquired upon exercise of stock options and warrants which are
currently exercisable or which become exercisable within 60 days of August 12, 2014). The approximately 3,292,313 remaining shares
constitute our public float. Rule
144 In
general, under Rule 144 as currently in effect, once we have been subject to public company reporting requirements for 90 days,
a person (or persons whose shares are aggregated) who is not deemed to have been an affiliate of ours at any time during the three
months preceding a sale, and who has beneficially owned restricted securities within the meaning of Rule 144 for a least six months
(including any period of consecutive ownership of preceding non-affiliated holders) would be entitled to sell those shares, subject
only to the availability of current public information about us. A non-affiliated person who has beneficially owned restricted
securities within the meaning of Rule 144 for at least six (6) months would be entitled to sell those shares without regard to
the provisions of Rule 144. In
general, under Rule 144 as currently in effect, once we have been subject to public company reporting requirements for 90 days,
our affiliates or persons selling shares on behalf of our affiliates who own shares that were acquired from us or an affiliate
of ours at least six months prior to the proposed sale are entitled to sell upon expiration of the lock-up agreements described
above, within any three-month period beginning 90 days after the date of this prospectus, a number of shares that does not exceed
the greater of: Sales
under Rule 144 by our affiliates or persons selling shares on behalf of our affiliates are also subject to certain manner of sale
provisions and notice requirements and to the availability of current public information about us. The
underwriters named below have agreed to buy, subject to the terms of the underwriting agreement, the number of shares of common
stock and warrants listed opposite their names below. The underwriters are committed to purchase and pay for all of the securities
if any are purchased. Number
of Shares Number
of Warrants The
underwriters have advised us that they propose to offer the shares of common stock and warrants to the public at the price set
forth on the cover page of this prospectus supplement. The underwriters propose to offer the shares of common stock and warrants
to certain dealers at the same price less a concession not in excess of a combined $ per share of common stock and related warrants.
The underwriters may allow, and the dealers may reallow, a concession of not more than a combined $ per share on sales to certain
other brokers and dealers. After this offering, these amounts may be changed by the underwriters. We
have granted to the underwriters an option to purchase up to an additional
shares of common stock and warrants to purchase up to
shares of our common stock from us at the same price to the public, and with the
same underwriting discount, as set forth in the table below. The underwriters may exercise this option any time during the
45-day period after the date of this prospectus, but only to cover over-allotments, if any. To the extent the underwriters
exercise the option, the underwriters will become obligated, subject to certain conditions, to purchase the securities for
which they exercise the option. The underwriters expect to deliver the securities to purchasers on or about , 2014. The
underwriting discount is equal to the public offering price per share of common stock and related warrant, less the amount paid
by the underwriters to us per share of common stock and related warrant. The following table shows the per combined share and
related warrant and total underwriting discount to be paid to the underwriters in this offering, assuming both no exercise and
full exercise of the over-allotment option. We
estimate expenses payable by us in connection with this offering, other than the underwriting discounts referred to above, will
be approximately $ . This estimate includes $150,000 of fees and expenses of the underwriters and excludes a corporate finance
fee payable by the Company to the underwriters equal to one percent of the gross proceeds of this offering ($50,000 of which was
already paid to the underwriters as a non-refundable retainer). We entered into an engagement letter with Northland Securities,
Inc., or Northland, and The Benchmark Company, LLC, or Benchmark, which may be terminated by any party subject to certain restrictions,
pursuant to which Northland and Benchmark provide us with certain financial advisory services. In connection with the successful
completion of this offering, for the price of $50, the underwriters may purchase a warrant to purchase shares of our common stock
equal to 5.0% of the shares sold in this offering at an exercise price that is the same as that for investors in this offering.
We also granted Northland and Benchmark a right of first refusal to participate as a manager or co-manager in any subsequent offering
or placement of our securities that takes place during the term of our engagement with Northland and Benchmark or within eighteen
months thereafter. In accordance with applicable rules of FINRA, Northland and Benchmark do not have more than one opportunity
to waive or terminate the right of first refusal in consideration of any payment or fee, and any payment or fee to waive or terminate
the right of first refusal must be paid in cash and have a value not in excess of the greater of 1% of the proceeds in this offering
(or, if greater, the maximum amount permitted by FINRA rules for compensation in connection with this offering) or 5% of the underwriting
discount or commission paid in connection with any future financing subject to right of first refusal (including any overallotment
option that may be exercised). This right of first refusal is not reflected in the table below. Except
as disclosed in this prospectus supplement, the underwriters have not received and will not receive from us any other item of
compensation or expense in connection with this offering considered by the Financial Industry Regulatory Authority to be underwriting
compensation under its rule of fair price. The underwriting discount was determined through an arms’ length negotiation
between us and the underwriters. We
have agreed to indemnify the underwriters against certain liabilities, including civil liabilities under the Securities Act of
1933, or Securities Act, or to contribute to payments that the underwriters may be required to make in respect of those liabilities. We
and each of our directors and executive officers have agreed to certain restrictions on the ability to sell shares of our common
stock for a period of 90 days after the date of this prospectus. The agreements provide exceptions for sales to the underwriters
pursuant to the underwriting agreement and certain other situations. The restrictions in these agreements may be waived by the
underwriters in its sole discretion. The lock-up periods discussed above are subject to extension such that, in the event that
either (i) during the last 17 days of the “lock-up” period, we issue an earnings or financial results release or material
news or a material event relating to us occurs, or (ii) prior to the expiration of the “lock-up” period, we announce
that we will release earnings or financial results during the 16-day period beginning on the last day of the “lock-up”
period, then in either case the expiration of the “lock-up” period will be extended until the expiration of the 18-day
period beginning on the issuance of the earnings or financial results release or the occurrence of the material news or material
event, as applicable, unless the underwriters waive, in writing, such an extension. The restrictions described above do not apply
to certain transactions by our officers and directors pursuant to any trading plan established pursuant to Rule 10b-5 of the Securities
and Exchange Act of 1934, or the Exchange Act. From
time to time in the ordinary course of business, the underwriters and certain of the underwriters’ affiliates have engaged,
and may in the future engage, in investment banking transactions with us or our affiliates. To
facilitate this offering, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of
shares of our common stock during and after this offering. Specifically, the underwriters may over-allot or otherwise create a
short position in our common stock for its own accounts by selling more shares of common stock than we have sold to them. The
underwriters may close out any short position by either exercising its option to purchase additional shares or purchasing shares
in the open market. In addition, the underwriters may stabilize or maintain the price of our common stock by bidding for or purchasing
shares in the open market and may impose penalty bids. If penalty bids are imposed, selling concessions allowed to syndicate members
or other broker-dealers participating in the offering are reclaimed if shares previously distributed in the offering are repurchased,
whether in connection with stabilization transactions or otherwise. The effect of these transactions may be to stabilize or maintain
the market price of our common stock at a level above that which might otherwise prevail in the open market. The imposition of
a penalty bid may also affect the price of our common stock to the extent that it discourages resales of shares of our common
stock. The magnitude or effect of any stabilization or other transactions is uncertain. These transactions may be effected on
the Nasdaq Capital Market, if we list on this exchange in connection with this offering, or otherwise and, if commenced, may be
discontinued at any time. In
connection with this offering, the underwriters and selling group members may also engage in passive market making transactions
in our common stock. Passive market making consists of displaying bids on the Nasdaq Capital Market limited by the prices of independent
market makers and effecting purchases limited by those prices in response to order flow. Rule 103 of Regulation M promulgated
by the SEC limits the amount of net purchases that each passive market maker may make and the displayed size of each bid. Passive
market making may stabilize the market price of our common stock at a level above that which might otherwise prevail in the open
market and, if commenced, may be discontinued at any time. The underwriters
may facilitate the marketing of this offering online directly or through one of the underwriters’ affiliates. In those cases,
prospective investors may view offering terms and a prospectus online and place orders online or through their financial advisors.
Such websites and the information contained on such websites, or connected to such sites, are not incorporated into and are not
a part of this prospectus supplement. The
validity of the shares of common stock offered by this prospectus and certain other legal matters as to Delaware law will be passed
upon for us by Robinson Brog Leinwand Greene Genovese & Gluck P.C. Faegre Baker Daniels LLP, Minneapolis, Minnesota, has acted
as counsel to the underwriters for this offering. Our
audited consolidated financial statements as of December 31, 2013 and 2012 and for the years then ended appearing in this prospectus
and registration statement have been audited by Marcum LLP, an independent registered
public accounting firm, as set forth in their report, which contains an explanatory paragraph regarding the Company’s ability
to continue as a going concern, thereon appearing elsewhere herein and in the registration statement, and are included in reliance
upon such report given on the authority of such firm as experts in accounting and auditing. WHERE
YOU CAN FIND MORE INFORMATION We
filed with the SEC a registration statement under the Securities Act for the common stock in this offering. This prospectus does
not contain all of the information in the registration statement and the exhibits and schedule that were filed with the registration
statement. For further information with respect to us and our common stock, we refer you to the registration statement and the
exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract
or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you
to the full text of the contract or other document filed as an exhibit to the registration statement. We
file annual, quarterly, and current reports and other information with the SEC. Our filings with the SEC are available to the
public on the SEC’s website at www.sec.gov. Those filings are also available to the public on our corporate website at www.nxt-id.com.
The information we file with the SEC or contained on, or linked to through, our corporate website or any other website that we
may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read
and copy, at the SEC’s prescribed rates, any document we file with the SEC, including the registration statement (and its
exhibits) of which this prospectus is a part, at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington,
D.C. 20549. You can call the SEC at 1-800-SEC-0330 to obtain information on the operation of the Public Reference Room. Nxt-ID,
Inc. and Subsidiary CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS FOR
THE QUARTER ENDED JUNE 30, 2014 Index
to Condensed Consolidated Financial Statements Nxt-ID,
Inc. and Subsidiary CONDENSED
CONSOLIDATED BALANCE SHEETS The
accompanying notes are an integral part of these condensed consolidated financial statements. Nxt-ID,
Inc. and Subsidiary CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) The
accompanying notes are an integral part of these condensed consolidated financial statements.
Nxt-ID,
Inc. and Subsidiary CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) The
accompanying notes are an integral part of these condensed consolidated financial statements.
Nxt-ID,
Inc. and Subsidiary CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) The
accompanying notes are an integral part of these condensed consolidated financial statements. NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note 1 – Organization
and Basis of Presentation Organization
and Principal Business Activity Nxt-ID, Inc. (“Nxt-ID” or the
“Company”) was incorporated in the state of Delaware on February 8, 2012. Nxt-ID is a biometrics and authentication
company focused on the growing m-commerce market with an innovative MobileBio™ suite of biometric solutions that secure
mobile platforms. The Company also serves the access control and law enforcement facial recognition markets. 3D-ID, LLC (“3D-ID”) was organized
and registered in the state of Florida on February 14, 2011. The Company is an early stage company engaged in the design, research
and development, integration, analysis, modeling, system networking, sales and support of intelligent surveillance, three dimensional
facial recognition and three dimensional imaging devices and systems primarily for identification and access control in the security
industries. On June 25, 2012, Nxt-ID, a company having
similar ownership as 3D-ID, acquired 100% of the membership interests in 3D-ID (the “Acquisition”) in exchange for
20,000,000 shares of Nxt-ID common stock. Since this was a transaction between entities under common control, in accordance with
Accounting Standards Codification (“ASC”) 805, “Business Combinations”, Nxt-ID recognized the net assets
of 3D-ID at their carrying amounts in the accounts of Nxt-ID on the date that 3D-ID was organized. Basis of Presentation The accompanying unaudited condensed consolidated
financial statements as of June 30, 2014 and for the three and six months then ended have been prepared in accordance with the
accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information
and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”)
and on the same basis as the Company prepares its annual audited consolidated financial statements. The condensed consolidated
balance sheet as of June 30, 2014, the condensed consolidated statements of operations for the three and six months ended June
30, 2014 and 2013 and the condensed consolidated statements of cash flows for the six months ended June 30, 2014 and 2013 are
unaudited, but include all adjustments, consisting only of normal recurring adjustments, which the Company considers necessary
for a fair presentation of the financial position, operating results and cash flows for the periods presented. The results for
the three and six months ended June 30, 2014 are not necessarily indicative of results to be expected for the year ending December
31, 2014 or for any future interim period. The condensed consolidated balance sheet at December 31, 2013 has been derived from
audited consolidated financial statements. However, it does not include all of the information and notes required by GAAP for
complete consolidated financial statements. The accompanying condensed consolidated financial statements should be read in conjunction
with the consolidated financial statements for the year ended December 31, 2013 and notes thereto included in the Company’s
annual report on Form 10-K, which was filed with the SEC on February 25, 2014. Nxt-ID, Inc. and
Subsidiary NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note
2 - Going Concern and Management Plans The Company is an early stage company and
incurred net losses of $3,822,887 during the six months ended June 30, 2014, which included an aggregate $2,404,352 of non-cash
charges. As of June 30, 2014, the Company had working capital and stockholders’ equity of $490,570 and $513,779, respectively.
During the six months ended June 30, 2014, the Company raised net proceeds of approximately $1,970,000 through the issuance of
common stock and warrants and the exercise of warrants. In order to execute the Company's long-term
strategic plan to develop and commercialize its core products, the Company will need to raise additional funds through public
or private equity offerings, debt financings, or other means. The Company can give no assurance that additional funds will be
available on reasonable terms, or available at all, or that it will generate sufficient revenue to alleviate the going concern.
These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to execute
its business plan is dependent upon its ability to raise additional equity, secure debt financing, and/or generate revenue. Should
the Company not be successful in obtaining the necessary financing, or generate sufficient revenue to fund its operations, the
Company would need to curtail certain of its operational activities. The accompanying financial statements do not include any
adjustments that might be necessary should the Company be unable to continue as a going concern. Note
3 - Summary Of Significant Accounting Policies Use
of Estimates in the Financial Statements The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates
and assumptions include the valuation allowance relating to the Company’s deferred tax assets, the fair value of the Company’s
equity and derivative financial instruments and stock-based compensation. Principles
of Consolidation The consolidated financial statements include
the accounts of Nxt-ID and its wholly-owned subsidiary, 3D-ID. Intercompany balances and transactions have been eliminated upon
consolidation. Restricted
Cash Restricted cash is comprised of amounts
held by credit card processors until the Company establishes a history of activity and the processor is able to estimate potential
charge back risk. The balances are rolling and held by the processor for a period of less than a year and therefore reported as
a current asset on the accompanying condensed consolidated balance sheets. Inventory Inventory consists principally of raw materials
and is valued at the lower of cost or market with cost determined using the first-in, first-out method and with market defined
as the lower of replacement cost or realizable value. As of June 30, 2014 inventory is comprised of $30,167 in raw materials on
hand. In addition, as an early stage entity, the Company is required to prepay for raw materials with certain vendors until credit
terms can be established. As of June 30, 2014, approximately $86,000 of prepaid inventory is included in prepaid expenses on the
condensed consolidated balance sheet. Nxt-ID, Inc. and
Subsidiary NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note
3 - Summary Of Significant Accounting Policies (continued) Revenue
Recognition The Company’s 3D facial recognition
and identification products are currently available for sale and the Company has begun accepting pre-orders on its Mobile Bio
Wocket. The Company recognizes revenue in connection with the sale of these products when persuasive evidence of an arrangement
exists, the service has been rendered or product delivery has occurred, the price is fixed or readily determinable and collectability
of the sale is reasonably assured. As of June 30, 2014, the Company has received $80,018 in customer deposits in connection with
pre-orders of its MobileBio Wocket. The Company requires all of its product
sales to be supported by evidence of a sale transaction that clearly indicates the selling price to the customer, shipping terms
and payment terms. Evidence of an arrangement generally consists of a contract or purchase order approved by the customer. The
Company recognizes revenue at the time in which it receives a confirmation that the goods were either tendered at their destination,
when shipped “FOB destination,” or transferred to a shipping agent, when shipped “FOB shipping point.”
Delivery to the customer is deemed to have occurred when the customer takes title to the product. Generally, title passes to the
customer upon shipment, but could occur when the customer receives the product based on the terms of the agreement with the customer.
The prices of all goods that the Company sells are fixed and agreed to with the customer prior to shipment. In the event a sale is made to a customer
under circumstances in which collectability is not reasonably assured, the Company either requires the customer to remit payment
prior to shipment or defers recognition of the revenue until payment is received. The Company maintains a reserve for amounts
that may not be collectible due to risk of credit losses. The Company’s sales typically do
not include multiple deliverable arrangements. Convertible
Instruments The Company applies the accounting standards
for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion
options. The accounting standards require companies to bifurcate conversion options from their host instruments and account for
them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which
(i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic
characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument
and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with
changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative
instrument would be considered a derivative instrument. The derivative is subsequently marked to
market at each reporting date based on current fair value, with the changes in fair value reported in the results of operations. Conversion options that contain variable
settlement features, such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities
at exercise prices more favorable than that featured in the hybrid contract, generally result in their bifurcation from the host
instrument. The Company accounts for convertible debt
instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments
in accordance with ASC 470-20 “Debt with Conversion and Other Options.” The Company records, when necessary, discounts
to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between
the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price
embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt. See Note 5 below. Nxt-ID, Inc. and
Subsidiary NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note
3 - Summary Of Significant Accounting Policies (continued) Debt
discount and amortization of debt discount Debt discount represents the fair value
of embedded conversion options of various convertible debt instruments and attached convertible equity instruments issued in connection
with debt instruments. The debt discount is amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt,
using the straight-line method which approximates the interest method. The amortization of debt discount is included as a component
of other expenses in the accompanying statements of operations. Income
Taxes The Company uses the asset and liability
method of accounting for income taxes in accordance with ASC Topic 740, "Income Taxes." Under this method, income tax
expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences
of temporary differences resulting from matters that have been recognized in an entity's financial statements or tax returns.
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which
those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change
in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance
is provided to reduce the deferred tax assets reported if, based on the weight of the available positive and negative evidence,
it is more likely than not that some portion or all of the deferred tax assets will not be realized. ASC Topic 740-10-30 clarifies the accounting
for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and
measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken
in a tax return. ASC Topic 740-10-40 provides guidance on de-recognition, classification, interest and penalties, accounting in
interim periods, disclosure, and transition. The Company will classify as income tax expense any interest and penalties. The Company
has no material uncertain tax positions for any of the reporting periods presented. Generally, the tax authorities may examine
the partnership/corporate tax returns for three years from the date of filing. The Company is in the process of filing its tax
returns for the year ended December 31, 2013. Therefore, the Company’s net operating loss carryovers will not be available
to offset future taxable income, if any, until the returns are filed. Stock-Based
Compensation The Company accounts for share-based awards
exchanged for employee services at the estimated grant date fair value of the award. The Company estimates the fair value of employee
stock options using the Black-Scholes option pricing model. The Company amortizes the fair value of employee stock options on
a straight-line basis over the requisite service period of the awards. Compensation expense includes the impact of an estimate
for forfeitures for all stock options. The Company accounts for equity instruments
issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to
periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Non-employee stock-based compensation
charges are amortized over the vesting period or as earned. Nxt-ID, Inc. and
Subsidiary NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note
3 - Summary Of Significant Accounting Policies (continued) Net
Loss per Share Basic loss per share was computed using
the weighted average number of common shares outstanding. Diluted loss per share includes the effect of diluted common stock equivalents.
Potentially dilutive securities realizable from the exercise of 1,396,139 warrants as of June 30, 2014 were excluded from the
computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. As of June 30,
2013, potentially dilutive securities realizable from the conversion of the Company’s then outstanding note payable into
120,000 shares of common stock and the exercise of warrants for the purchase of 304,600 common shares were excluded from the computation
of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. Research
and Development Research and development costs consist
of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge that
would be useful in developing new products or processes. The Company expenses all research and development costs as incurred. Note
4 - Accrued Expenses Accrued expenses consist of the following: Note 5 - Convertible
Notes Payable On December 13, 2012, the Company received
approval from Connecticut Innovations, Inc. (“CII”) for a Convertible Note (the “Note”) in the amount
of $150,000. The Company received the first tranche of $75,000 on December 21, 2012 and the second tranche of $75,000 on January
31, 2013. The Note’s maturity date was December 21, 2014. The Company received notice on February
11, 2014 from CII regarding converting its outstanding convertible note of $150,000, along with accrued interest of $21,485, into
common stock at a 25% discount to the Company’s closing stock price on February 17, 2014. Since February 17, 2014 was a
holiday, the Company used its closing stock price on February 18, 2014. The Company issued 55,497 shares in full relief of its
outstanding debt and accrued interest of $171,485. Nxt-ID, Inc. and
Subsidiary NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note 5 - Convertible
Notes Payable (continued) Since the Note was converted on February
18, 2014, the Company re-measured the conversion feature liability associated with the convertible note payable on that date.
The Company recorded an unrealized gain on the change in the fair value of the conversion feature liability of $20,218 for the
six months ended June 30, 2014 (see Note 7 below) and reclassified the re-measured conversion feature of $98,722 to additional
paid in capital. Since the Note was converted, the remaining unamortized portion of the debt discount of $26,755 was expensed
during the six months ended June 30, 2014. Note
6 - Stockholders' Equity On January 13, 2014, the Company closed
a “best efforts” private offering of $1,000,000 (the “Offering”) with a group of accredited investors
(the “Purchasers”) and the Company exercised the oversubscription amount allowed in the Offering of $350,000, for
total gross proceeds to the Company of $1,350,000 before deducting placement agent fees and other expenses. Pursuant to a securities
purchase agreement with the Purchasers (the “Purchase Agreement”), the Company issued to the Purchasers (i) 415,387
shares of the Company’s common stock, par value $0.0001 and (ii) 1,350,000 warrants (the “Warrants”) to purchase
shares (the “Warrant Shares”) of the Company’s common stock at an exercise price of $3.25 per share. In connection
with the Offering, 138,463 units were sold at the end of December 2013 and 276,924 units were sold in January 2014, all at $3.25
per unit. As a result, the Company received aggregate gross proceeds of $450,000 in December 2013 from the issuance of 138,463
shares of common stock and 450,000 Warrants, and the Company received $900,000 in January 2014 from the issuance of 276,924 shares
of common stock and 900,000 Warrants. Costs incurred associated with the Offering in December 2013 and January 2014 were $56,820
and $100,006, respectively. In January 2014, the placement agent received 41,539 Warrants from the Offering. Pursuant to the Purchase Agreement, the
Company’s founders who are members of management (the “Founders”) agreed to cancel a corresponding number of
shares to those shares issued in the Offering and place in escrow a corresponding number of shares to be cancelled for each Warrant
Share issued. As a result, the Founders retired 138,463 and 276,924 shares of common stock in December 2013 and January 2014,
respectively. The Warrants are exercisable for a period
of five years from the original issue date. The initial exercise price with respect to the Warrants was $3.25 per share. On the
date of issuance, the Warrants were recognized as derivative liabilities as they did not have fixed settlement provisions because
their exercise prices could be lowered if the Company was to issue securities at a lower price in the future. As a result, the
Company recorded $3,431,541 as derivative liability warrants on the condensed consolidated balance sheet on January 13, 2014. On February 21, 2014, the Company amended
the terms of the 1,359,539 Warrants issued in the Offering to eliminate the anti-dilution provision and to lower the exercise
price of the Warrants from $3.25 to $3.00. As a result of the Warrant modifications, the Company re-measured the Warrant liability
on the modification date and recorded an unrealized loss on derivative liabilities of $1,074,795 and reclassified the aggregate
re-measured value of the Warrants of $6,037,639 to additional paid in capital. See Note 7 below. On various dates, during the six months
ended June 30, 2014, the Company received gross proceeds of $1,200,000 in connection with the exercise of 400,000 warrants into
400,000 shares of common stock at an exercise price of $3.00 per share, net of fees to be paid upon the exercise of the warrants
issued in the Offering per the term of the underwriter agreement of $30,000. Upon exercise, pursuant to the Purchase Agreement,
the Company’s Founders agreed to cancel a corresponding number of shares to be cancelled for each Warrant Share issued.
As a result, the Founders retired 400,000 shares of common stock. Nxt-ID, Inc. and
Subsidiary NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note
6 - Stockholders' Equity (continued) Between June 12, 2014 and June 17, 2014,
the Company completed a private offering with a group of accredited investors (the “Purchasers”) who had previously
participated in the Offering that occurred between December 30, 2013 and January 13, 2014 (as discussed in this Note 6) for total
net proceeds to the Company of $4,000. Pursuant to a securities purchase agreement with the Purchasers, the Company issued to
the Purchasers warrants (the “Warrants”) to purchase an aggregate of 400,000 shares (the “Shares”) of
the Company’s common stock at an exercise price of $3.00 per share. The Warrants are exercisable for a period of five years
from the original issue date. The exercise price for the Warrants is subject to adjustment upon certain events, such as stock
splits, combinations, dividends, distributions, reclassifications, mergers or other corporate change and dilutive issuances. The
Company determined that the effect of the issuance of the warrants was to induce the Purchasers to exercise warrants previously
issued to them in the Offering. As a result, the Company recorded an inducement expense of $1,177,760 for the six and three months
ended June 30, 2014. In connection with the sale of the Warrants,
the Company entered into a registration rights agreement with the Purchasers pursuant to which the Company agreed to register
the Shares and the shares of the common stock underlying the Warrants (the “Registrable Securities”) on a Form S-1
registration statement (the “Registration Statement”) to be filed with the SEC 90 days following the completion of
an underwritten public offering (the “Filing Date”) and to cause the Registration Statement to be declared effective
under the Securities Act within 90 days following the Filing Date (the “Required Effective Date”). If
the Registration Statement is not filed by the Filing Date or declared effective by the Required Effective Date, the Company is
required to pay partial liquidated damages to each Purchaser in the amount equal to 2% for the purchase price paid for the Warrants
then owned by such Purchaser for each 30-day period for which the Company is non-compliant. The following table summarizes the Company's warrants outstanding
at June 30, 2014: Warrants outstanding and exercisable On
January 4, 2013, a majority of the Company’s stockholders approved by written consent the Company’s 2013 Long-Term
Stock Incentive Plan (“LTIP”). The maximum aggregate number of shares of common stock that may be issued under the
LTIP, including stock awards and stock appreciation rights, is limited to 10% of the shares of common stock outstanding on the
first business or trading day of any fiscal year, which is 2,193,782 at January 1, 2014. During the six and three months ended
June 30, 2014, the Company issued 6,347 and 2,558 restricted shares, respectively, under the plan to three non-executive directors
with an aggregate fair value of $25,000 and $10,000, respectively. For the six months ended
June 30, 2014, the Company issued 18,282 shares of common stock with an aggregate fair value of $75,000 to consultants for services
rendered to the Company. Nxt-ID,
Inc. and Subsidiary NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note 7 – Derivative
liabilities Fair value of financial instruments
is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability
in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the
fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities
with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets
generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and
liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using
valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment,
the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability.
The Company has categorized its financial assets and liabilities measured at fair value into a three-level hierarchy. The conversion feature embedded
within the Company’s convertible notes payable and the warrants issued in connection with the Offering (as defined in Note
6 above) did not have fixed settlement provisions on the dates they were initially issued because the conversion and exercises
prices could have been lowered if the Company would have issued securities at lower prices before conversion. The derivative liabilities
were valued using the Black-Scholes option valuation model and the following weighted average assumptions on the following dates: The risk-free interest rate
was based on rates established by the Federal Reserve. Since the Company’s common stock has not been publicly traded for
a sufficiently long period of time, the Company is utilizing an expected volatility figure based on a review of the historical
volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public
companies within its industry. The expected life of the conversion feature was determined by the maturity date of the Note (as
defined in Note 5) and the expected life of the Warrants was determined by their expiration dates. The expected dividend yield
was based upon the fact that the Company has not historically paid dividends on its common stock and does not expect to pay dividends
on its common stock in the future. Fair Value Measurement Valuation Hierarchy ASC 820, “Fair Value
Measurements and Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure
fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted)
in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in
active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration,
for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s
own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within
the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. Nxt-ID,
Inc. and Subsidiary NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note 7 – Derivative
liabilities (continued) The following table provides
the liabilities carried at fair value measured on a recurring basis as of June 30, 2014: Quoted
Prices in active markets
(Level 1) Significant other
observable
inputs (Level 2) Significant
Unobservable inputs (Level
3) The carrying amounts of cash,
inventory, prepaid expenses, accounts payable and accrued liabilities approximate their fair value due to their short maturities.
The Company’s other financial instruments included its convertible notes payable obligations. The carrying value of these
instruments approximated fair value, as they bear terms and conditions comparable to market for obligations with similar terms
and maturities. The Company measures the fair value of financial assets and liabilities based on the exchange price that would
be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the
asset or liability in an orderly transaction between market participants on the measurement date. The Company maximizes the use
of observable inputs and minimizes the use of unobservable inputs when measuring fair value. Level 3 liabilities are valued
using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative
liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s accounting
department, who reports to the Principal Financial Officer, determines its valuation policies and procedures. The development
and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility
of the Company’s accounting department and are approved by the Principal Financial Officer. Level 3 Valuation Techniques Level 3 financial liabilities
consisted of the conversion feature liability and common stock purchase warrants for which there is no current market for these
securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements
categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and
recorded as appropriate. A significant decrease in the volatility or a significant decrease in the Company’s stock price,
in isolation, would result in a significantly lower fair value measurement. As of June 30, 2014, there
were no transfers in or out of Level 3 from other levels in the fair value hierarchy. The following table sets
forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring
basis: Nxt-ID,
Inc. and Subsidiary NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note
8 - Commitments and Contingencies Legal
Matters From time to time, the Company
is subject to legal proceedings arising in the ordinary course of business. Such matters are subject to uncertainties and outcomes
are not predictable with assurance. Management believes at this time that there are no ongoing matters that will have a material
adverse effect on the Company's business, financial position, results of operations, or cash flows. Subsequent to the acquisition
of 3D-ID, the Company licensed sixteen (16) U.S. patents. The Company does not generally conduct exhaustive patent searches to
determine whether the technology used in our products infringes patents held by third parties. The Company may face claims by
third parties that its products or technology infringe their patents or other intellectual property rights in the future. Any
claim of infringement could cause the Company to incur substantial costs defending against the claim, even if the claim is invalid,
and could distract the attention of the Company’s management. If any of the Company’s products are found to violate
third-party proprietary rights, it may be required to pay substantial damages. Commitments On August 19, 2011, the Company
signed a licensing agreement with Technest Holdings, Inc. (“Technest”) and Genex Technologies, Inc., which granted
3D-ID a perpetual sub-licensable, exclusive, worldwide license to use their intellectual property in U.S. federal and state markets
and a non-exclusive license in all other markets. The Company’s Chief Executive Officer (“CEO”) is a stockholder
of and was the former CEO of Technest. In consideration of the license of rights affected by this agreement, 3D-ID is obligated
to pay Technest a royalty equal to 5% of net sales. To date, no royalties have been paid. As the Technest patents do not constitute
part of the Company’s core intellectual property in its present or anticipated future product offerings, it has decided
to forgo the exclusive rights to the Technest patents. As a result, the Company reversed an accrual of $35,000 which represented
a minimum royalty to maintain certain exclusive rights. The Company retains a perpetual non-exclusive worldwide license to these
patents. In October 2012, the Company
entered into an agreement with a consultant to provide public relations and marketing services to the Company for a period of
three months. Pursuant to the agreement, the Company agreed to pay the consultant a monthly cash retainer of $5,000 to be paid
in cash and to issue the consultant shares of common stock per month with a fair value of $10,000 as compensation for services
provided. The Company entered into a new agreement with this consultant on November 1, 2013 for a period of six months and agreed
to pay the consultant a monthly cash retainer of $5,000 to be paid in cash. On June 1, 2014, the Company and the consultant agreed
to extend the contract for a period of one year from that date. In connection with the amended agreement, the Company agreed to
pay the consultant a monthly retainer of $15,000, of which $5,000 shall be in cash and $10,000 in unregistered shares of the Company’s
common stock. In addition to the monthly retainer the consultant is to be reimbursed for other expenses incurred in connection
with certain marketing events. During the six and three months ended June 30, 2014, the Company paid the consultant $162,767 and
$112,640, respectively pursuant to this agreement. Also during the six and three months ended June 30, 2014, 2,445 and 2,445 shares
of common stock, respectively, with a fair value of $10,000 and $10,000, respectively, were paid to the consultant as compensation
for services provided. During the six and three months ended June 30, 2013, 150,000 and 30,000 shares of common stock, respectively,
with a fair value of $60,000 and $30,000, respectively, were paid to the consultant as compensation for services provided. In January 2013, the Company
entered into an agreement with a development and manufacturing company to provide samples of the Company’s smart card design
for an aggregate of $150,000. Unless terminated early, the agreement will continue in full force and effect until the samples
have been delivered to the Company. During the six months ended June 30, 2014 and 2013 the Company paid $0 and $125,000, respectively,
in consulting fees pursuant to this agreement. During the three months ended June 30, 2014 and 2013 the Company paid $0 and $125,000,
respectively, in consulting fees pursuant to this agreement. Nxt-ID,
Inc. and Subsidiary NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note
8 - Commitments and Contingencies (continued) In July 2013, the Company
entered into an agreement with a consultant to provide public relations and marketing services to the Company for a period of
six months. Pursuant to the agreement, the Company agreed to pay the consultant a monthly cash fee of $4,000 and to issue the
consultant 4,000 shares of common stock per month as compensation for services provided. Commencing September 16, 2013, the agreement
was amended to a monthly cash fee of $4,000 and to issue the consultant $4,000 in shares of common stock per month. In January
2014 the agreement was amended whereby the Company agreed to pay the consultant a monthly payment of $4,000 in cash only. During
the six and three months ended June 30, 2014, the consultant was issued 833 and 0 shares, respectively with an aggregate grant
date fair value of $4,000 and $0. During the six and three months ended June 30, 2014, the Company paid the consultant $19,000
and $10,000 respectively pursuant to this agreement. On October 16, 2013, the
Company entered into a lease agreement for office space in Palm Bay, Florida. The term of the lease is for three years with a
monthly rent of $1,250 per month in the first year, increasing 3% annually thereafter. The Company incurred $7,500 and $3,750
of rent expense for the six and three months ended June 30, 2014, respectively. Minimum lease payments for non-cancelable operating
leases are as follows: On November 7, 2013, the
Company entered into a three-year distribution and supply agreement with Voice of Big Data Solutions, Pvt. Ltd. (“VOBD”)
for the distribution of the Company’s 3D facial recognition products in India and Sri Lanka on an exclusive basis and the
Middle East and Singapore on a non-exclusive basis. The agreement is subject to termination at any time after the initial three-year
term by either the Company or VOBD upon sixty (60) days written notice. On January 6, 2014, the Company
entered into an agreement with a business consulting firm to provide consulting services to the Company for a period of a year.
Pursuant to the agreement, the Company agreed to pay the consultant a monthly cash fee of $5,000 and to issue the consultant $5,000
worth of restricted shares of common stock per month as compensation for services provided. During the six and three months ended
June 30, 2014, the consultant was issued 7,060 and 3,656 shares, respectively, with an aggregate grant date fair value of $30,000
and $15,000, respectively, and $30,000 and $15,000 in cash for a total aggregate consulting fee of $60,000 and $30,000. Employment
Agreement Effective October 1, 2012,
Nxt-ID entered into an employment agreement with its Chief Executive Officer. The employment agreement provides for: Nxt-ID,
Inc. and Subsidiary NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note
8 - Commitments and Contingencies – Employment Agreement (continued) Eligibility
to receive equity awards as determined by the board of directors, or a committee of the
board of directors, composed in compliance with the corporate governance standards of
any applicable listing exchange. Note
9 - Subsequent Events The Company evaluates events
that have occurred after the balance sheet date but before the condensed consolidated financial statements are issued. On July 1, 2014 the Company
issued 2,558 shares of its common stock for the payment of services with an aggregate grant date fair market value of $10,000. On July 1, 2014 and July
15, 2014, the Company entered into purchase commitments with certain vendors in the amounts of $54,923 and $360,006, respectively.
These purchase orders were issued for further development of the Wocket™ with deliveries
on end units are expected in September 2014. Index
to Consolidated Financial Statements Nxt-ID,
Inc. and Subsidiary REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Nxt-ID, Inc. We have audited the accompanying consolidated
balance sheets of Nxt-ID, Inc. and Subsidiary (the “Company”) as of December 31, 2013 and 2012, and the related consolidated
statements of operations, changes in stockholders’ deficiency and cash flows for the years then ended. These financial statements
are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements
based on our audits. We conducted our audits in accordance with
the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and
perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.
Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that
are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on
a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles
used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred
to above present fairly, in all material respects, the consolidated financial position of Nxt-ID, Inc. and Subsidiary, as of December
31, 2013 and 2012, and the consolidated results of its operations and its cash flows for the years then ended in conformity with
accounting principles generally accepted in the United States of America. The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 2, the Company
has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. These
conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans
in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty. /s/ Marcum LLP Marcum LLP New York, NY February 24, 2014 CONSOLIDATED BALANCE SHEETS The accompanying notes are an integral part
of these consolidated financial statements. CONSOLIDATED STATEMENTS OF OPERATIONS The accompanying notes are an integral part
of these consolidated financial statements. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS'
DEFICIENCY FOR THE YEARS ENDED DECEMBER 31, 2013 AND
2012 The accompanying notes are an integral part
of these consolidated financial statements. CONSOLIDATED STATEMENTS OF CASH FLOWS The accompanying notes are an integral part
of these consolidated financial statements. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 1 - ORGANIZATION AND PRINCIPAL BUSINESS ACTIVITY Nxt-ID, Inc. (“Nxt-ID” or the
“Company”) was incorporated in the State of Delaware on February 8, 2012. Nxt-ID is a biometrics company focused on
the growing m-commerce market with an innovative MobileBio suite of biometric solutions that secure mobile platforms. The Company
also serves the access control and law enforcement facial recognition markets. 3D-ID, LLC (“3D-ID”) was organized
and registered in the State of Florida on February 14, 2011. 3D-ID is an early stage company engaged in the design, research and
development, integration, analysis, modeling, system networking, sales and support of intelligent surveillance, three dimensional
facial recognition and three dimensional imaging devices and systems primarily for identification and access control in the security
industries. On September 25, 2012, Nxt-ID, a company having
similar ownership as 3D-ID, acquired 100% of the membership interests in 3D-ID (the “Acquisition”) in exchange for
20,000,000 shares of Nxt-ID common stock. Since this was a transaction between entities under common control in accordance with
Accounting Standards Codification (“ASC”) 805, “Business Combinations”, Nxt-ID recognized the net assets
of 3D-ID at their carrying amounts in the accounts of Nxt-ID on the date that 3D-ID was organized. In connection with the Acquisition, the Company’s
Board of Directors and stockholders approved an amendment to the Certificate of Incorporation of the Company to increase the Company’s
authorized stock from 1,000 shares of common stock, par value $0.0001 per share, to 110,000,000 shares, consisting of 100,000,000
shares of common stock, par value $0.0001 per share, and 10,000,000 shares of blank-check preferred stock, par value $0.0001 per
share. The amendment to the Certificate of Incorporation was approved by the State of Delaware on December 10, 2012, however,
has been accounted for retroactively as of February 14, 2011, the date that 3D-ID was organized. The approval of the amendment
was delayed for administrative reasons and was merely a perfunctory task. NOTE 2 - GOING CONCERN AND MANAGEMENT PLANS The Company is an early stage entity and incurred
net losses of $1,544,534 during the year ended December 31, 2013. As of December 31, 2013 the Company had a working capital deficiency
and stockholders’ deficiency of $1,839,127 and $1,831,393, respectively. Subsequent to December 31, 2013, the Company raised
$900,000 through the issuance of common stock and warrants in a private placement (see Note 11). The Company received notice on
February 11, 2014 from Connecticut Innovations, Inc. requesting the conversion of their outstanding convertible note of $150,000
and accrued interest of $21,485 into common stock on February 17, 2014. Since February 17
th was a holiday the Company issued the shares on February 18, 2014. The Company issued 55,497 shares in full relief
of the outstanding debt of $171,485. In order to execute the Company's long-term
strategic plan to develop and commercialize its core products, the Company will need to raise additional funds, through public
or private equity offerings, debt financings, or other means. The Company can give no assurance that the cash raised subsequent
to December 31, 2013 or any additional funds raised will be sufficient to execute its business plan. Additionally, the Company
can give no assurance that additional funds will be available on reasonable terms, or available at all, or that it will generate
sufficient revenue to alleviate the going concern. These conditions raise substantial doubt about the Company’s ability
to continue as a going concern. The Company’s ability to execute its
business plan is dependent upon its ability to raise additional equity, secure debt financing, and/or generate revenue. Should
the Company not be successful in obtaining the necessary financing, or generate sufficient revenue to fund its operations, the
Company would need to curtail certain of its operational activities. The accompanying financial statements do not include any
adjustments that might be necessary should the Company be unable to continue as a going concern. NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES USE OF ESTIMATES IN THE FINANCIAL STATEMENTS The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates. The Company’s significant estimates and assumptions include the valuation allowance
relating to the Company’s deferred tax asset, the fair value of the Company’s stock, derivative financial instruments
and stock-based compensation. Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED) PRINCIPLES OF CONSOLIDATION The consolidated financial statements include
the accounts of Nxt-ID and its wholly-owned subsidiary, 3D-ID. Intercompany balances and transactions have been eliminated upon
consolidation. CASH The Company considers all highly liquid securities
with an original maturity date of three months or less when purchased to be cash equivalents. At December 31, 2013 and 2012, the
Company had no cash equivalents. Due to their short-term nature, cash equivalents are carried at cost, which approximates fair
value. CONCENTRATIONS OF CREDIT RISK Financial instruments that potentially subject
the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances in
financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit
accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. REVENUE RECOGNITION The Company’s 3D facial recognition
and identification products are currently available for sale. The Company recognizes revenue in connection with the sale of these
products when persuasive evidence of an arrangement exists, the service has been rendered or product delivery has occurred, the
price is fixed or readily determinable and collectability of the sale is reasonably assured. The Company requires all of its product sales
to be supported by evidence of a sale transaction that clearly indicates the selling price to the customer, shipping terms and
payment terms. Evidence of an arrangement generally consists of a contract or purchase order approved by the customer. The Company
recognizes revenue at the time in which it receives a confirmation that the goods were either tendered at their destination, when
shipped “FOB destination,” or transferred to a shipping agent, when shipped “FOB shipping point.” Delivery
to the customer is deemed to have occurred when the customer takes title to the product. Generally, title passes to the customer
upon shipment, but could occur when the customer receives the product based on the terms of the agreement with the customer. The
selling prices of all goods that the Company sells are fixed, and agreed to with the customer, prior to shipment. In the event a sale is made to a customer
under circumstances in which collectability is not reasonably assured, the Company either requires the customer to remit payment
prior to shipment or defers recognition of the revenue until payment is received. The Company maintains a reserve for amounts
which may not be collectible due to risk of credit losses. The Company’s sales typically do not include multiple deliverable
arrangements. LONG-LIVED ASSETS Long-lived assets, such as property and equipment,
are evaluated for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable
in accordance with ASC 360-10-35-17 through 35-35 "Measurement of an Impairment Loss." The Company assesses the impairment
of the assets based on the undiscounted future cash flow the assets are expected to generate compared to the carrying value of
the assets. If the carrying amount of the assets is determined not to be recoverable, a write-down to fair value is recorded.
Management estimates future cash flows using assumptions about expected future operating performance. Management's estimates of
future cash flows may differ from actual cash flow due to, among other things, technological changes, economic conditions or changes
to the Company's business operations. PROPERTY AND EQUIPMENT Property and equipment consisting of furniture
and fixtures is stated at cost. The costs of additions and betterments are capitalized and expenditures for repairs and maintenance
are expensed in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated
depreciation are removed from the accounts and any gain or loss is included in income. Depreciation of property and equipment
is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows: Depreciation expense for the year ended December
31, 2013 and 2012 was $585 and $99, respectively. Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED) INVENTORY Inventory is valued at the lower of cost or
market with cost determined using the first-in, first-out method and with market defined as the lower of replacement cost or realizable
value. Inventory is comprised principally of raw materials. CONVERTIBLE INSTRUMENTS The Company applies the accounting standards
for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion
options. The accounting standards require companies to bifurcate conversion options from their host instruments and account for
them as free standing derivative financial instruments according to certain criteria. The criteria includes circumstances in which
(i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic
characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument
and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with
changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative
instrument would be considered a derivative instrument. The derivative is subsequently marked to market
at each reporting date based on current fair value, with the changes in fair value reported in the results of operations. Conversion options that contain variable settlement
features such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at
exercise prices more favorable than that featured in the hybrid contract generally result in their bifurcation from the host instrument. The Company accounts for convertible debt
instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments
in accordance with ASC 470-20 “Debt with Conversion and Other Options”. The Company records, when necessary, discounts
to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between
the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price
embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt. See Note 5. DERIVATIVE FINANCIALS INSTRUMENTS The Company does not use derivative instruments
to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of its financial instruments to determine
if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments
that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued
at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based
derivative financial instruments, the Company uses the Black-Scholes option valuation model to value the derivative instruments
at inception and on subsequent valuation dates. The conversion feature embedded within Company’s convertible note payable
does not have fixed settlement provisions as the conversion price varies based on the trading price of the Company’s common
stock and the potential number of common shares to be issued upon conversion is indeterminable up to a maximum of 120,000 shares
of common stock. In addition, the warrants issued in connection with the Offering (as defined in Note 8) do not have fixed settlement
provisions as their exercise prices may be lowered if the Company conducts an offering in the future at a price per share below
the exercise price of the warrants. Accordingly, the conversion feature and warrants have been recognized as derivative instruments.
Although the Company determined the conversion feature and warrants both include a implied downside protection feature, it performed
a Monte-Carlo simulation and concluded that the difference in value between the Monte-Carlo simulation and the Black-Scholes valuation
model is de minimis and the use of the Black-Scholes valuation model is considered to be a reasonable method to value each instrument.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity,
is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current
or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of
the balance sheet date. (See Note 6.) DEBT DISCOUNT AND AMORTIZATION OF DEBT
DISCOUNT Debt discount represents the fair value of
embedded conversion options of various convertible debt instruments and attached convertible equity instruments issued in connection
with debt instruments. The debt discount is amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt,
using the straight-line method which approximates the interest method. The amortization of debt discount is included as a component
of other expenses in the accompanying statements of operations. Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED) INCOME TAXES The Company uses the asset and liability method
of accounting for income taxes in accordance with ASC Topic 740, "Income Taxes." Under this method, income tax expense
is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary
differences resulting from matters that have been recognized in an entity's financial statements or tax returns. Deferred tax
assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates
is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to
reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely
than not some portion or all of the deferred tax assets will not be realized. ASC Topic 740-10-30 clarifies the accounting
for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and
measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken
in a tax return. ASC Topic 740-10-40 provides guidance on de-recognition, classification, interest and penalties, accounting in
interim periods, disclosure, and transition. The Company will classify as income tax expense any interest and penalties. The Company
has no material uncertain tax positions for any of the reporting periods presented. Generally, the tax authorities may examine
the partnership/corporate tax returns for three years from the date of filing. All periods are open for examination since the
Company is still in the process of filing its tax returns for all periods. Therefore, the Company’s net operating loss carryovers
will not be available to offset future taxable income, if any, until the returns are filed. STOCK-BASED COMPENSATION The Company accounts for share-based awards
exchanged for employee services at the estimated grant date fair value of the award. The Company estimates the fair value of employee
stock options using the Black-Scholes option pricing model. The Company amortizes the fair value of employee stock options on
a straight-line basis over the requisite service period of the awards. Compensation expense includes the impact of an estimate
for forfeitures for all stock options. The Company accounts for equity instruments
issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to
periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Non-employee stock-based compensation
charges are amortized over the vesting period or as earned. NET LOSS PER SHARE Basic loss per share was computed using the
weighted average number of common shares outstanding. Diluted loss per share includes the effect of diluted common stock equivalents.
Potentially dilutive securities realizable from the exercise of 454,600 warrants and from the conversion of the Company’s
notes payable into 50,000 shares of common stock as of December 31, 2013, respectively, were excluded from the computation of
diluted net loss per share because the effect of their inclusion would have been anti-dilutive. As of December 31, 2012 there
were no potentially dilutive securities. RESEARCH AND DEVELOPMENT Research and development costs consist of
expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge, which will
be useful in developing new products or processes. The Company expenses all research and development costs as incurred. RECENT ACCOUNTING PRONOUNCEMENTS The Financial Accounting Standards Board (“FASB”)
has issued Accounting Standards Update (“ASU”) No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized
Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the
FASB Emerging Issues Task Force). The amendments in this ASU state that an unrecognized tax benefit, or a portion of an unrecognized
tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward,
a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar
tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction
to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable
jurisdiction does Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED) RECENT ACCOUNTING PRONOUNCEMENTS, CONTINUED not require the entity to use, and the entity
does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial
statements as a liability and should not be combined with deferred tax assets. The amendments in this ASU are effective for fiscal
years, and interim periods within those years, beginning after December 15, 2013. For nonpublic entities, the amendments are effective
for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted. The
amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application
is permitted. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial
position and results of operations. NOTE 4 - ACCRUED EXPENSES Accrued expenses and other current liabilities consist of the following: NOTE 5 - CONVERTIBLE NOTES PAYABLE On December 13, 2012, the Company received
approval from Connecticut Innovations, Inc. (“CII”) for a Convertible Note (the “Note”) in the amount
of $150,000 The Company received the first tranche of $75,000 on December 21, 2012, and the second tranche of $75,000 on January
31, 2013. As of December 31, 2013, the Company has accrued $17,497 in interest in connection with the Note. The Note’s maturity
date is December 21, 2014. The Note accrues interest at the annual rate
of 12% and all principal and interest is repayable in full on December 21, 2014 if it has not been converted. CII has the option
to convert the outstanding principal and interest on the Note into shares of the Company’s common stock at a discount of
25% of the Company’s common stock price, but not less than $1.25 as agreed by the two parties. In accordance with ASC 470,
“Accounting for Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratios,” the
Note is considered to have a beneficial conversion feature as the effective conversion price will be less than the Company’s
stock price. In addition, in accordance with ASC 815 the conversion feature is considered to be a derivative instrument
as the conversion price varies based on the trading price of the Company’s common stock and the potential number of common
shares to be issued upon conversion is variable up to a maximum of 120,000 shares. At December 31, 2013, the note payable is convertible
into 50,000 shares of the Company’s common stock. The conversion feature embedded in the note
payable was triggered once the Company completed a qualified financing, as defined in the note agreement. The Company determined
that a qualified financing occurred during the second quarter of 2013 in connection with the issuance of the registered units
under its initial registration statement (See Note 8). As a result, the Company recorded a conversion feature liability
and a corresponding debt discount of $44,966 on the accompanying consolidated balance sheet on the date the qualified financing
was determined to have occurred. The unrealized loss on the change in the fair
value of the conversion feature liability was determined to be $73,974 for the year ended December 31, 2013 (See Note 6). Amortization
expense relating to the Company’s debt discount for the year ended December 31, 2013 was $18,211. Nxt-ID, Inc.
and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 6 - DERIVATIVE LIABILITIES Fair value of financial instruments is defined
as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly
transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of
assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily
available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally
have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities
that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models
that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of
which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. The Company
has categorized its financial assets and liabilities measured at fair value into a three-level hierarchy. The conversion feature embedded within the
Company’s convertible notes payable and the warrants issued in connection with the Offering (as defined in Note 8) do not
have fixed settlement provisions because the conversion and exercises prices may be lowered if the Company issues securities at
lower prices in the future. The derivative liabilities were valued using
the Black-Scholes option valuation model and the following weighted average assumptions on the following dates: The risk-free interest rate was based on rates
established by the Federal Reserve. Since the Company’s stock has not been publicly traded for a sufficiently long period
of time, the Company is utilizing an expected volatility figure based on a review of the historical volatilities, over a period
of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry.
The expected life of the conversion feature was determined by the maturity date of the Note and the expected life of the warrants
was determined by their expiration dates. The expected dividend yield was based upon the fact that the Company has not historically
paid dividends on its common stock, and does not expect to pay dividends on its common stock in the future. Fair Value Measurement Valuation Hierarchy ASC 820, “Fair Value Measurements and
Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This
hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets
for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or
inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially
the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions
used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy
is determined based on the lowest level input that is significant to the fair value measurement. The following table provides the liabilities
carried at fair value measured on a recurring basis as of December 31, 2013: Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 6 - DERIVATIVE LIABILITIES (CONTINUED) The carrying amounts of cash, inventory, prepaid
expenses, accounts payable and accrued liabilities approximate their fair value due to their short maturities. The Company’s
other financial instruments include its convertible notes payable obligations. The carrying value of these instruments approximate
fair value, as they bear terms and conditions comparable to market, for obligations with similar terms and maturities. The Company
measures the fair value of financial assets and liabilities based on the exchange price that would be received for an asset or
paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly
transaction between market participants on the measurement date. The Company maximizes the use of observable inputs and minimizes
the use of unobservable inputs when measuring fair value. Level 3 liabilities are valued using unobservable
inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For
fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s accounting department, who
reports to the Principal Financial Officer, determines its valuation policies and procedures. The development and determination
of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s
accounting department and are approved by the Principal Financial Officer. Level 3 Valuation Techniques Level 3 financial liabilities consist of the
conversion feature liability and common stock purchase warrants for which there are no current market for these securities such
that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized
within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded
as appropriate. A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation,
would result in a significantly lower fair value measurement. As of December 31, 2013, there were no transfers
in or out of level 3 from other levels in the fair value hierarchy. The following table sets forth a summary of
the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis: NOTE 7 - ADVANCES FROM OFFICER During the year ended December 31, 2013, the
Company received an aggregate of $64,000 of cash advances from an officer of the Company and made aggregate repayments of $64,000.
The advances were non-interest bearing and short-term in nature. NOTE 8 - STOCKHOLDERS’ DEFICIENCY Common Stock Issuances During the first quarter of 2013, the Company
issued 204,000 shares of common stock at $0.25 per share in a private placement and received net proceeds of $51,000. On May 10, 2013, a registration statement
under the Securities Act of 1933 with respect to a public offering of 1,000,000 Units at $1.00 per unit consisting of one share
of common stock and one warrant to purchase one share of common stock was declared effective by the U.S. Securities and Exchange
Commission. The warrants have an exercise price of $1.00 per share and a term of three years and contain customary anti-dilution
provisions. During the year ended December 31, 2013, the Company sold 304,600 Units and has received proceeds of $304,600, less
offering costs of approximately $109,000. Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 8 - STOCKHOLDERS’ DEFICIENCY (CONTINUED) On January 13, 2014, the Company closed a
“best efforts” private offering of $1,000,000 (the “Offering”) with a group of accredited investors (the
“Purchasers”) and the Company exercised the oversubscription amount allowed in the Offering of $350,000, for total
gross proceeds to the Company of $1,350,000 before deducting placement agent fees and other expenses. Pursuant to a securities
purchase agreement with the Purchasers (the “Purchase Agreement”), the Company issued to the Purchasers (i) 415,387
shares (the “Shares”) of the Company’s common stock, par value, $0.0001 (the “Common Stock”) and
(ii) 1,350,000 warrants (the “Warrants”) to purchase shares (the “Warrant Shares” and together with the
Shares and the Warrants, the “Securities”) of the Company’s Common Stock at an exercise price of $3.25 per share.
In connection with the Offering, 138,463 units were sold at the end of December of 2013 and 276,924 units were sold in January
2014, all at $3.25 per unit. As a result, the Company received aggregate gross proceeds of $450,000 in December 2013 from the
issuance of 138,463 shares of common stock and 450,000 warrants, and the Company received $900,000 in January 2014 from the issuance
of 276,924 shares of common stock and 900,000 warrants. Costs incurred associated with the Offering in December 2013 were $56,820.
In January 2014, the placement agent received 41,539 warrants from the Offering. The Warrants are exercisable for a period
of five years from the original issue date. The exercise price with respect to the Warrants is $3.25 per share. The exercise price
for the Warrants is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications,
mergers or other corporate change and dilutive issuances. See Note 6. Pursuant to the Purchase Agreement, the Company’s
founders who are members of management (the “Founders”) agreed to cancel a corresponding number of shares to those
Shares issued in the Offering and place in escrow a corresponding number of shares to be cancelled for each Warrant Share issued.
As a result, the Founders retired 138,463 and 276,924 shares of common stock in December 2013 and January 2014, respectively. In connection with the sale of the Shares
and Warrants, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with
the Purchasers, pursuant to which the Company agreed to register the Shares and the shares of our Common Stock underlying the
Warrants (the “Registrable Securities”) on a Form S-1 registration statement (the “Registration Statement”)
to be filed with the SEC on the earlier of February 25, 2014 or within 3 business days following the filing of our Annual Report
on Form 10-K for the year ended December 31, 2013 (the “Filing Date”) and to cause the Registration Statement to be
declared effective under the Securities Act within 90 days following the Filing Date (the “Required Filing Date”).
If the Registration Statement is not filed by the Filing Date or declared effective by the Required Effective Date, the Company
is required to pay partial liquidated damages to each Purchaser in the amount equal to 2% for the purchase price paid for the
Shares and Warrants then owned by such Purchaser for each 30-day period for which the Company is non-compliant. During the year ended December 31, 2012, the
Company issued 632,000 shares of common stock at $0.25 per share and received proceeds of $158,000. During the year ended December 31, 2012, the
founders of 3D-ID contributed $4,300 to fund the Company’s activities. Common Stock Purchase Warrants During the year ended December 31, 2013, the
Company received $300,000 in net proceeds from the exercise of 300,000 warrants from holders of the units. The following table summarizes the Company's warrants outstanding
at December 31, 2013: Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 8 - STOCKHOLDERS’ DEFICIENCY (CONTINUED) Long-Term Stock Incentive Plan On January 4, 2013, a majority the Company’s
stockholders approved by written consent the Company’s 2013 Long-Term Stock Incentive Plan (“LTIP”). The maximum
aggregate number of shares of common stock that may be issued under the LTIP, including stock awards and stock appreciation rights,
is limited to 10% of the shares of common stock outstanding on the first business or trading day of any fiscal year, which is
2,193,782 at December 31, 2013. During the year ended December 31, 2013, the Company issued 48,833 restricted shares under the
plan to two non-executive directors with an aggregate fair value of $30,000. During the year ended December 31, 2013, the Company
issued 100,000 shares with an aggregate value of $100,000 to four non-executive employees. At December 31, 2013, a total of 148,833
shares have been issued from the Plan and 2,044,949 are available to be issued. NOTE 9 - INCOME TAXES As of December 31, 2013 and 2012, the Company
had approximately $1,641,000 and $194,000, respectively, of US federal and state net operating loss (“NOLs”) carryovers
available to offset future taxable income, which expire beginning in 2033. In accordance with Section 382 of the Internal
Revenue Code, deductibility of the Company’s NOLs may be subject to an annual limitation in the event of a change of control.
The Company has performed a preliminary evaluation and has determined that a change of control has not occurred as of December
31, 2013. The Company is still in the process of filing its tax returns for all periods. Therefore, the Company’s net operating
loss carryovers will not be available to offset future taxable income, if any, until the returns are filed. The income tax provision (benefit) consists of the following: A reconciliation of the effective income tax rate and the statutory
federal income tax rate is as follows: In assessing the realization of deferred tax
assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be
realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the
periods in which temporary differences representing net future deductible amounts became deductible. Management considers the
scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.
After consideration of all of the information available, Management believes that significant uncertainties exists with respect
to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended
December 31, 2013 and 2012, the change in valuation allowance was $563,400 and $75,700. Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 9 - INCOME TAXES (CONTINUED) The tax effects of temporary differences that give rise to deferred
tax assets are presented below: NOTE 10 - COMMITMENTS AND CONTINGENCIES LEGAL MATTERS From time to time, the Company is subject
to legal proceedings arising in the ordinary course of business. Such matters are subject to uncertainties and outcomes are not
predictable with assurance. Management believes at this time, there are no ongoing matters that will have a material adverse effect
on the Company's business, financial position, results of operations, or cash flows. Subsequent to the acquisition of 3D-ID, the
Company licensed sixteen (16) U.S. patents. The Company does not generally conduct exhaustive patent searches to determine whether
the technology used in our products infringes patents held by third parties. The Company may face claims by third parties that
its products or technology infringe their patents or other intellectual property rights in the future. Any claim of infringement
could cause the Company to incur substantial costs defending against the claim, even if the claim is invalid, and could distract
the attention of the Company’s management. If any of the Company’s products are found to violate third-party proprietary
rights, it may be required to pay substantial damages. COMMITMENTS Around the date of the Acquisition the Company
signed a licensing agreement with Aellipsys Holdings, Inc., an unrelated party, which granted 3D-ID a perpetual sub-licensable,
non-exclusive, worldwide license to use their intellectual property, including, but not limited to, those of GeoMetrix, Inc.,
which has 18 patents in the field of 3D facial recognition and Active ID systems for access control and identification of individuals.
3D-ID is required to pay Aellipsys Holdings a royalty for each product manufactured, sold and installed at a customer by 3D-ID
equal to two thousand dollars ($2,000). An additional royalty of ten percent (10%) is payable on recurring revenues from the same
installation. The term of the initial agreement is five years. During the years ended December 31, 2013 and 2012 the Company paid
$0 and $10,000, respectively, in royalty payments to GeoMetrix, Inc. On August 19, 2011, the Company signed a licensing
agreement with Technest Holdings, Inc. and Genex Technologies, Inc., which granted 3D-ID a perpetual sub-licensable, exclusive,
worldwide license to use their intellectual property in U.S. Federal and State markets, and a non-exclusive license in all other
markets. The Company’s Chief Executive Officer (“CEO”) is a stockholder of and was the former CEO of Technest
Holdings, Inc. In consideration of the license of rights affected by this Agreement, 3D-ID is obligated to pay Technest a royalty
equal to 5% of net sales with a minimum royalty of $15,000 during the first two years and $20,000 for each contract year thereafter.
For the years ended December 31, 2013 and 2012, the Company incurred $15,000 each year, in connection with the agreement. As of
December 31, 2013, $35,000 of minimum royalties are included in accrued expenses in the consolidated balance sheet in connection
with the agreement. Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 10 - COMMITMENTS AND CONTINGENCIES
(CONTINUED) In October 2012, the Company entered into
an agreement with a consultant to provide public relations and marketing services to the Company for a period of three months.
Pursuant to the agreement, the Company agreed to pay the consultant a monthly cash fee of $5,000 and to issue the consultant shares
of common stock per month with a fair value of $10,000 as compensation for services provided. During the year, the Company and the consultant verbally extended
the agreement until October 30, 2013, with the same terms and conditions. The Company entered into a new agreement on November
1, 2013 for a period of six months and agreed to pay the consultant a monthly cash fee of $5,000. During the year ended December 31, 2013, the
Company issued 165,744 shares of common stock with an aggregate fair value of $90,000 and paid $60,000 in cash as compensation
for services provided from January 1, 2013 to December 31, 2013. In addition the consultant was paid $41,875 for additional marketing
services. In November 2012, the Company entered into
an agreement with a technology consulting firm to provide strategic marketing and sales services to the Company with respect to
developing business opportunities with the Federal Government through March 2013. Pursuant to the agreement, the Company agreed
to pay the consultant a monthly cash fee of $5,500 and a sales commission of 5% on executed contracts. The agreement ended in
May, 2013. For the years ended December 31, 2013 and 2012, the Company incurred expenses in connection with this agreement of
$11,000 and $5,500, respectively. In January 2013, the Company entered into
an agreement with a consultant to provide business development services to the Company for a period of three months. Pursuant
to the agreement, the Company issued the consultant 20,000 shares of common stock with an aggregate fair value of $5,000.
The company also entered into an agreement with the same consultant for additional services ending December 31, 2013 in the amount
of $65,000 in cash and 4,878 shares of common stock with a fair value of $20,000. In January 2013, the Company entered into
an agreement with a development and manufacturing company to provide samples of the Company’s smart card design for an aggregate
of $150,000. Unless terminated early, the agreement will continue in full force and effect until the samples have been delivered
to the Company. During the year ended December 31, 2013 the Company paid $125,000 and samples are currently in the process of
being built. In July 2013, the Company entered into an
agreement with a consultant to provide public relations and marketing services to the Company for a period of six months. Pursuant
to the agreement, the Company agreed to pay the consultant a monthly cash fee of $4,000 and to issue the consultant 4,000 shares
of common stock per month as compensation for services provided. Commencing September 16, 2013, the agreement was amended to a
monthly cash fee of $4,000 and to issue the consultant $4,000 in shares of common stock per month. During the year ended December
31, 2013, the consultant was issued 13,767 shares with an aggregate fair value of $42,240. In August 2013, the Company entered into an
agreement with a consultant to provide public relations and marketing services to the Company for a period of three months. Pursuant
to the agreement, the Company issued the consultant 24,000 shares of common stock with an aggregate fair value of $24,000 as compensation
for services provided. On October 16, 2013, the Company entered into
a lease agreement for office space in Palm Bay, Florida. The term of the lease is for three years with a monthly rent of $1,250
per month in the first year, increasing 3% annually thereafter. The Company’s rent expense in 2013 was not material, however,
it is obligated to pay $15,000 in 2014, 15,450 in 2015 and 15,914 in 2016, for a total remaining lease commitment as of December
31, 2013 of $46,364. Nxt-ID, Inc. and Subsidiary NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 10 - COMMITMENTS AND CONTINGENCIES
(CONTINUED) On November 7, 2013, the Company entered into
a three-year distribution and supply agreement with Voice of Big Data Solutions, Pvt. Ltd. (“VOBD”) for the distribution
of the Company’s 3D facial recognition products in India and Sri Lanka on an exclusive basis and The Middle East and Singapore
on a non-exclusive basis. The agreement is subject to termination at any time after the initial three-year term by either the
Company or VOBD upon sixty (60) days written notice. EMPLOYMENT AGREEMENT Effective October 1, 2012, Nxt-ID entered
into an employment agreement with its Chief Executive Officer. The employment agreement provides for: NOTE 11 - SUBSEQUENT EVENTS The Company evaluates events that have occurred
after the balance sheet date but before the financial statements are issued. In January 2014, upon the successful completion
of the Wocket prototype, the Chief Executive Officer’s salary was increased to $300,000 from $150,000 pursuant to his employment
agreement. The Company received notice on February 11,
2014 from CII requesting the conversion of their outstanding convertible note of $150,000 and accrued interest of $21,485 into
common stock on February 17, 2014. Since February 17 th was a holiday the Company
utilized the trading price of its common stock on February 18, 2014 in order to calculate the number of common shares to issue
to CII. The company will issue 55,497 shares in full relief of the outstanding debt of $171,485. Shares
of Common Stock Warrants
to Purchase Shares of Common Stock Newport
Coast Securities Inc. The
date of this prospectus is , 2014 PART
II – INFORMATION NOT REQUIRED IN THE PROSPECTUS Item
13. Other Expenses of Issuance and Distribution. All
amounts are estimates other than the SEC’s registration fee. We are paying all expenses of the offering listed above. No
portion of these expenses will be borne by the selling stockholders. The selling stockholders, however, will pay any other expenses
incurred in selling their common stock, including any brokerage commissions or costs of sale. Item
14. Indemnification of Directors and Officers. Section
102(b)(7) of the General Corporation Law of the State of Delaware allows a corporation to provide in its certificate of incorporation
that a director of the corporation will not be personally liable to the corporation or its stockholders for monetary damages for
breach of fiduciary duty as a director, except where the directors breached the duty of loyalty, failed to act in good faith,
engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase
in violation of Delaware corporate law or obtained an improper personal benefit. Our certificate of incorporation provides for
this limitation of liability. Section
145 of the General Corporation Law of the State of Delaware provides that a Delaware corporation may indemnify any person who
was, is or is threatened to be made, party to any threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact
that such person is or was an officer, director, employee or agent of such corporation or is or was serving at the request of
such corporation as a director, officer employee or agent of another corporation or enterprise. The indemnity may include expenses
(including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person
in connection with such action, suit or proceeding, provided such person acted in good faith and in a manner he reasonably believed
to be in or not opposed to the corporation’s best interests and, with respect to any criminal action or proceeding, had
no reasonable cause to believe that his conduct was illegal. A Delaware corporation may indemnify any persons who are, or were,
a party to any threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that
such person is or was a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses
(including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement
of such action or suit, provided such person acted in good faith and in a manner he reasonably believed to be in or not opposed
to the corporation’s best interests, provided that no indemnification is permitted without judicial approval if the officer,
director, employee or agent is adjudged to be liable to the corporation. Where an officer or director is successful on the merits
or otherwise in the defense of any action referred to above, the corporation must indemnify him against the expenses which such
officer or directors has actually and reasonably incurred. Section
145 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer,
employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or
agent of another corporation or enterprise, against any liability asserted against him and incurred by him in any such capacity,
or arising out of his status as such, whether or not the corporation would otherwise have the power to indemnify him under Section
145. The
indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter
acquire under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person’s
official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased
to be a director, officer, employee, or agent and shall inure to the benefit of the heirs, executors, and administrators of such
person. We
maintain a general liability insurance policy that covers liabilities of directors and officers of our corporation arising out
of claims based on acts or omissions in their capacities as directors or officers. Item
15. Recent Sales of Unregistered Securities. At
inception (February 2011), our Chief Executive Officer and Chief Technology Officer contributed approximately $10,000 in cash
in exchange for our securities in respect of various start-up costs. From
August 1, 2012 until January 9, 2013, we conducted a private placement whereby we raised $209,000 through the sale of 836,000
shares of stock, at a purchase price of $0.25 per share (the “2012 Offering”). The Company used the proceeds
from the above stock issuances for general working capital purposes. The shares of common stock issued in the transaction described
above have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and were issued
and sold in reliance upon the exemption from registration contained in Section 4(a)(2) of the Securities Act and Regulation D
promulgated thereunder. These securities may not be offered or sold in the United States in the absence of an effective registration
statement or exemption from the registration requirements under the Securities Act. On
October 5, 2012, the Company entered into an agreement with a consultant to provide public relations and marketing services to
the Company for a period of three months. Pursuant to the agreement, the Company agreed to pay the consultant a monthly cash fee
of $5,000 and to issue the consultant shares of common stock per month with a fair value of $10,000 as compensation for services
provided. The Company issued the consultant 120,000 shares of common stock in connection with the agreement. This agreement has
been extended until March 31, 2013 on the same terms and conditions. In connection with the extension, 120,000 shares of common
stock with a fair value of $30,000 as compensation for services provided from January 1, 2013 to March 31, 2013 was issued on
March 31, 2013. On
January 9, 2013, the Company entered into an agreement with a consultant to provide business development services to the Company
for a period of three months. Pursuant to the agreement, the Company issued the consultant 20,000 shares of common stock. On
January 11, 2013, we awarded $5,000 of stock to our director, David Gust, as a quarterly retainer at an assumed price of $0.25
per share. The shares were awarded from our Long-term Incentive Plan. On
March 31, 2013, we awarded 20,000 shares of common stock to our director, David Gust, as a quarterly retainer at an assumed price
of $0.25 per share. During
the three months ended September 30, 2013, the Company issued 6,333 unregistered shares of common stock with a value of $10,000
to a Board member. During
the three months ended September 30, 2013, the Company issued 77,744 unregistered shares of common stock with a value of $100,400
to consultants. During
the three months ended September 30, 2013, the Company issued 100,000 unregistered shares of common stock with a value of $100,000
to non-executive employees. Between
October 15, 2013 and December 31, 2013 the Company issued 13,145 shares of common stock to consultants and board members with
an aggregate fair value of $55,840. The
above transactions were not registered under the Securities Act in reliance on an exemption from registration set forth in Section
4(a)(2) of the Securities Act in a transaction by the Company not involving a public offering as the shares were granted as compensation
for services and the recipients had access to adequate current public information concerning the Company. Between
December 30, 2013 and January 13, 2014, the Company completed a “best efforts” private offering of $1,000,000
(the “Offering”) with a group of accredited investors (the “Purchasers”) and the Company exercised the
oversubscription amount allowed in the Offering of $350,000, for total gross proceeds to the Company of $1,350,000 before deducting
placement agent fees and other expenses. Pursuant to a securities purchase agreement with the Purchasers (the “Purchase
Agreement”), the Company issued to the Purchasers (i) 415,387 shares (the “Shares”) of the Company’s common
stock, par value, $0.0001 (the “Common Stock”) and (ii) warrants (the “Warrants”) to purchase shares (the
“Warrant Shares” and together with the Shares and the Warrants, the “Securities”) of our Common Stock
at an exercise price of $3.25 per share. On
January 13, 2014, we issued a warrant to acquire an aggregate of 41,539 shares of our common stock (the “Agent Warrant”)
to the placement agent and its sub-agents, or their respective designees, in the Offering. The Agent Warrant is exercisable
for a period of five years from the original issuance date with an exercise price of $3.25 per share. The exercise price
of the Agent Warrant is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions,
reclassifications, mergers or other corporate change and dilutive issuances. Between
June 12, 2014 and June 17, 2014, the Company completed a private offering (the “Offering”) with a group of accredited
investors, who had previously participated in the Company’s private offering that had occurred between December 30, 2013
and January 13, 2014 (the “Purchasers”) for total net proceeds to the Company of $4,000. Pursuant to a securities
purchase agreement with the Purchasers (the “Purchase Agreement”), the Company issued to the Purchasers warrants (the
“Warrants”) to purchase an aggregate of 400,000 shares (the “Warrant Shares”) of our Common Stock at an
exercise price of $3.00 per share. The Warrants are exercisable for a period of five years from the original issue date. The exercise
price for the Warrants is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions,
reclassifications, mergers or other corporate change. If exercised, the Warrants will provide the Company with gross proceeds
of approximately $1.2 million. The Company determined that the effect of the issuance of the warrants was to induce the
Purchasers to exercise warrants previously issued to them in the Offering and thus accounted for the issuance as an inducement. The
sale and the issuance of the Securities, the Agent Warrants, and the Warrants were offered and sold in reliance upon exemptions
from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) and
Rule 506 of Regulation D promulgated under the Securities Act (“Regulation D”). We made this determination
based on the representations of each Purchaser which included, in pertinent part, that each such Purchaser was (a) an “accredited
investor” within the meaning of Rule 501 of Regulation D or (b) a “qualified institutional buyer” within the
meaning of Rule 144A under the Securities Act and upon such further representations from each Purchaser that (i) such Purchaser
is acquiring the securities for his, her or its own account for investment and not for the account of any other person and not
with a view to or for distribution, assignment or resale in connection with any distribution within the meaning of the Securities
Act, (ii) the Purchaser agrees not to sell or otherwise transfer the purchased shares unless they are registered under the Securities
Act and any applicable state securities laws, or an exemption or exemptions from such registration are available, (iii) the Purchaser
has knowledge and experience in financial and business matters such that he, she or it is capable of evaluating the merits and
risks of an investment in us, (iv) the Purchaser had access to all of our documents, records, and books pertaining to the investment
and was provided the opportunity to ask questions and receive answers regarding the terms and conditions of the offering and to
obtain any additional information which we possessed or were able to acquire without unreasonable effort and expense, and (v)
the Purchaser has no need for the liquidity in its investment in us and could afford the complete loss of such investment. In
addition, there was no general solicitation or advertising for securities issued in reliance upon Regulation D. See
Exhibit Index following the signature page. Item
17. Undertakings. Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant
of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,
the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue. The undersigned
registrant hereby undertakes that: (1)
For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed
as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant
pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement
as of the time it was declared effective. (2)
For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof. SIGNATURES Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereonto duly authorized, in the City of Shelton, State of Connecticut, on August 14,
2014. We,
the undersigned officers and directors of Nxt-ID, Inc., hereby severally constitute Gino Pereira, and each of them singly, as
true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names, in the capacities
indicated below the registration statement filed herewith and any amendments to said registration statement, and generally to
do all such things in our name and behalf in our capacities as officers and directors to enable Nxt-ID, Inc. to comply with the
provisions of the Securities Act of 1933 and all requirements of the Securities and Exchange Commission, hereby ratifying and
confirming our signatures as they may be signed by our said attorneys, or any of them, to said registration statement and any
and all amendments thereto, including any registration statement filed pursuant to Rule 462(b) of the Securities Act of 1933.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons
in the capacities and on the dates indicated. EXHIBIT
INDEX *
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or
prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section
18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections. **
To be filed by amendment. †
Management contract or compensatory plan or arrangement. ††
Confidential treatment has been received for schedules A, C, and D to the agreement E-1 Exhibit 1.1 [_______]
Shares of Common Stock1 and Warrants
to Purchase [_______] Shares of Common Stock NXT-ID,
INC. PURCHASE
AGREEMENT [________], 2014 NORTHLAND
SECURITIES, INC. As
Representative of the several Underwriters
named in Schedule I hereto c/o
Northland Securities, Inc. 45
S. 7th St., Suite 2000 Minneapolis,
Minnesota 55402 Ladies
and Gentlemen: Nxt-ID,
Inc., a Delaware corporation (the “Company”), proposes to sell to the several Underwriters named in
Schedule I hereto (“you” or, the “Underwriters”), for whom Northland Securities,
Inc. is acting as representative (the “Representative”), (i) an aggregate of [●] authorized but
unissued shares (the “Firm Shares”) of Common Stock, $0.0001 par value per share (the “Common
Stock”), of the Company and (ii) warrants of the Company, in the form set forth in Exhibit A hereto, to purchase
[●] shares (“Warrant Shares”) of Common Stock at an exercise price of [●] per share (the “Firm
Warrants”). Each Firm Share is being sold together with a Firm Warrant to purchase [●] of a share of Common Stock
at an exercise price of [●] per share. The Company also has granted the Underwriter an option to purchase up to [●] additional
shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”)
and warrants of the Company, in the form set forth in Exhibit A hereto, to purchase [●] shares of Common Stock at an exercise
price of [●] per share (the “Option Warrants,” together with the Firm Warrants, the “Warrants”) in each
case on the terms and for the purposes set forth in Section 3 hereof. The Firm Shares, the Firm Warrants, the Warrant Shares,
any Option Shares and any Option warrants purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.” The
Company hereby confirms its agreement with respect to the sale of the Securities to the several Underwriters. 1. Registration
Statement and Prospectus. A registration statement on Form S-1 (File No. 333-[●]) with respect to the Securities,
including a preliminary form of prospectus, has been prepared by the Company in conformity with the requirements of the Securities
Act of 1933, as amended (the “Act”), and the rules and regulations (“Rules and Regulations”)
of the Securities and Exchange Commission (the “Commission”) thereunder and has been filed with the
Commission. Such registration statement, including the amendments, exhibits and schedules thereto, as of the time it became effective,
including the Rule 430A Information (as defined below), is referred to herein as the Registration Statement”.
The Company will prepare and file a prospectus pursuant to Rule 424(b) of the Rules and Regulations that discloses the information
previously omitted from the prospectus in the Registration Statement in reliance upon Rule 430A of the Rules and Regulations,
which information will be deemed retroactively to be a part of the Registration Statement in accordance with Rule 430A of the
Rules and Regulations (“Rule 430A Information”). If the Company has elected to rely upon Rule 462(b)
of the Rules and Regulations to increase the size of the offering registered under the Act, the Company will prepare and file
with the Commission a registration statement with respect to such increase pursuant to Rule 462(b) of the Rules and Regulations
(such registration statement, including the contents of the Registration Statement incorporated by reference therein is the “Rule
462(b) Registration Statement”). References herein to the “Registration Statement” will
be deemed to include the Rule 462(b) Registration Statement at and after the time of filing of the Rule 462(b) Registration Statement.
“Preliminary Prospectus” means any prospectus included in the Registration Statement prior to the effective
time of the Registration Statement, any prospectus filed with the Commission pursuant to Rule 424(a) under the Rules and Regulations
and each prospectus that omits Rule 430A Information used after the effective time of the Registration Statement. “Prospectus”
means the prospectus that discloses the public offering price and other final terms of the Securities and the offering
and otherwise satisfies Section 10(a) of the Act. All references in this Agreement to the Registration Statement,
any Preliminary Prospectus, the Prospectus or any amendment or supplement to any of the foregoing, is deemed to include the copy
filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval System or any successor system thereto
(“EDGAR”). All
references herein to the Registration Statement, any Preliminary Prospectus or a Prospectus shall be deemed as of any time to
include the documents and information incorporated therein by reference in accordance with the Rules and Regulations. 2. Representations
and Warranties of the Company. (a) Representations
and Warranties of the Company. The Company represents and warrants to, and agrees with, the several Underwriters as follows: (i) Registration
Statement and Prospectuses. The Registration Statement and any post-effective amendment thereto has become effective under
the Act. No stop order suspending the effectiveness of the Registration Statement or any post-effective amendment to any Registration
Statement has been issued, and no proceeding for that purpose has been initiated or, to the Company’s knowledge, threatened
by the Commission. No order preventing or suspending the use of any Preliminary Prospectus or the Prospectus (or any supplement
thereto) has been issued by the Commission and no proceeding for that purpose has been initiated or is pending or, to the Company’s
knowledge, threatened by the Commission. As of the time each part of the Registration Statement (or any post-effective amendment
thereto) became or becomes effective, such part conformed or will conform in all material respects to the requirements of the
Act and the Rules and Regulations. Upon the filing or first use within the meaning of the Rules and Regulations, each Preliminary
Prospectus and the Prospectus (or any supplement to either) conformed or will conform in all material respects to the requirements
of the Act and the Rules and Regulations. (ii) Accurate
Disclosure. Each Preliminary Prospectus, at the time of filing thereof or the time of first use within the meaning of
the Rules and Regulations, did not contain an untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading. Neither the Registration Statement nor any amendment thereto, at the effective time of each part thereof, at the First
Closing Date (as defined below) or at the Second Closing Date (as defined below), contained, contains or will contain an untrue
statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary
to make the statements therein not misleading. As of the Time of Sale (as defined below), the Time of Sale Disclosure Package
(as defined below), when considered together with the Time of Sale Disclosure Package, did not include an untrue statement of
a material fact or omitted to state a material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. Neither the Prospectus nor any supplement thereto, as of its issue date, at the time
of any filing with the Commission pursuant to Rule 424(b) of the Rules and Regulations, at the First Closing Date or at the Second
Closing, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
The representations and warranties in this Section 2(a)(ii) shall not apply to statements in or omissions from any
Preliminary Prospectus, the Registration Statement (or any amendment thereto), the Time of Sale Disclosure Package or the Prospectus
(or any supplement thereto) made in reliance upon, and in conformity with, written information
furnished to the Company by the Underwriter specifically for use in the preparation of such document, it being understood and
agreed that the only such information furnished by the Underwriter consists of the information described as such in Section 6(e). “Time
of Sale Disclosure Package” means the Preliminary Prospectus dated [●], 2014, and the information on Schedule III,
all considered together. Each
reference to a “free writing prospectus” herein means a free writing prospectus as defined in Rule 405
of the Rules and Regulations. “Time
of Sale” means [_______ a/p.m.] (Eastern time) on the date of this Agreement. (iii) No
Other Offering Materials. The Company has not distributed and will not distribute any prospectus or other offering
material in connection with the offering and sale of the Securities other than any Preliminary Prospectus, the Time of Sale
Disclosure Package or the Prospectus or other materials permitted by the Act to be distributed by the Company; provided,
however, that the Company has not made and will not make any offer relating to the Securities that would constitute a free
writing prospectus. (iv) Financial
Statements. The financial statements of the Company, together with the related notes, set forth in the Registration Statement,
the Time of Sale Disclosure Package and Prospectus comply in all material respects with the requirements of the Act and the Rules
and Regulations and fairly present the financial condition of the Company and its consolidated subsidiaries as of the dates indicated
and the results of operations, cash flows and changes in stockholders’ equity for the periods therein specified. The financial
statements of the Company, together with the related notes, set forth in the Registration Statement, the Time of Sale Disclosure
Package and Prospectus are in conformity with generally accepted accounting principles in the United States consistently applied
throughout the periods involved. The supporting schedules of the Company included in the Registration Statement present fairly
the information required to be stated therein. All non-GAAP financial information included in the Registration Statement, the
Time of Sale Disclosure Package and the Prospectus complies with the requirements of Regulation G and Item 10 of Regulation S-K
under the Act. Except as disclosed in the Time of Sale Disclosure Package and the Prospectus, there are no material off-balance
sheet arrangements (as defined in Regulation S-K under the Act, Item 303(a)(4)(ii)) or any other relationships with unconsolidated
entities or other persons, that may have a material current or, to the Company’s knowledge, material future effect on the
Company’s financial condition, results of operations, liquidity, capital expenditures, capital resources or significant
components of revenue or expenses. No other financial statements or schedules are required to be included in the Registration
Statement, the Time of Sale Disclosure Package or the Prospectus. Marcum LLP, which has expressed its opinion with respect to
the financial statements of the Company and related schedules filed as a part of the Registration Statement and included in the
Registration Statement, the Time of Sale Disclosure Package and the Prospectus, is (x) an independent public accounting firm within
the meaning of the Act and the Rules and Regulations, (y) a registered public accounting firm (as defined in Section 2(a)(12)
of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”)) and (z) not in violation of the auditor
independence requirements of the Sarbanes-Oxley Act. (v) Organization
and Good Standing. Each of the Company and its subsidiaries has been duly organized and is validly existing
as a corporation in good standing under the laws of its jurisdiction of incorporation. Each of the Company and its
subsidiaries has full corporate power and authority to own its properties and conduct its business as currently being carried
on and as described in the Registration Statement, the Time of Sale Disclosure Package and Prospectus, and is duly qualified
to do business as a foreign corporation in good standing in each jurisdiction in which it owns or leases real property or in
which the conduct of its business makes such qualification necessary and in which the failure to so qualify would have a
material adverse effect upon the business, prospects, management, properties, operations, condition (financial or otherwise)
or results of operations of the Company and its subsidiaries, taken as a whole (“Material Adverse
Effect”). (vi) Absence
of Certain Events. Except as contemplated in the Time of Sale Disclosure Package and in the Prospectus, subsequent to
the respective dates as of which information is given in the Time of Sale Disclosure Package and the Prospectus, neither the Company
nor any of its subsidiaries has incurred any material liabilities or obligations, direct or contingent, or entered into any material
transactions, or declared or paid any dividends or made any distribution of any kind with respect to its capital stock; and there
has not been any change in the capital stock (other than a change in the number of outstanding shares of Common Stock due to the
issuance of shares upon the exercise of outstanding options or warrants or conversion of convertible securities), or any material
change in the short-term or long-term debt (other than as a result of the conversion of convertible securities), or any issuance
of options, warrants, convertible securities or other rights to purchase the capital stock, of the Company or any of its subsidiaries,
or any material adverse change in the general affairs, condition (financial or otherwise), business, prospects, management, properties,
operations or results of operations of the Company and its subsidiaries, taken as a whole (“Material Adverse Change”)
or any development which could reasonably be expected to result in any Material Adverse Change. (vii) Absence
of Proceedings. Except as set forth in the Time of Sale Disclosure Package and in the Prospectus, there
is not pending or, to the knowledge of the Company, threatened or contemplated, any action, suit or proceeding (a) to which the
Company or any of its subsidiaries is a party or (b) which has as the subject thereof any officer or director of the Company or
any subsidiary, any employee benefit plan sponsored by the Company or any subsidiary or any property or assets owned or leased
by the Company or any subsidiary before or by any court or Governmental Authority (as defined below), or any arbitrator, which,
individually or in the aggregate, might result in any Material Adverse Change, or would materially and adversely affect the ability
of the Company to perform its obligations under this Agreement or which are otherwise material in the context of the sale of the
Securities. There are no current or, to the knowledge of the Company, pending, legal, governmental or regulatory actions, suits
or proceedings (x) to which the Company or any of its subsidiaries is subject or (y) which has as the subject thereof any officer
or director of the Company or any subsidiary, any employee plan sponsored by the Company or any subsidiary or any property or
assets owned or leased by the Company or any subsidiary, that are required to be described in the Registration Statement, Time
of Sale Disclosure Package and Prospectus by the Act or by the Rules and Regulations and that have not been so described. (viii) Authorization;
No Conflicts; Authority. This Agreement has been, and as of the applicable closing date the Underwriters’ Warrants
will be, duly authorized, executed and delivered by the Company, and constitutes a valid, legal and binding obligation of the
Company, enforceable in accordance with its terms, except as rights to indemnity hereunder may be limited by federal or state
securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting
the rights of creditors generally and subject to general principles of equity. The execution, delivery and performance of this
Agreement and the consummation of the transactions herein contemplated will not (A) conflict with or result in a breach or violation
of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge
or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to any indenture, mortgage, deed
of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which
the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries
is subject, (B) result in any violation of the provisions of the Company’s charter or by-laws or (C) result in the violation
of any law or statute or any judgment, order, rule, regulation or decree of any court or arbitrator or federal, state, local or
foreign governmental agency or regulatory authority having jurisdiction over the Company or any of its subsidiaries or any of
their properties or assets (each, a “Governmental Authority”), except in the case of clause (A) as would
not result in a Material Adverse Effect. No consent, approval, authorization or order of, or registration or filing with any Governmental
Authority is required for the execution, delivery and performance of this Agreement or for the consummation of the transactions
contemplated hereby, including the issuance or sale of the Securities by the Company, except such as may be required under the
Act, the rules of the Financial Industry Regulatory Authority (“FINRA”) or state securities or blue
sky laws; and the Company has full power and authority to enter into this Agreement and to consummate the transactions contemplated
hereby, including the authorization, issuance and sale of the Securities as contemplated by this Agreement. (ix) Capitalization;
the Securities; Registration Rights. All of the issued and outstanding shares of capital stock of the Company, including
the outstanding shares of Common Stock, are duly authorized and validly issued, fully paid and nonassessable, have been issued
in compliance with all federal and state and foreign securities laws, were not issued in violation of or subject to any preemptive
rights or other rights to subscribe for or purchase securities that have not been waived in writing (a copy of which has been
delivered to counsel to the Underwriters), and the holders thereof are not subject to personal liability by reason of being such
holders; the Securities which may be sold hereunder by the Company and the shares of Common Stock issuable upon exercise of the
Underwriters’ Warrant have been duly authorized and, when issued, delivered and paid for in accordance with the terms of
this Agreement, or, if applicable, in accordance with the terms of the Underwriters’ Warrant, such shares, will have been
validly issued and will be fully paid and nonassessable, and the holders thereof, as well as the holders of the Underwrtiers’
Warrant, will not be subject to personal liability by reason of being such holders; and the capital stock of the Company, including
the Common Stock and the shares of Common Stock issuable upon exercise of the Underwriters’ Warrant, conforms to the description
thereof in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus. Except as otherwise stated
in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus, (A) there are no preemptive
rights or other rights to subscribe for or to purchase, or any restriction upon the voting or transfer of, any shares of Common
Stock pursuant to the Company’s charter, by-laws or any agreement or other instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its subsidiaries is bound, (B) neither the filing of the Registration
Statement nor the offering or sale of the Securities as contemplated by this Agreement gives rise to any rights for or relating
to the registration of any shares of Common Stock or other securities of the Company (collectively “Registration Rights”)
and (C) any person to whom the Company has granted Registration Rights has agreed not to exercise such rights until after
expiration of the Lock-Up Period (as defined below). All of the issued and outstanding shares of capital stock of each of the
Company’s subsidiaries have been duly and validly authorized and issued and are fully paid and nonassessable, and, except
as otherwise described in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus, the Company
owns of record and beneficially, free and clear of any security interests, claims, liens, proxies, equities or other encumbrances,
all of the issued and outstanding shares of such common stock. The Company has an authorized and outstanding capitalization as
set forth in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus under the caption “Description
of Capital Stock.” The Common Stock (including the Securities) conforms in all material respects to the description thereof
contained in the Registration Statement, Time of Sale Disclosure Package and the Prospectus. (x) Stock
Options. Except as described in the Registration Statement, in the Time of Sale Disclosure Package and in the
Prospectus, there are no options, warrants, agreements, contracts or other rights in existence to purchase or acquire from
the Company or any subsidiary of the Company any shares of the capital stock of the Company or any subsidiary of the Company.
The description of the Company’s stock option, stock bonus and other stock plans or arrangements (the “Company
Stock Plans”), and the options (the “Options”) or other rights granted thereunder,
set forth in the Registration Statement, Time of Sale Disclosure Package and the Prospectus accurately and fairly presents
the information required to be shown with respect to such plans, arrangements, options and rights. Each grant of an Option
(A) was duly authorized by all necessary corporate action no later than the date on which the grant of such Option was by its
terms to be effective, including, as applicable, approval by the board of directors of the Company (or a duly constituted and
authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and
the award agreement governing such grant (if any) was duly executed and delivered by each party thereto and (B) was made
in accordance with the terms of the applicable Company Stock Plan (except for options and warrants that were granted outside
the Company Stock Plans, as disclosed in the Company’s public filings filed with the Commission, including, but not
limited to the Registration Statement), and all applicable laws and regulatory rules or requirements, including all
applicable federal securities laws. (xi) Compliance
with Laws. The Company and each of its subsidiaries holds, and is operating in compliance in all material respects
with, all franchises, grants, authorizations, licenses, permits, easements, consents, certificates and orders of any
Governmental Authority or self-regulatory body required for the conduct of its business and all such franchises, grants,
authorizations, licenses, permits, easements, consents, certifications and orders are valid and in full force and effect; and
neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such franchise,
grant, authorization, license, permit, easement, consent, certification or order or has reason to believe that any such
franchise, grant, authorization, license, permit, easement, consent, certification or order will not be renewed in the
ordinary course; and the Company and each of its subsidiaries is in compliance in all material respects with all applicable
federal, state, local and foreign laws, regulations, orders and decrees. (xii) Ownership
of Assets. The Company and its subsidiaries have good and marketable title to all property (whether real or personal)
described in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus, as being owned by them,
in each case free and clear of all liens, claims, security interests, other encumbrances or defects except such as are described
in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus. The property held under lease by
the Company and its subsidiaries is held by them under valid, subsisting and enforceable leases with only such exceptions with
respect to any particular lease as do not interfere in any material respect with the conduct of the business of the Company or
its subsidiaries. (xiii) Intellectual
Property. The Company and each of its subsidiaries owns, possesses, has a valid license to or can acquire on reasonable
terms, all material Intellectual Property necessary for the conduct of the Company’s and it subsidiaries’ business
as now conducted or as described in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus to be conducted.
Furthermore, (A) to the knowledge of the Company, there is no infringement, misappropriation or violation by third parties of
any such Intellectual Property; (B) there is no pending or, to the knowledge of the Company, threatened, action, suit, proceeding
or claim by others challenging the Company’s or any of its subsidiaries’ rights in or to any such Intellectual Property,
and the Company is unaware of any facts which would form a reasonable basis for any such claim; (C) the Intellectual Property
owned by the Company and its subsidiaries, and to the knowledge of the Company, the Intellectual Property licensed to the Company
and its subsidiaries, has not been adjudged invalid or unenforceable, in whole or in part, and there is no pending or, to the
knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such
Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (D) there
is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others that the Company or
any of its subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property or other proprietary rights
of others, neither the Company or any of its subsidiaries has received any written notice of such claim and the Company is unaware
of any other fact which would form a reasonable basis for any such claim; and (E) to the Company’s knowledge, no employee
of the Company or any of its subsidiaries is in or has ever been in violation of any term of any employment contract, patent disclosure
agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any
restrictive covenant to or with a former employer where the basis of such violation relates to such employee’s employment
with the Company or any of its subsidiaries or actions undertaken by the employee while employed with the Company or any of its
subsidiaries, except as such violation would not result in a Material Adverse Effect. “Intellectual Property”
shall mean all patents, patent applications, trade and service marks, trade and service mark registrations, trade names,
copyrights, licenses, inventions, trade secrets, domain names, technology, know-how and other intellectual property. All patent
applications owned by the Company and filed with the U.S. Patent and Trademark Office (the “PTO”) or
any foreign or international patent authority that have resulted in patents or currently pending applications that describe inventions
necessary to conduct the business of the Company in the manner described in the Time of Sale Disclosure Package (collectively,
the “Company Patent Applications”) have been or were duly and properly filed. The Company has complied
with its duty of candor and disclosure to the PTO for the Company Patent Applications. The Company is not aware of any facts required
to be disclosed to the PTO that were not disclosed to the PTO and which would preclude the grant of a patent for the Company Patent
Applications. The Company has no knowledge of any facts which would preclude it from having clear title to the Company Patent
Applications that have been identified by the Company as being exclusively owned by the Company. (xiv) No
Violations or Defaults. Except as described in the Registration Statement, the Time of Sale Disclosure Package and the
Prospectus, neither the Company nor any of its subsidiaries is currently in violation of its respective charter, by-laws or other
organizational documents, or in breach of or otherwise in default, and no event has occurred which, with notice or lapse of time
or both, would constitute such a default in the performance of any material obligation, agreement or condition contained in any
bond, debenture, note, indenture, loan agreement or any other material contract, lease or other instrument to which it is subject
or by which any of them may be bound, or to which any of the material property or assets of the Company or any of its subsidiaries
is subject. (xv) Taxes.
The Company and its subsidiaries have timely filed all federal, state, local and foreign income and franchise tax returns required
to be filed and are not in default in the payment of any taxes which were payable pursuant to said returns or any assessments
with respect thereto, other than any which the Company or any of its subsidiaries is contesting in good faith. There is no pending
dispute with any taxing authority relating to any of such returns, and the Company has no knowledge of any proposed liability
for any tax to be imposed upon the properties or assets of the Company or any of its subsidiaries for which there is not an adequate
reserve reflected in the Company’s financial statements included in the Registration Statement, the Time of Sale Disclosure
Package and the Prospectus. (xvi) Exchange
Act Registration. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is quoted on the Over-the-Counter
Quotation Board (the “OTCQB”) and the Over-the-Counter Bulletin Board (the “OTCBB”)
and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock
under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
The Company has complied in all material respects with the applicable requirements of the OTCQB and OTCBB for maintenance of inclusion
of the Common Stock on the OTCQB’s and OTCBB’s automated quotation system. Except as previously disclosed to counsel
for the Underwriters or as set forth in the Time of Sale Disclosure Package and the Prospectus, there are no affiliations with
members of FINRA among the Company’s officers or directors or, to the knowledge of the Company, any five percent or greater
stockholders of the Company or any beneficial owner of the Company’s unregistered equity securities that were acquired during
the 180-day period immediately preceding the initial filing date of the Registration Statement. The Company is currently in compliance
in all material respects with the applicable requirements of the Nasdaq Capital Market for maintenance of inclusion of the Common
Stock (including the Firm Shares, the Option Shares, and the Warrant Shares) and [Warrants] thereon. The Company’s board
of directors has, subject to the exceptions, cure periods and the phase-in periods specified in the applicable stock exchange
rules (“Exchange Rules”), validly appointed an audit committee to oversee internal accounting controls
whose composition satisfies the applicable requirements of the Exchange Rules and the Company’s board of directors and/or
the audit committee has adopted a charter that satisfies the requirements of the Exchange Rules. (xvii) Ownership
of Other Entities. Other than the subsidiaries of the Company listed in Exhibit 21 to the Registration Statement or as
otherwise disclosed in the Registration Statement, Time of Sale Disclosure Package and Prospectus, the Company, directly or indirectly,
owns no capital stock or other equity or ownership or proprietary interest in any corporation, partnership, association, trust
or other entity. (xviii) Internal
Controls. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, the
Company and its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurances that
(i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles
in the United States and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with
management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing
assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as disclosed in the Registration
Statement, in the Time of Sale Disclosure Package and in the Prospectus, the Company’s internal control over financial reporting
is effective and none of the Company, its board of directors and audit committee is aware of any “significant deficiencies”
or “material weaknesses” (each as defined by the Public Company Accounting Oversight Board) in its internal control
over financial reporting, or any fraud, whether or not material, that involves management or other employees of the Company or
its subsidiaries who have a significant role in the Company’s internal controls; and since the end of the latest audited
fiscal year, there has been no change in the Company’s internal control over financial reporting (whether or not remediated)
that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial
reporting. The Company’s board of directors has validly appointed an audit committee to oversee internal accounting controls,
and the Company’s board of directors and/or the audit committee has adopted a charter. (xix) No
Brokers or Finders. Other than as contemplated by this Agreement, the Company has not incurred and will not incur any
liability for any finder’s or broker’s fee or agent’s commission in connection with the execution and delivery
of this Agreement or the consummation of the transactions contemplated hereby. (xx) Insurance. The Company
and each of its subsidiaries carries, or is covered by, insurance from reputable insurers in such amounts and covering such risks
as is adequate for the conduct of its business and the value of its properties and the properties of its subsidiaries and as is
customary for companies engaged in similar businesses in similar industries; all policies of insurance and any fidelity or surety
bonds insuring the Company or any of its subsidiaries or its business, assets, employees, officers and directors are in full force
and effect; the Company and its subsidiaries are in compliance with the terms of such policies and instruments in all material
respects; there are no claims by the Company or any of its subsidiaries under any such policy or instrument as to which any insurance
company is denying liability or defending under a reservation of rights clause; neither the Company nor any of its subsidiaries
has been refused any insurance coverage sought or applied for; and neither the Company nor any of its subsidiaries has reason
to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.
(xxi) Investment
Company Act. The Company is not and, after giving effect to the offering and sale of the Securities, will not be an “investment
company,” as such term is defined in the Investment Company Act of 1940, as amended. (xxii) Sarbanes-Oxley
Act. The Company is in compliance, in all material respects, with all applicable provisions of the Sarbanes-Oxley Act
and the rules and regulations of the Commission thereunder. (xxiii) Disclosure
Controls. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, the
Company has established and maintains disclosure controls and procedures (as defined in Rules 13a-14 and 15d-14 under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”)) and such controls and procedures are effective
in ensuring that material information relating to the Company, including its subsidiaries, is made known to the principal executive
officer and the principal financial officer. The Company has utilized such controls and procedures, subject to the disclosures
in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, in preparing and evaluating the disclosures
in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus. (xxiv) Anti-Bribery
and Anti-Money Laundering Laws. Each of the Company, its subsidiaries, its affiliates and any of their respective officers,
directors, supervisors, managers, agents, or employees, has not violated, and its participation in the offering will not violate,
each of the following laws: (A) anti-bribery laws, including but not limited to, any applicable law, rule, or regulation of any
locality, including but not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating
Bribery of Foreign Public Officials in International Business Transactions, signed December 17, 1997, including the U.S.
Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any other law, rule or regulation of similar
purposes and scope or (B) anti-money laundering laws, including but not limited to, applicable federal, state, international,
foreign or other laws, regulations or government guidance regarding anti-money laundering, including, without limitation, Title
18 US. Code section 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or
procedures by an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which
the United States is a member and with which designation the United States representative to the group or organization continues
to concur, all as amended, and any Executive order, directive, or regulation pursuant to the authority of any of the foregoing,
or any orders or licenses issued thereunder. (xxv) OFAC.
(A) Neither
the Company nor any of its subsidiaries, nor any or their directors, officers or employees, nor, to the Company’s knowledge,
any agent, affiliate or representative of the Company or its subsidiaries, is an individual or entity that is, or is owned or
controlled by an individual or entity that is: (1) the
subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Assets Control,
the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively,
“Sanctions”), nor (2) located, organized or resident in a country or territory that is the subject
of Sanctions (including, without limitation, Burma/Myanmar, Cuba, Iran, Libya, North Korea, Sudan and Syria). (B) Neither
the Company nor any of its subsidiaries will, directly or indirectly, use the proceeds of the offering, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other individual or entity: (1) to
fund or facilitate any activities or business of or with any individual or entity or in any country or territory that, at the
time of such funding or facilitation, is the subject of Sanctions; or (2) in
any other manner that will result in a violation of Sanctions by any individual or entity (including any individual or entity
participating in the offering, whether as underwriter, advisor, investor or otherwise). (C) For
the past five years, neither the Company nor any of its subsidiaries has knowingly engaged in, and is not now knowingly engaged
in, any dealings or transactions with any individual or entity, or in any country or territory, that at the time of the dealing
or transaction is or was the subject of Sanctions. (xxvi) Compliance
with Environmental Laws. Except as disclosed in the Time of Disclosure Package and the Prospectus, neither the Company
nor any of its subsidiaries is in violation of any statute, any rule, regulation, decision or order of any Governmental Authority
or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the
protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “Environmental
Laws”), owns or operates any real property contaminated with any substance that is subject to any Environmental
Laws, is liable for any off-site disposal or contamination pursuant to any Environmental Laws, or is subject to any claim relating
to any Environmental Laws, which violation, contamination, liability or claim would individually or in the aggregate, have a Material
Adverse Effect; and the Company is not aware of any pending investigation which might lead to such a claim. Neither the Company
nor any of its subsidiaries anticipates incurring any material capital expenditures relating to compliance with Environmental
Laws. (xxvii) Compliance
with Occupational Laws. The Company and each of its subsidiaries (A) is in compliance, in all material respects, with
any and all applicable foreign, federal, state and local laws, rules, regulations, treaties, statutes and codes promulgated by
any and all Governmental Authorities (including pursuant to the Occupational Health and Safety Act) relating to the protection
of human health and safety in the workplace (“Occupational Laws”); (B) has received all material permits,
licenses or other approvals required of it under applicable Occupational Laws to conduct its business as currently conducted;
and (C) is in compliance, in all material respects, with all terms and conditions of such permit, license or approval. No action,
proceeding, revocation proceeding, writ, injunction or claim is pending or, to the Company’s knowledge, threatened against
the Company or any of its subsidiaries relating to Occupational Laws, and the Company does not have knowledge of any facts, circumstances
or developments relating to its operations or cost accounting practices that could reasonably be expected to form the basis for
or give rise to such actions, suits, investigations or proceedings. (xxviii) ERISA
and Employee Benefits Matters. (A) To the knowledge of the Company, no “prohibited transaction” as defined
under Section 406 of ERISA or Section 4975 of the Code and not exempt under ERISA Section 408 and the regulations and published
interpretations thereunder has occurred with respect to any Employee Benefit Plan. At no time has the Company or any ERISA Affiliate
maintained, sponsored, participated in, contributed to or has or had any liability or obligation in respect of any Employee Benefit
Plan subject to Part 3 of Subtitle B of Title I of ERISA, Title IV of ERISA, or Section 412 of the Code or any “multiemployer
plan” as defined in Section 3(37) of ERISA or any multiple employer plan for which the Company or any ERISA Affiliate has
incurred or could incur liability under Section 4063 or 4064 of ERISA. No Employee Benefit Plan provides or promises, or at any
time provided or promised, retiree health, life insurance, or other retiree welfare benefits except as may be required by the
Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or similar state law. Each Employee Benefit Plan is and has
been operated in material compliance with its terms and all applicable laws, including but not limited to ERISA and the Code and,
to the knowledge of the Company, no event has occurred (including a “reportable event” as such term is defined in
Section 4043 of ERISA) and no condition to the knowledge of the Company exists that would subject the Company or any ERISA Affiliate
to any material tax, fine, lien, penalty or liability imposed by ERISA, the Code or other applicable law. Each Employee Benefit
Plan intended to be qualified under Code Section 401(a) is so qualified and has a favorable determination or opinion letter from
the IRS upon which it can rely, and any such determination or opinion letter remains in effect and has not been revoked; to the
knowledge of the Company, nothing has occurred since the date of any such determination or opinion letter that is reasonably likely
to adversely affect such qualification; (B) with respect to each Foreign Benefit Plan, such Foreign Benefit Plan (1) if intended
to qualify for special tax treatment, meets, in all material respects, the requirements for such treatment, and (2) if required
to be funded, is funded to the extent required by applicable law, and with respect to all other Foreign Benefit Plans, adequate
reserves therefor have been established on the accounting statements of the applicable Company or subsidiary; (C) the Company
does not have any obligations under any collective bargaining agreement with any union and no organization efforts are underway
with respect to Company employees. As used in this Agreement, “Code” means the Internal Revenue Code
of 1986, as amended; “Employee Benefit Plan” means any “employee benefit plan” within the
meaning of Section 3(3) of ERISA, including, without limitation, all stock purchase, stock option, stock-based severance, employment,
change-in-control, medical, disability, fringe benefit, bonus, incentive, deferred compensation, employee loan and all other employee
benefit plans, agreements, programs, policies or other arrangements, whether or not subject to ERISA, under which (x) any current
or former employee, director or independent contractor of the Company or its subsidiaries has any present or future right to benefits
and which are contributed to, sponsored by or maintained by the Company or any of its respective subsidiaries or (y) the Company
or any of its subsidiaries has had or has any present or future obligation or liability; “ERISA” means
the Employee Retirement Income Security Act of 1974, as amended; “ERISA Affiliate” means any member
of the company’s controlled group as defined in Code Section 414(b), (c), (m) or (o); and “Foreign Benefit Plan”
means any Employee Benefit Plan established, maintained or contributed to outside of the United States of America or which
covers any employee working or residing outside of the United States. (xxix) Business
Arrangements. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package, the Prospectus,
neither the Company nor any of its subsidiaries has granted any material rights to develop, manufacture, produce, assemble, distribute,
license, market or sell its products to any other person and is not bound by any material agreement that affects the exclusive
right of the Company or such subsidiary to develop, manufacture, produce, assemble, distribute, license, market or sell its products. (xxx) Labor
Matters. No labor problem or dispute with the employees of the Company or any of its subsidiaries exists or is threatened
or imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or its
subsidiaries’ principal suppliers, contractors or customers, that could have a Material Adverse Effect. (xxxi) Restrictions
on Subsidiary Payments to the Company. No subsidiary of the Company is currently prohibited, directly or indirectly, from
paying any dividends to the Company, from making any other distribution on such subsidiary’s capital stock, from repaying
to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary’s property
or assets to the Company or any other subsidiary of the Company, except as described in or contemplated by the Registration Statement,
Time of Sale Disclosure Package and the Prospectus. (xxxii) Disclosure of Legal Matters. To the knowledge of the Company, there are no statutes, regulations, legal or governmental
proceedings or contracts or other documents required to be described in the Registration Statement, Time of Sale Disclosure Package
or in the Prospectus or included as exhibits to the Registration Statement that are not described or included as required. (xxxiii) Statistical
Information. Any third-party statistical and market-related data included in the Registration Statement, the Time of Sale
Disclosure Package and the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate
in all material respects. (xxxiv) Forward-looking
Statements. No forward-looking statement (within the meaning of Section 27A of the Act and Section 21E of
the Exchange Act) contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus has been
made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. (xxxv) Public
Filings. The Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2013 and each of
the documents filed by the Company pursuant to the Act or the Exchange Act subsequent thereto when they became effective or were
filed with the Commission, as the case may be, conformed in all material respects to the requirements of the Act or Exchange Act,
as applicable, were filed on a timely basis (including within the applicable time period pursuant to Rule 12b-25 promulgated under
the Exchange Act) with the Commission and none of such documents contained an untrue statement of a material fact or omitted to
state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading. (xxxvi) Related Party Transactions. To the Company’s
knowledge, no transaction has occurred between or among the Company, on the one hand, and any of the Company’s officers,
directors or 5% stockholders or any affiliate or affiliates of any such officer, director or 5% stockholders that is required
to be described that is not so described in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus.
The Company has not, directly or indirectly, extended or maintained credit, or arranged for the extension of credit, or renewed
an extension of credit, in the form of a personal loan to or for any of its directors or executive officers in violation of applicable
laws, including Section 402 of the Sarbanes-Oxley Act (b) Effect
of Certificates. Any certificate signed by any officer of the Company and delivered to you, as Representative of the Underwriters,
or to counsel for the Underwriters shall be deemed a representation and warranty by the Company to each Underwriter as to the
matters covered thereby. 3. Purchase,
Sale and Delivery of Securities. (a) Firm
Shares. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and
conditions herein set forth, the Company agrees to issue and sell the Firm Shares to the several Underwriters, and each Underwriter
agrees to purchase from the Company the number of Firm Shares set forth opposite the name of such Underwriter in Schedule I hereto.
The purchase price for each Firm Share shall be $[______] per share. (b) Firm
Warrants. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and
conditions herein set forth, the Company agrees to issue and sell Firm Warrants to purchase _________ shares of Common Stock to
the several Underwriters, and each Underwriter agrees to purchase from the Company the Firm Warrants
set forth opposite the name of such Underwriter in Schedule I hereto. The purchase price shall be $________ for each Firm
Warrant to purchase ____ of a share of Common Stock. The
Firm Warrants will be delivered by the Company to the Representative for the accounts of the several Underwriters against payment
of the purchase price therefor by wire transfer of same day funds payable to the order of the Company, at the offices of Northland
Securities, Inc., 45 South 7th Street, Suite 2000, Minneapolis, Minnesota 55402, or such other location as may be mutually
acceptable, at 9:00 a.m. Central time on the third (or if the Securities are priced, as contemplated by Rule 15c6-1(c) under
the Exchange Act, after 4:30 p.m. Eastern time, the fourth) full business day following the date hereof, or at such other time
and date as you and the Company determine pursuant to Rule 15c6-1(a) under the Exchange Act. (c) Option
Shares. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and
conditions herein set forth, the Company hereby grants to the several Underwriters an option to purchase all or any portion of
the Option Shares at the same purchase price as the Firm Shares, for use solely in covering any over-allotments made by the Underwriters
in the sale and distribution of the Firm Shares. The option granted hereunder may be exercised in whole or in part at any time
(but not more than once) within 45 days after the effective date of this Agreement upon notice (confirmed in writing) by the Representative
to the Company setting forth the aggregate number of Option Shares as to which the several Underwriters are exercising the option
and the date and time, as determined by you, when the Option Shares are to be delivered, but in no event earlier than the First
Closing Date (as defined below) nor earlier than the second business day or later than the tenth business day after the date on
which the option shall have been exercised. No Option Shares shall be sold and delivered unless the Firm Shares previously have
been, or simultaneously are, sold and delivered. (d) Option
Warrants. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and
conditions herein set forth, the Company, with respect to the Option Warrants hereby grants to the several Underwriters an option
to purchase all or any portion of the Option Warrants at the same purchase price as the Firm Warrants, for use solely in covering
any over-allotments made by the Underwriters in the sale and distribution of the Securities. The option granted hereunder may
be exercised in whole or in part at any time (but not more than once) within 45 days after the effective date of this Agreement
upon notice (confirmed in writing) by the Representative to the Company setting forth the aggregate number of Option Warrants
as to which the several Underwriters are exercising the option and the date and time, as determined by the Representative, when
the Option Warrants are to be delivered, but in no event earlier than the First Closing Date (as defined below) nor earlier than
the second business day or later than the tenth business day after the date on which the option shall have been exercised. No
Option Warrants shall be sold and delivered unless the Firm Warrants previously have been, or simultaneously are, sold and delivered. The
Option Shares will be delivered by the Company to the Representative for the accounts of the several Underwriters against payment
of the purchase price therefor by wire transfer of same day funds payable to the order of the Company at the offices of Northland
Securities, Inc., 45 South 7th Street, Suite 2000, Minneapolis, Minnesota 55402, or such other location as may be mutually
acceptable at 9:00 a.m., Central time, on the Second Closing Date. (e) Payment
and Delivery. (i) The Securities to be purchased by the Underwriters hereunder, in book-entry form in such authorized denominations and
registered in such names as the Representative may request upon at least forty-eight hours’ prior notice to the
Company, shall be delivered by or on behalf of the Company to the Representative, through the facilities of the Depository
Trust Company (“DTC”), for the accounts of the several Underwriters, with any transfer taxes
payable in connection with the transfer of the Securities to the several Underwriters duly paid, against payment by or on
behalf of such Underwriter of the purchase price therefor by wire transfer of Federal (same-day) funds to the account
specified by the Company to you at least forty-eight hours in advance. The time and date of such delivery and payment shall
be, with respect to the Firm Shares, 9:30 a.m., New York City time, on [_______], 2014 or such other time and date as
you and the Company may agree upon in writing, and, with respect to the Option Shares, 9:30 a.m., New York City time, on
the date specified by you in each written notice given by you of the election to purchase such Option Shares, or such other
time and date as you and the Company may agree upon in writing. Such time and date for delivery of the Firm Shares is herein
called the “First Closing Date”, each such time and date for delivery of the Option Shares, if not
the First Closing Date, is herein called a “Second Closing Date”, and each such time and date for
delivery is herein called a “Closing”. (ii) The
documents to be delivered at each Closing by or on behalf of the parties hereto pursuant to Section 5 hereof, including the
cross receipt for the Securities and any additional documents requested by the Represenative pursuant to Section 5(j) hereof,
will be delivered at the offices of the Company, and the Securities will be delivered to you, through the facilities of the DTC,
for the account of the Underwriter, all at such Closing. 4. Covenants.
The Company covenants and agrees with the several Underwriters as follows: (a) Required
Filings. The Company will prepare and file a Prospectus with the Commission containing the Rule 430A Information
omitted from the Preliminary Prospectus within the time period required by, and otherwise in accordance with the provisions of,
Rules 424(b) and 430A of the Rules and Regulations. If the Company has elected to rely upon Rule 462(b) of the Rules and Regulations
to increase the size of the offering registered under the Act and the Rule 462(b) Registration Statement has not yet been filed
and become effective, the Company will prepare and file the Rule 462 Registration Statement with the Commission within the time
period required by, and otherwise in accordance with the provisions of, Rule 462(b) of the Rules and Regulations and the
Act. The Company will prepare and file with the Commission, promptly upon your request, any amendments or supplements to the Registration
Statement or Prospectus that, in your opinion, may be necessary or advisable in connection with the distribution of the Securities
by the Underwriters; and the Company will furnish you and counsel for the Underwriters a copy of any proposed amendment or supplement
to the Registration Statement or Prospectus and will not file any amendment or supplement to the Registration Statement or Prospectus
to which you shall reasonably object by notice to the Company after having been furnished a copy a reasonable time prior to the
filing. (b) Notification
of Certain Commission Actions. The Company will advise you, promptly after it shall receive notice or obtain knowledge
thereof, of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, or any
post-effective amendment thereto or preventing or suspending the use of any Preliminary Prospectus, the Time of Sale Disclosure
Package, or the Prospectus, of the suspension of the qualification of the Securities for offering or sale in any jurisdiction,
or of the initiation or threatening of any proceeding for any such purpose; and the Company will promptly use its best efforts
to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued. (c) Continued
Compliance with Securities Laws. Within the time during which a prospectus (assuming the absence of Rule 172) relating
to the Securities is required to be delivered under the Act by any Underwriter or any dealer, the Company will comply with all
requirements imposed upon it by the Act, as now and hereafter amended, and by the Rules and Regulations, as from time to time
in force, so far as necessary to permit the continuance of sales of or dealings in the Securities as contemplated by the provisions
hereof, the Time of Sale Disclosure Package and the Prospectus; provided further that the Company use its commercially reasonable
efforts to keep the Registration Statement continuously effective under the Securities Act until the earliest of (i) such
time as all of the Securities (including the Firm Warrants, Option Warrants and Underwriters’ Warrants) covered by such
Registration Statement have been sold by the holders of such Securities; and (ii) the fifth anniversary of the Closing. If during
such period any event occurs as a result of which the Registration Statement or Prospectus (or if the Prospectus is not yet available
to prospective purchasers, the Time of Sale Disclosure Package) would include an untrue statement of a material fact or omit to
state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading,
or if during such period it is necessary to amend the Registration Statement or supplement the Prospectus (or if the Prospectus
is not yet available to prospective investors, the Time of Sale Disclosure Package) to comply with the Act, the Company promptly
will (x) notify you of such untrue statement or omission, (y) amend the Registration Statement or supplement the Prospectus
(or, if the Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure Package) (at the expense of
the Company) so as to correct such statement or omission or effect such compliance and (z) notify you when any amendment to the
Registration Statement is filed or becomes effective or when any supplement to the Prospectus (or, if the Prospectus is not yet
available to prospective purchasers, the Time of Sale Disclosure Package) is filed. (d) Provision
of Documents. The Company will furnish, at its own expense, to the Underwriters and counsel for the Underwriters copies
of the Registration Statement (three of which will be signed electronically and will include all consents and exhibits filed therewith),
and to the Underwriters and any dealer each Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus, and all
amendments and supplements to such documents, in each case as soon as available and in such quantities as you may from time to
time reasonably request. (e) Rule
158. The Company will make generally available to its security holders as soon as practicable, but in no event later than
15 months after the end of the Company’s current fiscal quarter, an earnings statement (which need not be audited) covering
a 12-month period beginning after the effective date of the Registration Statement (which, for purposes of this paragraph, will
be deemed to be the effective date of the Rule 462(b) Registration Statement, if applicable) that shall satisfy the provisions
of Section 11(a) of the Act and Rule 158 of the Rules and Regulations. (f) Payment
and Reimbursement of Expenses; Right of First Refusal; Retainer. The Company, whether or not the
transactions contemplated hereunder are consummated or this Agreement is terminated, will pay or cause to be paid (A) all
expenses (including transfer taxes allocated to the respective transferees) incurred in connection with the delivery to
the Underwriters of the Securities, (B) all expenses and fees (including, without limitation, fees and expenses of
the Company’s accountants and counsel) in connection with the preparation, printing, filing, delivery, and shipping of
the Registration Statement (including the financial statements therein and all amendments, schedules, and exhibits thereto),
the Securities, each Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus, certificates or
warrants representing the Securities and any amendment thereof or supplement thereto, and the printing, delivery, and
shipping of this Agreement and other underwriting documents, including Blue Sky Memoranda (covering the states and other
applicable jurisdictions), (C) all filing fees and fees incurred in connection with the qualification of the Securities for
offering and sale by the Underwriters or by dealers under the securities or blue sky laws of the states and other
jurisdictions which the Underwrtier shall designate (including reasonable out-of-pocket accountable fees and disbursements
incurred by Underwriters’ counsel not to exceed $25,000), (D) the fees and expenses of any transfer agent, warrant
agent or registrar, (E) the fees and expenses of any public relations firm hired by the Company, (F) the reasonable
out-of-pocket accountable fees and disbursements incurred by the Underwriters in connection with the offer, sale or marketing
of the Securities and performance of the Underwriters’ obligations hereunder, including all reasonable
out-of-pocket accountable fees and disbursements of Underwriters’ counsel, which will not exceed $150,000, (G) listing
fees, if any, (H) the cost and expenses of the Company relating to investor presentations or any “road show”
undertaken in connection with marketing of the Securities, including, without limitation, expenses associated with the
preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and
graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval
of the Company, and travel and lodging expenses of the representatives and officers of the Company and any such consultants,
(I) all fees, expenses and disbursements relating to background checks of the Company’s officers and directors (at a
cost not to exceed $1,500 per person) and (J) all other costs and expenses of the Company incident to the performance of its
obligations hereunder that are not otherwise specifically provided for herein. If this Agreement is terminated by you
pursuant to Section 8 hereof or if the sale of the Securities provided for herein is not consummated by reason of any
failure, refusal or inability on the part of the Company to perform any agreement on its part to be performed, or because any
other condition of the Underwriters’ obligations hereunder required to be fulfilled by the Company is not fulfilled,
the Company will reimburse the Underwriters for all reasonable out-of-pocket accountable disbursements incurred by the
Underwriters in connection with their investigation, preparing to market and marketing the Securities or in contemplation of
performing their obligations hereunder. If the offering of the Firm Shares is consummated and the Company undertakes to
engage in any offering of securities (excluding (i) sales to employees under any compensation or stock option plan approved
by the shareholders of the Company, (ii) Common Stock or securities issued in payment of the consideration for an acquisition
or as part of a joint venture or other bona fide strategic relationship where the primary purpose is not financing;
(iii) conventional banking arrangements and commercial debt financing; and (iv) sales to existing shareholders of the Company
or holders of securities convertible into or exercisable
or exchangeable for Common Stock), whether on its own behalf or on behalf of
its shareholders, at any time within eighteen months following the effective date of the Registration Statement, the Company
will first offer the Underwriters the right to serve as manager or co-manager in connection with such offering or transaction
on the same terms and conditions as any bona fide offer to be provided to or received from a third party. The
Underwriters will have 14 days after receipt of notice of such an offer from the Company to elect to enter into an agreement
with the Company on the terms set forth in this paragraph. If the Underwriters decline to accept the offer from the Company
or fails to notify the Company within 14 days after receipt of notice of the offer, then, the Company may enter into an
agreement with a third party from whom it has received a bona fide offer to act as placement agent,
lead-managing underwriter or financial advisor (as applicable) on terms no more favorable to such third party than those
offered to the Underwriters and the Underwriters will have no right to participate in such offering or transaction. If the
Underwriters agree to act in such capacity, the Company and the Underwriters will enter into an appropriate form of separate
agreement containing customary terms and conditions to be mutually agreed upon. The Underwriters are not, expressly or
impliedly, committing to act in any capacity in any such offering or transaction or to purchase any securities in connection
therewith, which commitment will only be set forth in a separate agreement. The Underwriters may waive or terminate the
foregoing right of first refusal in consideration of any payment or fee no more than once. Any payment or fee to waive or
terminate the foregoing right of first will be subject to FINRA Rule 5110(f)(2)(F). The Underwriters shall also be entitled
to a corporate finance fee of $[_____] (the “Corporate Finance Fee”) at the First Closing (and
Second Closing as may be applicable); provided that the Company has paid the Underwriters $50,000 as a non-refundable advance
to be applied toward this Corporate Finance Fee. (g) Use
of Proceeds. The Company will apply the net proceeds from the sale of the Securities to be sold by it hereunder for the
purposes set forth in the Registration Statement, Time of Sale Disclosure Package and
in the Prospectus and will file such reports with the Commission with respect to the sale
of the Securities and the application of the proceeds therefrom as may be required in accordance with Rule 463 of the Rules
and Regulations. (h) Company
Lock Up. The Company will not, without the prior written consent of the Representative,
from the date of execution of this Agreement and continuing to and including the date 90 days after the date of the Prospectus
(the “Lock-Up Period”), (A) offer, pledge, announce the intention to sell, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or
otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable
or exchangeable for Common Stock or (B) enter into any swap or other agreement that transfers, in whole or in part, any of the
economic consequences of ownership of the Common Stock, whether any such transaction described in clause (A) or (B) above is to
be settled by delivery of Common Stock or such other securities, in cash or otherwise, except to the Underwriters pursuant to
this Agreement and (x) grants of options, shares of Common Stock and other awards to
purchase or receive shares of Common Stock under the Company Stock Plans that are in effect as of or prior to the date hereof,
(y) issuances of shares of Common Stock upon the exercise of options or other awards granted under such Company Stock Plans
as of the date hereof pursuant to the terms thereof as of such date or (z) issuances of shares of Common Stock to holders of existing
warrants of the Company pursuant to the exercise thereof. The Company agrees not to accelerate the vesting of any option
or warrant or the lapse of any repurchase right prior to the expiration of the Lock-Up Period. If
(1) during the last 17 days of the Lock-Up Period, (a) the Company issues an earnings release, (b) the Company publicly announces
material news or (c) a material event relating to the Company occurs; or (2) prior to the expiration of the Lock-Up Period, the
Company announces that it will release earnings results during the 16-day period beginning on the last day of the Lock-Up Period,
then the restrictions in this Agreement, unless otherwise waived by you in writing, shall continue to apply until the expiration
of the date that is 18 calendar days after the date on which (a) the Company issues the earnings release, (b) the Company publicly
announces material news or (c) a material event relating to the Company occurs. The Company will provide the Representative and
each shareholder subject to the Lock-Up Agreement (as defined below) with prior notice of any such announcement that gives rise
to the extension of the Lock-Up Period. (i) Stockholder
Lock-Ups. The Company has caused to be delivered to you prior to the date of this Agreement a letter, in the form of Exhibit
B hereto (the “Lock-Up Agreement”), from each individual or entity listed on Schedule II. The
Company will enforce the terms of each Lock-Up Agreement and issue stop-transfer instructions to its transfer agent and registrar
for the Common Stock with respect to any transaction or contemplated transaction that would constitute a breach of or default
under the applicable Lock-Up Agreement. (j) No
Market Stabilization or Manipulation. The Company has not taken and will not take, directly or indirectly, any action
designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales
of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have
not been so disclosed in the Registration Statement. (k) SEC
Reports. The Company will file on a timely basis (including within the time extension provided by Rule 12b-25 promulgated
under the Exchange Act) with the Commission such periodic and special reports as required by the Rules and Regulations. (l) Free
Writing Prospectuses. The Company represents and agrees that, unless it obtains
the prior written consent of the Representative, and the Representative represents
and agrees that, unless it obtains the prior written consent of the Company and the Underwriters,
it has not made and will not make any offer relating to the Securities that would constitute an issuer free writing prospectus
or that would otherwise constitute a free writing prospectus. 5. Conditions
of Underwriters’ Obligations. The obligations of the several Underwriters hereunder are subject to the accuracy,
as of the date hereof and at each of the First Closing Date and the Second Closing Date (as if made at such Closing Date), of
and compliance with all representations, warranties and agreements of the Company contained herein, to the performance by the
Company of its obligations hereunder and to the following additional conditions: (a) Required
Filings; Absence of Certain Commission Actions. The Registration Statement shall have become effective not later than
5:00 p.m., Central time, on the date of this Agreement, or such later time and date as you, as Representative of the several Underwriter,
shall approve and all filings required by Rules 424, 430A and 433 of the Rules and Regulations shall have been timely made
(without reliance on Rule 424(b)(8) or Rule 164(b)); no stop order suspending the effectiveness of the Registration Statement
or any part thereof or any amendment thereof, nor suspending or preventing the use of the Time of Sale Disclosure Package, or
the Prospectus shall have been issued; no proceedings for the issuance of such an order shall have been initiated or threatened;
and any request of the Commission for additional information (to be included in the Registration Statement, the Time of Sale Disclosure
Package, the Prospectus or otherwise) shall have been complied with to your reasonable satisfaction. (b) Continued
Compliance with Securities Laws. No Underwriter shall have advised the Company that (i) the Registration Statement or
any amendment thereof or supplement thereto contains an untrue statement of a material fact which, in your opinion, is material
or omits to state a material fact which, in your opinion, is required to be stated therein or necessary to make the statements
therein not misleading, or (ii) the Time of Sale Disclosure Package or the Prospectus, or any amendment thereof or supplement
thereto, contains an untrue statement of fact which, in your opinion, is material, or omits to state a fact which, in your opinion,
is material and is required to be stated therein, or necessary to make the statements therein, in light of the circumstances under
which they are made, not misleading. (c) Absence
of Certain Events. Except as contemplated in the Registration Statement, Time of Sale Disclosure Package and in the Prospectus,
subsequent to the respective dates as of which information is given in the Registration Statement, Time of Sale Disclosure Package
and the Prospectus, neither the Company nor any of its subsidiaries shall have incurred any material liabilities or obligations,
direct or contingent, or entered into any material transactions, or declared or paid any dividends or made any distribution of
any kind with respect to its capital stock; and there shall not have been any change in the capital stock (other than a change
in the number of outstanding shares of Common Stock due to the issuance of shares upon the exercise of outstanding options or
warrants or conversion of convertible securities), or any material change in the short-term or long-term debt of the Company (other
than as a result of the conversion of convertible securities), or any issuance of options, warrants, convertible securities or
other rights to purchase the capital stock of the Company or any of its subsidiaries, or any Material Adverse Change or any development
involving a prospective Material Adverse Change (whether or not arising in the ordinary course of business), that, in your judgment,
makes it impractical or inadvisable to offer or deliver the Securities on the terms and in the manner contemplated in the Registration
Statement, Time of Sale Disclosure Package and in the Prospectus. (d) Opinion
of Company Counsel. On each Closing Date, there shall have been furnished to you, as Representative of the several Underwriters,
the opinion of Robinson Brog Leinwand Greene Genovese & Gluck P.C., counsel for the Company, dated such Closing Date and addressed
to you in substantially the form attached hereto as Exhibit C-1. (e) Opinion
of Company IP Counsel. On each Closing Date, there shall have been furnished to you, as Representative of the several
Underwriters, the opinion of Beusse Wolter Sanks Mora & Maire, P.A., counsel for the Company, dated such Closing Date and
addressed to you in substantially the form attached hereto as Exhibit C-2. (f) Opinion
of Underwriters’ Counsel. On each Closing Date, there shall have been furnished to you, as Representative of
the several Underwriters, such opinion or opinions from Faegre Baker Daniels LLP, counsel for the Underwriter, dated such
Closing Date and addressed to you, with respect to the formation of the Company, the validity of the Securities, the
Registration Statement, the Time of Sale Disclosure Package or the Prospectus and other related matters as you reasonably may
request, and such counsel shall have received such papers and information as they request to enable them to pass upon such
matters. (g) Comfort
Letter. On the date hereof, on the effective date of any post-effective amendment to the Registration Statement filed
after the date hereof and on each Closing Date, the Underwriter, shall have received a letter from each of Marcum LLP, dated
such date and addressed to you, in form and substance satisfactory to you. (h) Officers’
Certificate. On each Closing Date, there shall have been furnished to the Underwriter a certificate, dated such Closing
Date and addressed to you, signed by the chief executive officer and by the chief financial officer of the Company, to the effect
that: (i) The
representations and warranties of the Company in this Agreement are true and correct as if made at and as of such Closing Date,
and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied
at or prior to such Closing Date; and (ii) No
stop order or other order suspending the effectiveness of the Registration Statement or any part thereof or any amendment thereof
or the qualification of the Securities for offering or sale, nor suspending or preventing the use of the Time of Sale Disclosure
Package, or the Prospectus, has been issued, and no proceeding for that purpose has been instituted or, to the best of their knowledge,
is contemplated by the Commission or any state or regulatory body. (i) Lock-Up
Agreement. The Underwriter shall have received all of the Lock-Up Agreements referenced in Section 4 and the Lock-Up Agreements
shall remain in full force and effect. (j) Other
Documents. The Company shall have furnished to you and counsel for the Underwriter such additional documents, certificates
and evidence as you or they may have reasonably requested. (k) FINRA
No Objections. FINRA shall have raised no objection to the fairness and reasonableness of the underwriting terms and arrangements. (l) Underwriters’
Warrants. On the First Closing Date, the Company shall sell to the Underwriter, for an aggregate purchase price
of $50, warrants (the “Underwriters’ Warrants”) to purchase [_______]
shares of Common Stock in substantially the form attached hereto as Exhibit D. On the Second Closing Date, the Company
shall sell to the Underwriter, for an aggregate purchase price of $50, additional Underwriters’ Warrants to purchase a number
of shares of Common Stock equal to 5.0% (rounded up to the nearest whole share) of the shares to be purchased by the Underwriter
on such Second Closing Day in substantially the form attached hereto as Exhibit D. The Underwriters’ Warrants and the shares
acquirable upon exercise thereof will be subject to the restrictions provided for under FINRA Rule 5110(g)(1). (m) Nasdaq
Listing. The Securities to be delivered on such Closing Date will have been approved for listing on the NASDAQ
Capital Market. All
such opinions, certificates, letters and other documents will be in compliance with the provisions hereof only if they are satisfactory
in form and substance to the Representative and counsel for the Underwriters. The Company will furnish you with such conformed
copies of such opinions, certificates, letters and other documents as you shall reasonably request. 6. Indemnification
and Contribution. (a) Indemnification
by the Company. The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors and officers
and each person, if any, who controls the Underwriters within the meaning of Section 15 of the Act or Section 20 of the Exchange
Act, from and against any losses, claims, damages or liabilities, joint or several, to which such Underwriter may become subject,
under the Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent
of the Company), insofar as such losses, claims, damages or liabilities (or actions in respect thereof) (i) arise out of
or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement,
including the 430A Information and any other information deemed to be a part of the Registration Statement at the time of effectiveness
and at any subsequent time pursuant to the Rules and Regulations, if applicable, any Preliminary Prospectus, the Time of Sale
Disclosure Package, the Prospectus, or any amendment or supplement thereto, any issuer information that the Company has filed
or is required to file pursuant to Rule 433(d) of the Rules and Regulations, or any road show as defined in Rule 433(h) under
the Act (a “road show”), or (ii) arise out of or are based upon the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and
will reimburse each Underwriter for any legal or other expenses reasonably incurred by it in connection with investigating or
defending against such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that
the Company will not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out
of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and
in conformity with written information furnished to the Company by you, or by any Underwriter through you, specifically for use
in the preparation thereof; it being understood and agreed that the only information furnished by an Underwriter consists of the
information described as such in Section 6(e). (b) Indemnification
by the Underwriter. Each Underwriter will, severally and not jointly, indemnify and hold harmless the Company, its affiliates,
directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the Act and Section
20 of the Exchange Act, from and against any losses, claims, damages or liabilities to which the Company may become subject, under
the Act or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of such
Underwriter), insofar as such losses, claims, damages or liabilities (or actions in respect thereof) (i) arise out of or
are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any
Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus, or any amendment or supplement thereto, any issuer
information that the Company has filed or is required to file pursuant to Rule 433(d) of the Rules and Regulations, or any road
show, or (ii) arise out of or are based upon the omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent,
that such untrue statement or alleged untrue statement or omission or alleged omission was made in conformity with written information
furnished to the Company by you, or by such Underwriter through you, specifically for use in the preparation thereof (it being
understood and agreed that the only information furnished by an Underwriter consists of the information described as such in Section 6(e)),
and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection with investigating
or defending against any such loss, claim, damage, liability or action as such expenses are incurred. (c) Notice
and Procedures. Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement
of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under
such subsection, notify the indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying
party shall not relieve the indemnifying party from any liability that it may have to any indemnified party except to the extent
such indemnifying party has been materially prejudiced by such failure (through the forfeiture of substantive rights or defenses).
In case any such action shall be brought against any indemnified party, and it shall notify the indemnifying party of the commencement
thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall wish, jointly with any other
indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to such indemnified party, and
after notice from the indemnifying party to such indemnified party of the indemnifying party’s election so to assume the
defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal or other
expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of
investigation. An indemnifying party shall not be obligated under any settlement agreement relating to any action under this Section 6
to which it has not agreed in writing. In addition, no indemnifying party shall, without the prior written consent of the indemnified
party (which consent shall not be unreasonably withheld or delayed) effect any settlement of any pending or threatened proceeding
unless such settlement includes an unconditional release of such indemnified party for all liability on claims that are the subject
matter of such proceeding and does not include a statement as to, or an admission of, fault, culpability or a failure to act by
or on behalf of an indemnified party. Notwithstanding the foregoing, if at any time an indemnified party shall have requested
an indemnifying party to reimburse the indemnified party for fees and expenses of counsel pursuant to this Section 6(c),
such indemnifying party agrees that it shall be liable for any settlement effected without its written consent if (i) such settlement
is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying
party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement. (d) Contribution;
Limitations on Liability; Non-Exclusive Remedy. If the indemnification provided for in this Section 6 is unavailable
or insufficient to hold harmless an indemnified party under subsection (a) or (b) above, then each indemnifying party shall
contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred
to in subsection (a) or (b), (i) in such proportion as is appropriate to reflect the relative benefits received by the
Company on the one hand and the Underwriters on the other from the offering of the Securities or (ii) if the allocation provided
by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i) above but also the relative fault of the Company on the one hand and the Underwriters
on the other in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well
as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters
on the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses)
received by the Company bear to the total underwriting discounts and commissions received by the Underwriters, in each case as
set forth in the table on the cover page of the Prospectus. The relative fault shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information supplied by the Company or the Underwriters and the parties’ relevant intent, knowledge, access
to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriters agree
that it would not be just and equitable if contributions pursuant to this subsection (d) were to be determined by pro rata
allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does
not take account of the equitable considerations referred to in the first sentence of this subsection (d). The amount paid
by an indemnified party as a result of the losses, claims, damages or liabilities referred to in the first sentence of this subsection (d)
shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating
or defending against any action or claim which is the subject of this subsection (d). Notwithstanding the provisions of this
subsection (d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total underwriting
discounts and commissions received by such Underwriter with respect to the Securities exceeds the amount of any damages that such
Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation. The remedies provided for in this Section 6 are not exclusive
and shall not limit any rights or remedies that might otherwise be available to any indemnified party at law or in equity. (e) Information
Provided by the Underwriter. The Underwriters severally confirm, and the Company acknowledges, that the
statements with respect to the public offering of the Securities by the Underwriter set forth in the second paragraph under
the caption “Underwriting” in the Time of Sale Disclosure Package and in the Prospectus are correct and
constitute the only information concerning the Underwriters furnished in writing to the Company by or on behalf of the
Underwriters specifically for inclusion in the Registration Statement, any Preliminary Prospectus, the Time of Sale
Disclosure Package, or the Prospectus. 7. Representations
and Agreements to Survive Delivery. All representations, warranties, and agreements of the Company herein or in certificates
delivered pursuant hereto, and the agreements of the several Underwriters and the Company contained in Section 6 hereof, shall
remain operative and in full force and effect regardless of any investigation made by or on behalf of any Underwriter or any controlling
person thereof, or the Company or any of its officers, directors, or controlling persons, and shall survive delivery of, and payment
for, the Securities to and by the Underwriters hereunder and any termination of this Agreement. 8. Termination. (a) Right
to Terminate. You, as Representative of the several Underwriters, shall have the right to terminate this Agreement by
giving notice as hereinafter specified at any time at or prior to the First Closing Date, and the option referred to in Section 3(b),
if exercised, may be cancelled at any time prior to the Second Closing Date, if (i) the Company shall have failed, refused
or been unable, at or prior to such Closing Date, to perform any agreement on its part to be performed hereunder, (ii) any
other condition of the Underwriters’ obligations hereunder is not fulfilled, (iii) trading on the NASDAQ Stock Market
or the New York Stock Exchange shall have been wholly suspended, (iv) minimum or maximum prices for trading shall have been
fixed, or maximum ranges for prices for securities shall have been required, on the NASDAQ Stock Market or the New York Stock
Exchange or by order of the Commission or any other Governmental Authority, (v) a banking moratorium shall have been declared
by federal or state authorities, or (vi) there shall have occurred any outbreak or escalation of hostilities or any change in
financial markets or any calamity or crisis that, in your judgment, is material and adverse and makes it impractical or inadvisable
to proceed with the completion of the sale of and payment for the Securities. Any such termination shall be without liability
of any party to any other party except that the provisions of Section 4(g) and Section 6 hereof shall at all times be
effective (which, for the avoidance of doubt, will not provide the Underwriters a right of first refusal pursuant to Section 4(g)
if this Agreement is terminated). (b) Notice
of Termination. If you elect to terminate this Agreement as provided in this Section, the Company shall be notified promptly
by you by telephone, confirmed by letter. 9. Default
by the Company. (a) Default
by the Company. If the Company shall fail at the First Closing Date to sell and deliver the Securities which it is obligated
to sell hereunder, then this Agreement shall terminate without any liability on the part of any Underwriter. (b) No
Relief from Liability. No action taken pursuant to this Section shall relieve the Company from liability, if any, in respect
of any default hereunder. 10. Notices.
Except as otherwise provided herein, all communications hereunder shall be in writing and, if to the Underwriters, shall
be mailed via overnight delivery service or hand delivered via courier, to the Representative c/o Northland Securities, Inc.,
45 South 7th Street, Minneapolis, MN 55402, Attention: Investment Banking; and (ii) if to the Company, shall be mailed
or delivered to it at 4 Research Drive, Suite 402, Shelton, CT 06484, Attention: Chief Executive Officer. Any party to this Agreement
may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. 11. Persons
Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto
and their respective successors and assigns and the controlling persons, officers and directors referred to in Section 6. Nothing
in this Agreement is intended or shall be construed to give to any other person, firm or corporation any legal or equitable remedy
or claim under or in respect of this Agreement or any provision herein contained. The term “successors and assigns”
as herein used shall not include any purchaser, as such purchaser, of any of the Securities from any of the several Underwriters. 12. Absence
of Fiduciary Relationship. The Company acknowledges and agrees that: (a) the Representative has been retained solely to
act as an underwriter in connection with the sale of the Securities and that no fiduciary, advisory or agency relationship between
the Company and the Representative has been created in respect of any of the transactions contemplated by this Agreement, irrespective
of whether the Representative has advised or is advising the Company on other matters; (b) the price and other terms of the Securities
set forth in this Agreement were established by the Company following discussions and arms-length negotiations with the Representative
and the Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the
transactions contemplated by this Agreement; (c) it has been advised that the Representative and its affiliates are engaged in
a broad range of transactions which may involve interests that differ from those of the Company and that the Representative has
no obligation to disclose such interest and transactions to the Company by virtue of any fiduciary, advisory or agency relationship;
(d) it has been advised that the Representative is acting, in respect of the transactions contemplated by this Agreement, solely
for the benefit of the Representative and the other Underwriters, and not on behalf of the Company; (e) it waives to the fullest
extent permitted by law, any claims it may have against the Representative for breach of fiduciary duty or alleged breach of fiduciary
duty in respect of any of the transactions contemplated by this Agreement and agrees that the Representative shall have no liability
(whether direct or indirect) to the Company in respect of such a fiduciary duty claim on behalf of or in right of the Company,
including stockholders, employees or creditors of the Company. 13. Governing
Law; Waiver of Jury Trial. This Agreement shall be governed by and construed in accordance with the laws of the State
of New York. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates)
and the Representative hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. 14. Counterparts.
This Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts
shall each be deemed to be an original and all such counterparts shall together constitute one and the same instrument. 15. General
Provisions. This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior
written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof,
including the letter agreement dated July 30, 2014 between the Company and the Underwriters. This Agreement may not be amended
or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless
waived in writing by each party whom the condition is meant to benefit. The Section headings herein are for the convenience of
the parties only and shall not affect the construction or interpretation of this Agreement. The invalidity or unenforceability
of any Section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other Section,
paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason determined to be invalid
or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it
valid and enforceable. [Signature
Page Follows] Please
sign and return to the Company the enclosed duplicates of this letter whereupon this letter will become a binding agreement between
the Company and the several Underwriters in accordance with its terms. Confirmed
as of the date first above
mentioned, on behalf of themselves and
the other several Underwriters named in
Schedule I hereto Northland
Securities, Inc. SCHEDULE
I SCHEDULE
II List
of Individuals and Entities Executing Lock-Up Agreements Gino
Pereira David
Tunnell Major
General David Gust Michael
D’Almada-Remedios Daniel
Sharkey SCHEDULE III Pricing
Information Firm Shares
offered by the Company: [●] Firm
Warrants offered by the Company: Warrants to purchase [●] shares of common stock. Each warrant will have an exercise price of
$[●] per share, will be exercisable upon issuance and will expire [●] years from the date of issuance. Firm Share
Public Offering price: $[______] per share Firm Share
Price to the Underwriters: $[______] per share Firm Warrant
Public Offering Price: $[______] per share Firm Warrant
Price to the Underwriters: $[______] per share EXHIBIT
A See
attached EXHIBIT
B See
attached EXHIBIT C-1 See
attached EXHIBIT
C-2 See
attached EXHIBIT D See
attached
Exhibit 4.5 Form of Warrant Agreement THIS WARRANT AGREEMENT
(the “Agreement”), dated [_______], 2014, by and between Nxt-ID, a Delaware corporation (the “Company”)
and [___________], a [_______ corporation] (the “Warrant Agent”). 1. Definitions.
As used in this Agreement, the following terms shall have the respective definitions set forth in this Section 1. Capitalized terms
that are used and not defined in this Agreement that are defined in the Purchase Agreement (as defined below) shall have the respective
definitions set forth in the Purchase Agreement. “Closing Price”
means, for any date of determination, the price determined by the first of the following clauses that applies: (i) if the Common
Stock is then listed or quoted on a Trading Market, the closing bid price per share of the Common Stock for such date (or the nearest
preceding date) on such market; (ii) if prices for the Common Stock are then quoted on the OTC Bulletin Board or OTC Quotation
Board, the closing bid price per share of the Common Stock for such date (or the nearest preceding date) so quoted; (iii) if prices
for the Common Stock are then reported in the “Pink Sheets” published by the National Quotation Bureau Incorporated
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported; or (iv) in all other cases, the fair market value of a share of Common Stock as determined by an independent
qualified appraiser selected in good faith and paid for by the Company. “Common Stock”
means the common stock of the Company, par value $0.001 per share, and any securities into which such common stock may hereafter
be reclassified. “Exercise Price” means $[___],[1]
subject to adjustment in accordance with Section 10. “Fundamental Transaction”
means any of the following: (i) the Company effects any merger or consolidation of the Company with or into another person, (ii)
the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender
offer or exchange offer (whether by the Company or another person) is completed pursuant to which holders of Common Stock are permitted
to tender or exchange their shares for other securities, cash or property, or (iv) the Company effects any reclassification of
the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged
for other securities, cash or property. “Purchase Agreement”
means the Underwriting Agreement, dated [___________], 2014, to which the Company and Northland Securities, Inc. are parties. “Trading Day”
means (i) a day on which the Common Stock is traded on a Trading Market (other than the OTC Bulletin Board or OTC Quotation Board),
or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board or OTC Quotation Board), a day
on which the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin Board or OTC Quotation Board,
or (iii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter
market as reported by the National Quotation Bureau Incorporated (or any similar organization or agency succeeding to its functions
of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in clauses (i), (ii)
and (iii) hereof, then Trading Day shall mean a Business Day. “Trading Market”
means whichever of the New York Stock Exchange, NYSE AMEX, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ
Capital Market or the OTC Bulletin Board or OTC Quotation Board on which the Common Stock is listed or quoted for trading on the
date in question. 2. Form of
Warrant Certificate. Each Common Stock Purchase Warrant (the “Warrant”) will certify that for value received,
the holder or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise
and the conditions hereinafter set forth, at any time on or after the date hereof (the “Original Issue Date”)
and on or prior to 5:30 p.m., New York City time, on the date that is five (5) years following the Original Issue Date (the “Expiration
Date”) but not thereafter, to subscribe for and purchase from the Company, up to [______] shares (as subject to adjustment
hereunder, the “Warrant Shares”) of Common Stock. The purchase price of $[___] per share of Common Stock under
the Warrant shall be equal to the Exercise Price, as defined in Section 1. The Company shall issue each Warrant in registered form
only, in substantially the form of Exhibit A hereto, the provisions of which are incorporated herein and shall be signed
by, or bear the facsimile signature of an authorized officer of the Company. [1]
Note: To be 120% of the public offering price of the common stock in the public offering 3. Registration
of Warrant. The Company shall register the Warrants upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of the Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and
for all other purposes, absent actual notice to the contrary. 4. Registration
of Transfers. The Company shall register the transfer of any portion of the Warrant in the Warrant Register, upon surrender
of the Warrant, with the Form of Assignment attached hereto duly completed and signed, to the Company at its address specified
herein. Upon any such registration or transfer, a new Warrant to purchase Common Stock, in substantially the form of the Warrant
(any such new Warrant, a “New Warrant”), evidencing the portion of the Warrant so transferred shall be issued
to the transferee and a New Warrant evidencing the remaining portion of the Warrant not so transferred, if any, shall be issued
to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such
transferee of all of the rights and obligations of a holder of a Warrant. 5. Exercise and
Duration of Warrants. (a)
The Warrant shall be exercisable by the registered Holder in whole at any time and in part from time to time from the Original
Issue Date through and including the Expiration Date. On the Expiration Date, the portion of the Warrant not exercised prior thereto
shall be and become void and of no value. The Company may not call or redeem any portion of the Warrant without the prior written
consent of the affected Holder. In no event will the
Company be required to net cash settle the Warrant exercise. (b) Notwithstanding
anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of
the Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to insure that, following such exercise (or
other issuance), the total number of shares of Common Stock then beneficially owned by such Holder and its affiliates (as defined
under Rule 144, “Affiliates”) and any other persons whose beneficial ownership of Common Stock would be aggregated
with the Holder’s for purposes of Section 13(d) of the Exchange Act, does not exceed 4.999% of the total number of issued
and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such exercise). For
such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder. This provision shall not restrict the number of shares of Common Stock which a Holder may receive
or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event
of a Fundamental Transaction as contemplated in Section 10 of this Agreement. By written notice to the Company, the Holder may
waive the provisions of this Section 5(b) but any such waiver will not be effective until the 61st day after delivery of such notice,
nor will any such waiver effect any other Holder. Notwithstanding anything
to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of the Warrant
(or otherwise in respect hereof) shall be limited to the extent necessary to insure that, following such exercise (or other issuance),
the total number of shares of Common Stock then beneficially owned by such Holder and its Affiliates and any other persons whose
beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange
Act, does not exceed 9.999% of the total number of issued and outstanding shares of Common Stock (including for such purpose the
shares of Common Stock issuable upon such exercise). For such purposes, beneficial ownership shall be determined in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. This provision shall not restrict
the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities
or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 10 of
this Agreement. This restriction may not be waived. 6. Delivery of Warrant
Shares. (a) To effect
exercises hereunder, the Holder shall not be required to physically surrender the Warrant unless the aggregate Warrant Shares represented
by the Warrant are being exercised. Upon delivery of the Exercise Notice (in the form attached hereto) to the Warrant Agent (with
the attached Warrant Shares Exercise Log) at its address for notice set forth herein and upon payment of the Exercise Price multiplied
by the number of Warrant Shares that the Holder intends to purchase hereunder and the Warrant Agent shall promptly (but in no event
later than three Trading Days after the Date of Exercise (as defined herein)) issue and deliver to the Holder, a certificate for
the Warrant Shares issuable upon such exercise, which, unless otherwise required by the Purchase Agreement, shall be free of restrictive
legends. The Warrant Agent shall deliver Warrant Shares hereunder electronically through the Depository Trust Corporation or another
established clearing corporation performing similar functions, if available. A “Date of Exercise” means the
date on which the Holder shall have delivered to the Warrant Agent: (i) the Exercise Notice (with the Warrant Exercise Log attached
to it), appropriately completed and duly signed and (ii) if such Holder is not utilizing the cashless exercise provisions set forth
in this Agreement, payment of the Exercise Price for the number of Warrant Shares so indicated by the Holder to be purchased. (b) If by the
third Trading Day after the Company receives notice of the Warrant Agent receiving an Exercise Notice, the Company fails to cause
the Warrant Agent to deliver the required number of Warrant Shares in the manner required pursuant to Section 6(a), then the Holder
will have the right to rescind such exercise. (c) If by the
third Trading Day after the Company receives notice of the Warrant Agent receiving an Exercise Notice, the Company fails to cause
the Warrant Agent to deliver the required number of Warrant Shares in the manner required pursuant to Section 6(a), and if after
such third Trading Day and prior to the receipt of such Warrant Shares, the Holder purchases (in an open market transaction or
otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
receiving upon such exercise (a “Buy-In”), then the Company shall (1) pay in cash to the Holder the amount by
which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased
exceeds (y) the amount obtained by multiplying (A) the number of Warrant Shares that the Company was required to deliver to the
Holder in connection with the exercise at issue by (B) the closing bid price of the Common Stock at the time of the obligation
giving rise to such purchase obligation and (2) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. The Holder shall
provide the Warrant Agent written notice indicating the amounts payable to the Holder in respect of the Buy-In. (d) The Company’s
obligations to cause the Warrant Agent to issue and deliver Warrant Shares in accordance with the terms hereof are absolute and
unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to
any provision hereof, the recovery of any judgment against any person or any action to enforce the same, or any setoff, counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other person of any obligation to the
Company or any violation or alleged violation of law by the Holder or any other person, and irrespective of any other circumstance
which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing
herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely
deliver certificates representing Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof. (e) If the Warrant
is exercised in part, the Warrant Agent shall, at the request of a Holder and upon surrender of the Warrant, at the time of delivery
of the certificate or certificates representing Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the
Holder to purchase the unpurchased Warrant Shares called for by the Warrant, which new Warrant shall in all other respects be identical
with the Warrant 7. Charges,
Taxes and Expenses. Issuance and delivery of Warrant Shares upon exercise of the Warrant shall be made without charge to the
Holder for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect of the
issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company
shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration of any certificates
for Warrant Shares or Warrants in a name other than that of the Holder. The Holder shall be responsible for all other tax liability
that may arise as a result of holding or transferring the Warrant or receiving Warrant Shares upon exercise hereof. The Company
shall pay all Warrant Agent fees required for same-day processing of any Notice of Exercise. 8. Replacement
of Warrant. If the Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and substitution for the Warrant, a New Warrant, but only upon
receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity
(which shall not include a surety bond), if requested. Applicants for a New Warrant under such circumstances shall also comply
with such other reasonable regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe.
If a New Warrant is requested as a result of a mutilation of the Warrant, then the Holder shall deliver such mutilated Warrant
to the Company as a condition precedent to the Company’s obligation to issue the New Warrant. 9. Reservation
of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of the aggregate of its authorized
but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise
of the Warrant as herein provided, the number of Warrant Shares which are then issuable and deliverable upon the exercise of this
entire Warrant, free from preemptive rights or any other contingent purchase rights of Persons other than the Holder (taking into
account the adjustments and restrictions of Section 10). The Company covenants that all Warrant Shares so issuable and deliverable
shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly
authorized, issued and fully paid and nonassessable. 10. Certain
Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of the Warrant are subject to adjustment
from time to time as set forth in this Section 10. (a) Stock
Dividends and Splits. If the Company, at any time while the Warrant is outstanding, (i) pays a stock dividend on its Common
Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, or (iii) combines outstanding shares of Common Stock into a
smaller number of shares, then in each such case the Exercise Price shall be adjusted to equal the product obtained by multiplying
the then-current Exercise Price by a fraction of which the numerator shall be the number of shares of Common Stock outstanding
immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately
after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause
(ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. (b) Fundamental
Transactions. If, at any time while the Warrant is outstanding there is a Fundamental Transaction, then the Holder shall have
the right thereafter to receive, upon exercise of the Warrant, the same amount and kind of securities, cash or property as it would
have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental
Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of the Warrant (the “Alternate
Consideration”). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted
to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in
a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of the Warrant following such Fundamental
Transaction. At the Holder’s option and request, any successor to the Company or surviving entity in such Fundamental Transaction
shall, either (1) issue to the Holder a new warrant substantially in the form of the Warrant and consistent with the foregoing
provisions and evidencing the Holder’s right to purchase the Alternate Consideration for the aggregate Exercise Price upon
exercise thereof, or (2) purchase the Warrant from the Holder for a purchase price, payable in cash within five Trading Days after
such request (or, if later, on the effective date of the Fundamental Transaction), equal to the Black Scholes value of the remaining
unexercised portion of the Warrant on the date of such request. The terms of any agreement pursuant to which a Fundamental Transaction
is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this paragraph
(b) and insuring that the Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction
analogous to a Fundamental Transaction. (c) Number
of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 10, the number of Warrant
Shares that may be purchased upon exercise of the Warrant shall be increased or decreased proportionately, so that after such adjustment
the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise
Price in effect immediately prior to such adjustment. (d)
Calculations. All calculations under this Section 10 shall be made to the nearest cent or the nearest 1/100th
of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or
held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common
Stock. (e) Notice
of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 10, the Company at its expense will promptly
compute such adjustment in accordance with the terms of the Warrant and prepare a certificate setting forth such adjustment, including
a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise
of the Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon
which such adjustment is based. Upon written request, the Warrant Agent will promptly deliver a copy of each such certificate to
the Holder. 11. Payment
of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash
Exercise. The Holder may deliver immediately available funds; or (b) Cashless
Exercise. If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant
Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the
Warrant Shares, then the Holder may notify the Warrant Agent in an Exercise Notice of its election to utilize a cashless exercise,
in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: X = Y [(A-B)/A] where: X = the number
of Warrant Shares to be issued to the Holder. Y = the number
of Warrant Shares with respect to which the Warrant is being exercised. A = the average
of the Closing Prices for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise
Price. For purposes of Rule 144 promulgated under
the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction
shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced,
on the date the Warrant was originally issued. (c) Disposition
of Proceeds on Exercise of Warrants. The Warrant Agent shall promptly forward to the Company all monies received by the Warrant
Agent for the purchase of shares of Common Stock through the exercise of Warrants. 12. No Fractional
Shares. No fractional shares of Warrant Shares will be issued in connection with any exercise of any Warrant. In lieu of any
fractional shares which would, otherwise be issuable, the Company shall, at its election, either pay cash equal to the product
of such fraction multiplied by the Closing Price of one Warrant Share on the date of exercise or round up to the next whole share. 13. Notices.
Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall
be in writing and shall be deemed given and effective if provided pursuant to the Purchase Agreement. In case any time: (1) the
Company shall declare any cash dividend on its capital stock; (2) the Company shall pay any dividend payable in stock upon its
capital stock or make any distribution to the holders of its capital stock; (3) the Company shall offer for subscription pro rata
to the holders of its capital stock any additional shares of stock of any class or other rights; (4) there shall be any capital
reorganization, or reclassification of the capital stock of the Company, or consolidation or merger of the Company with, or sale
of all or substantially all of its assets to, another corporation; or (5) there shall be a voluntary or involuntary dissolution,
liquidation or winding up of the Company; then, in any one or more of said cases, the Company shall give prompt written notice
to the Holder. Such notice shall also specify the date as of which the holders of capital stock of record shall participate in
such dividend, distribution or subscription rights, or shall be entitled to exchange their capital stock for securities or other
property deliverable upon such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding
up, or conversion or redemption, as the case may be. Such written notice shall be given at least 20 days prior to the action in
question and not less than 20 days prior to the record date or the date on which the Company’s transfer books are closed
in respect thereto. 14. Warrant
Agent. The Company’s transfer agent for its Common Stock and Warrants, *[____________], shall serve as warrant agent
under the Warrant (the “Warrant Agent”). Upon thirty (30) days’ notice to the Holder, the Company may
appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting
from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or
any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor
warrant agent under the Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession
as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as shown
on the Warrant Register. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of
this Agreement, the Warrant Shares required to be issued pursuant to the provisions of Section 6, and the Company, whenever required
by the Warrant Agent, will supply the Warrant Agent with certificates duly executed on behalf of the Company for such purpose.
The Warrant Agent shall be liable under this Agreement only for its own negligence, willful misconduct and bad faith. The Company
agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable
counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result of the Warrant
Agent’s negligence, willful misconduct or bad faith. The Warrant Agent shall have no responsibility with respect to the validity
of this Agreement or any Warrant (except its countersignature thereof), nor shall it be responsible for any breach by the Company
of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent hereby accepts the agency established
by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account
promptly to the company with respect to the Warrants exercised and concurrently account for, and pay to the Company, all moneys
received by the Warrant Agent for the purchase of shares of the Company’s Common stock through the exercise of Warrants.
The Warrant Agent shall keep copies of this Agreement available for inspection by holders of Warrants during normal business hours. 15. Miscellaneous. (a) Successors
and Assigns. This Agreement shall be binding on and inure to the benefit of the parties hereto and their respective successors
and assigns. Subject to the preceding sentence, nothing in this Agreement shall be construed to give to any Person other than the
Company and the Holder any legal or equitable right, remedy or cause of action under this Agreement. (b) Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed
by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of
conflicts of law thereof. (c) Amendment.
The provisions of the Warrant and all warrants issued pursuant to the Purchase Agreement may be amended and the Company may
take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Holders representing not less than a majority of the Warrant Shares obtainable upon exercise of the
Warrants then outstanding. (d) Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit
or affect any of the provisions hereof. (e) Severability. In case any one or more of the provisions of this Agreement
shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this
Agreement shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid
and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Agreement. (f) No Rights
as Stockholder Until Exercise. Prior to exercise of the Warrant, the Holder hereof shall not, by reason of by being a Holder,
be entitled to any rights of a stockholder with respect to the Warrant Shares. (g) Closing
of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of the
Warrant, pursuant to the terms hereof. [signature page follows] In witness whereof, the
undersigned have caused this Agreement to be duly executed as of the date first indicated above. THIS CERTIFIES THAT, for value received,
SPECIMEN is the registered holder of a Warrant or Warrants
expiring [_______], 2018 (the “Warrant”) to purchase [___] of one fully paid and non-assessable share of common stock,
$0,0001 par value (“Shares”) of Nxt-ID, Inc., a Delaware corporation (the “Company”) for each Warrant evidenced
by this Warrant Certificate. The Warrant entitles the holder thereof to purchase from the Company, commencing upon the date of
issuance, such number of Shares of the Company at the price of $[___] per full Share (the “Exercise Price”), upon surrender
of the Warrant, with a duly executed facsimile copy of the Notice of Exercise Form attached hereto and payment of the Exercise
Price at the office or agency of the Warrant Agent, Corporate Stock Transfer, Inc. (the “Warrant Agent”), but subject
to the conditions set forth herein and in the Common Stock Purchase Warrant Agreement between the Company and the Warrant Agent
(the “Warrant Agreement”). The terms of the Warrant Agreement are incorporated herein in their entirety. In the event
of a conflict between this Warrant Certificate and the Warrant Agreement, the terms of the Warrant Agreement shall control. This Warrant will expire on the date first
written above if it is not exercised prior to such date by the registered holder pursuant to the terms of the Warrant Agreement. No fraction of a Share will be issued upon
any exercise of a Warrant. If the holder of a Warrant would be entitled to receive a fraction of a Share upon any exercise of a
Warrant, the Company shall, upon such exercise, round up to the nearest whole number the number of Shares to be issued to such
holder or pay a cash adjustment in respect of such fractional amount. Warrant Certificates, when surrendered at the
office or agency of the Warrant Agent by the registered holder hereof in person or by attorney duly authorized in writing, may
be exchanged in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service
charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants. Upon due presentment for registration of transfer
of the Warrant Certificate at the office or agency of the Warrant Agent in the manner provided in the Warrant Agreement, a new
Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued
to the transferee in exchange for this Warrant Certificate as provided in the Warrant Agreement. The Company and the Warrant Agent may deem
and treat the registered holder as the absolute owner of this Warrant Certificate (notwithstanding any notation of ownership or
writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the registered holder, and for all
other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. This Warrant does not entitle the registered
holder to any of the rights of a stockholder of the Company. EXERCISE NOTICE The undersigned Holder hereby irrevocably elects
to purchase shares of Common Stock pursuant to the attached Warrant. Capitalized terms used herein and not otherwise defined have
the respective meanings set forth in the Warrant. (1) The undersigned Holder hereby exercises
its right to purchase Warrant Shares pursuant to the Warrant. (2) The Holder intends that payment of the
Exercise Price shall be made as (check one): ¨
“Cash Exercise” under Section 10 ¨
“Cashless Exercise” under Section 10 (3) If the holder has elected a Cash Exercise,
the holder shall pay the sum of $____________ to the Company in accordance with the terms of the Warrant. (4) Pursuant to this Exercise Notice, the Company
shall deliver to the holder Warrant Shares in accordance with the terms of the Warrant. Warrant Shares Exercise Log Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised FORM OF ASSIGNMENT [To be completed and signed
only upon transfer of Warrant] FOR VALUE RECEIVED, the undersigned hereby sells,
assigns and transfers unto the right represented by the attached Warrant to purchase shares of Common Stock to which such Warrant
relates and appoints attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: __________ __, _______ (Signature must conform in all respects to name of holder as specified
on the face of the Warrant) Address of Transferee 12 Exhibit 4.6 NXT-ID, INC. FORM OF WARRANT Warrant No.: UW-[__] Original Issue: Date: [______], 2014
[______], 2014 NXT-ID, INC.
a Delaware corporation (the “Company”), hereby certifies that, for value received, [_____________] or its registered
assigns (the “Holder”), is entitled to purchase from the Company up to a total of [_______]1 shares
of Common Stock (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”),
at any time and from time to time from and after the Original Issue Date and through and including [_______]2 (the “Expiration
Date”) relating to a public offering (the “Offering”) of Common Stock by the Company and certain of
its stockholders, and subject to the following terms and conditions: This Warrant is granted
in connection with that certain Purchase Agreement, dated [______], 2014 between the Company and Northland Securities, Inc. as
representative of the Underwriters (the “Purchase Agreement”) and the public offering of [_______] Shares of
the Common Stock and warrants to purchase [_______] shares of Common Stock registered on the Company’s Registration Statement
on Form S-1 (the “Registration Statement”) filed with the U.S. Securities and Exchange Commission (the “SEC”)
and declared effective on [_____], as amended (the “Offering”). 1. Definitions.
As used in this Warrant, the following terms shall have the respective definitions set forth in this Section 1. Capitalized terms
that are used and not defined in this Warrant that are defined in the Purchase Agreement shall have the respective definitions
set forth in the Purchase Agreement. “Closing
Price” means, for any date of determination, the price determined by the first of the following clauses that applies:
(i) if the Common Stock is then listed or quoted on a Trading Market, the closing bid price per share of the Common Stock for such
date (or the nearest preceding date) on such market; (ii) if prices for the Common Stock are then quoted on the OTC Bulletin Board
or OTC Quotation Board, the closing bid price per share of the Common Stock for such date (or the nearest preceding date) so quoted;
(iii) if prices for the Common Stock are then reported in the “Pink Sheets” published by the National Quotation Bureau
Incorporated (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported; or (iv) in all other cases, the fair market value of a share of Common Stock as determined
by an independent qualified appraiser selected in good faith and paid for by the Company. “Common
Stock” means the common stock of the Company, par value $0.0001 per share, and any securities into which such common
stock may hereafter be reclassified. “Exercise Price”
means $[_____]3, subject to adjustment in accordance with Section 9. “Fundamental
Transaction” means any of the following: (i) the Company effects any merger or consolidation of the Company with or into
another person, (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions,
(iii) any tender offer or exchange offer (whether by the Company or another person) is completed pursuant to which holders of Common
Stock are permitted to tender or exchange their shares for other securities, cash or property, or (iv) the Company effects any
reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property. 1 Equal to 5% of
the number of shares of common stock sold on the applicable closing date 2 Date that is five
years from effective date of Registration Statement 3 120% of the price
of the common stock issued in the Offering “Original
Issue Date” means the Original Issue Date first set forth on the first page of this Warrant or its predecessor instrument. “Trading
Day” means (i) a day on which the Common Stock is traded on a Trading Market (other than the OTC Bulletin Board or OTC
Quotation Board), or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board or OTC Quotation
Board), a day on which the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin Board or OTC
Quotation Board, or (iii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in
the over-the-counter market as reported by the National Quotation Bureau Incorporated (or any similar organization or agency succeeding
to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth
in clauses (i), (ii) and (iii) hereof, then Trading Day shall mean any day, other than a Saturday or Sunday and other than a day
that banks in the State of New York are generally authorized or required by applicable law to be closed. “Trading
Market” means whichever of the New York Stock Exchange, NYSE AMEX, the NASDAQ Global Select Market, the NASDAQ Global
Market, the NASDAQ Capital Market or the OTC Bulletin Board or OTC Quotation Board on which the Common Stock is listed or quoted
for trading on the date in question. 2. Registration
of Warrant. The Company shall register this Warrant upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary. 3.
Registration of Transfers. The Company shall register the transfer of any portion of this Warrant in the Warrant Register,
upon surrender of this Warrant, with the Form of Assignment attached hereto duly completed and signed, to the Company at its address
specified herein. Upon any such registration or transfer, a new Warrant to purchase Common Stock, in substantially the form of
this Warrant (any such new Warrant, a “New Warrant”), evidencing the portion of this Warrant so transferred
shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any,
shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance
by such transferee of all of the rights and obligations of a holder of a Warrant. 4. Exercise
and Duration of Warrants. (a) This
Warrant shall be exercisable by the registered Holder in whole at any time and in part from time to time from the Original Issue
Date through and including the Expiration Date. At 5:00 p.m., Eastern time on the Expiration Date, the portion of this Warrant
not exercised prior thereto shall be and become void and of no value. The Company may not call or redeem any portion of this Warrant
without the prior written consent of the affected Holder. In no event will the Company be required to net cash settle the
Warrant exercise. (b) Notwithstanding
anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of
this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to ensure that, following such exercise
(or other issuance), the total number of shares of Common Stock then beneficially owned by such Holder and its affiliates (as
defined under Rule 144, “Affiliates”) and any other persons whose beneficial ownership of Common Stock would
be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act, does not exceed 4.999% of the total number
of issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such exercise).
For such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules
and regulations promulgated thereunder. This provision shall not restrict the number of shares of Common Stock which a Holder
may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive
in the event of a Fundamental Transaction as contemplated in Section 9 of this Warrant. By written notice to the Company,
the Holder may waive the provisions of this Section 4(b) but any such waiver will not be effective until the 61st day after delivery
of such notice, nor will any such waiver effect any other Holder. Notwithstanding
anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of
this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to insure that, following such exercise
(or other issuance), the total number of shares of Common Stock then beneficially owned by such Holder and its Affiliates and any
other persons whose beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d)
of the Exchange Act, does not exceed 9.999% of the total number of issued and outstanding shares of Common Stock (including for
such purpose the shares of Common Stock issuable upon such exercise). For such purposes, beneficial ownership shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. This provision
shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the
amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated
in Section 9 of this Warrant. This restriction may not be waived. 5. Delivery
of Warrant Shares. (a) To
effect exercises hereunder, the Holder shall not be required to physically surrender this Warrant unless the aggregate Warrant
Shares represented by this Warrant are being exercised. Upon delivery of the Exercise Notice (in the form attached hereto) to
the Company (with the attached Warrant Shares Exercise Log) at its address for notice set forth herein and upon payment of the
Exercise Price multiplied by the number of Warrant Shares that the Holder intends to purchase hereunder and the Company shall
promptly (but in no event later than three Trading Days after the Date of Exercise (as defined herein)) issue and deliver to the
Holder, a certificate for the Warrant Shares issuable upon such exercise, which, unless otherwise required by applicable law,
shall be free of restrictive legends. A “Date of Exercise” means the date on which the Holder shall have delivered
to the Company: (i) the Exercise Notice (with the Warrant Exercise Log attached to it), appropriately completed and duly signed
and (ii) if such Holder is not utilizing the cashless exercise provisions set forth in this Warrant, payment of the Exercise Price
for the number of Warrant Shares so indicated by the Holder to be purchased. (b) If
by the third Trading Day after a Date of Exercise the Company fails to deliver the required number of Warrant Shares in the manner
required pursuant to Section 5(a), then the Holder will have the right to rescind such exercise. (c) If by the third
Trading Day after a Date of Exercise the Company fails to deliver the required number of Warrant Shares in the manner required
pursuant to Section 5(a), and if after such third Trading Day and prior to the receipt of such Warrant Shares, the Holder purchases
(in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the
Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall
(1) pay in cash to the Holder the amount by which (x) the Holder’s total purchase price (including brokerage commissions,
if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the number of Warrant Shares
that the Company was required to deliver to the Holder in connection with the exercise at issue by (B) the closing bid price of
the Common Stock at the time of the obligation giving rise to such purchase obligation and (2) at the option of the Holder, either
reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored or deliver
to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise
and delivery obligations hereunder. The Holder shall provide the Company written notice indicating the amounts payable to the
Holder in respect of the Buy-In. (d) The
Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof are absolute and unconditional,
irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision
hereof, the recovery of any judgment against any person or any action to enforce the same, or any setoff, counterclaim, recoupment,
limitation or termination, or any breach or alleged breach by the Holder or any other person of any obligation to the Company
or any violation or alleged violation of law by the Holder or any other person, and irrespective of any other circumstance which
might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing
herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely
deliver certificates representing Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof. 6. Charges,
Taxes and Expenses. Issuance and delivery of Warrant Shares upon exercise of this Warrant shall be made without charge to
the Holder for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect of
the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company
shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration of any certificates
for Warrant Shares or Warrants in a name other than that of the Holder. The Holder shall be responsible for all other tax liability
that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof. 7. Replacement
of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon
receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity
(which shall not include a surety bond), if requested. Applicants for a New Warrant under such circumstances shall also comply
with such other reasonable regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe.
If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant
to the Company as a condition precedent to the Company’s obligation to issue the New Warrant. 8. Reservation
of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of the aggregate of its
authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon
exercise of this Warrant as herein provided, the number of Warrant Shares which are then issuable and deliverable upon the exercise
of this entire Warrant, free from preemptive rights or any other contingent purchase rights of Persons other than the Holder (taking
into account the adjustments and restrictions of Section 9). The Company covenants that all Warrant Shares so issuable and deliverable
shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly
authorized, issued and fully paid and nonassessable. 9. Certain
Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section 9. (a) Stock Dividends and Splits.
If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes
a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides outstanding shares of Common
Stock into a larger number of shares, or (iii) combines outstanding shares of Common Stock into a smaller number of shares, then
in each such case the Exercise Price shall be adjusted to equal the product obtained by multiplying the then-current Exercise Price
by a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and
of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment
made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of
stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph
shall become effective immediately after the effective date of such subdivision or combination. (b) Fundamental Transactions.
If, at any time while this Warrant is outstanding there is a Fundamental Transaction, then the Holder shall have the right thereafter
to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled
to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction,
the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (the “Alternate Consideration”).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting
the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice
as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice
as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. At the
Holder’s option and request, any successor to the Company or surviving entity in such Fundamental Transaction shall, either
(1) issue to the Holder a new warrant substantially in the form of this Warrant and consistent with the foregoing provisions and
evidencing the Holder’s right to purchase the Alternate Consideration for the aggregate Exercise Price upon exercise thereof,
or (2) purchase the Warrant from the Holder for a purchase price, payable in cash within five Trading Days after such request (or,
if later, on the effective date of the Fundamental Transaction), equal to the Black Scholes value of the remaining unexercised
portion of this Warrant on the date of such request. The terms of any agreement pursuant to which a Fundamental Transaction is
effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this paragraph (b)
and insuring that the Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous
to a Fundamental Transaction. (c) Number
of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 9, the number of Warrant
Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such
adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate
Exercise Price in effect immediately prior to such adjustment. (d) Calculations. All
calculations under this Section 9 shall be made to the nearest cent or the nearest 1/100th of a share, as applicable.
The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account
of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock. (e) Notice of Adjustments.
Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will promptly compute such adjustment
in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of
the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant
(as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such adjustment
is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company’s
transfer agent. 10. Payment
of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The
Holder may deliver immediately available funds; or (b) Cashless Exercise.
The Holder may notify the Company in an Exercise Notice of its election to utilize a cashless exercise, in which event the Company
shall issue to the Holder the number of Warrant Shares determined as follows: X = Y [(A-B)/A] where: X = the
number of Warrant Shares to be issued to the Holder. Y = the
number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the Closing
Prices for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated
under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction
shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced,
on the date this Warrant was originally issued. 11. No
Fractional Shares. No fractional shares of Warrant Shares will be issued in connection with any exercise of this Warrant.
In lieu of any fractional shares which would, otherwise be issuable, the Company shall pay cash equal to the product of such fraction
multiplied by the Closing Price of one Warrant Share on the date of exercise. 12. Notices.
Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall
be in writing and shall be deemed given and effective if provided pursuant to the Purchase Agreement. In
case any time: (1) the Company shall declare any cash dividend on its capital stock; (2) the Company shall pay any dividend payable
in stock upon its capital stock or make any distribution to the holders of its capital stock; (3) the Company shall offer for
subscription pro rata to the holders of its capital stock any additional shares of stock of any class or other rights; (4) there
shall be any capital reorganization, or reclassification of the capital stock of the Company, or consolidation or merger of the
Company with, or sale of all or substantially all of its assets to, another corporation; or (5) there shall be a voluntary or
involuntary dissolution, liquidation or winding up of the Company; then, in any one or more of said cases, the Company shall give
prompt written notice to the Holder. Such notice shall also specify the date as of which the holders of capital stock of record
shall participate in such dividend, distribution or subscription rights, or shall be entitled to exchange their capital stock
for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, sale, dissolution,
liquidation or winding up, or conversion or redemption, as the case may be. Such written notice shall be given at least 20 days
prior to the action in question and not less than 20 days prior to the record date or the date on which the Company’s transfer
books are closed in respect thereto. 13. Lock
Up. Notwithstanding any other provision of this Warrant, in accordance with FINRA Rule 5110(g), this Warrant shall not be
sold during the Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale,
derivative, put, or call transaction that would result in the effective economic disposition of this Warrant or the Warrant Shares,
by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the Offering,
except as provided in paragraph (g)(2) of FINRA Rule 5110. 14.
Transfer; Assignment. Subject to compliance with any applicable securities laws, this Warrant may be transferred
or assigned by the Holder without the consent of the Company (including, without limitation, transfers or assignments to the Holder’s
employees and affiliates). This Warrant may not be assigned by the Company without the written consent of the Holder. 15. Miscellaneous. (a) This Warrant shall
be binding on and inure to the benefit of the parties hereto and their respective successors and assigns. Subject to the preceding
sentence, nothing in this Warrant shall be construed to give to any person other than the Company and the Holder any legal or equitable
right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the
Holder and their successors and assigns. (b) All questions concerning
the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance
with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. (c) The
headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect
any of the provisions hereof. (d) In
case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability
of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will
attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor,
and upon so agreeing, shall incorporate such substitute provision in this Warrant. (e) Prior
to exercise of this Warrant, the Holder hereof shall not, by reason of by being a Holder, be entitled to any rights of a stockholder
with respect to the Warrant Shares. [Remainder of page intentionally left
blank, signature page follows] In witness
whereof, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.
nxt-id, inc. By:____________________ Name:__________________ Its: ____________________ Accepted and agreed: NORTHLAND SECURITIES,
INC. By:_______________________ Name:_____________________ Its:________________________ EXERCISE NOTICE The undersigned Holder
hereby irrevocably elects to purchase
shares of Common Stock pursuant to the attached Warrant. Capitalized terms used herein and not otherwise defined have the respective
meanings set forth in the Warrant. (1) The undersigned Holder hereby exercises
its right to purchase
Warrant Shares pursuant to the Warrant. (2) The Holder intends that payment of the
Exercise Price shall be made as (check one): ¨
“Cash Exercise” under Section 10 ¨
“Cashless Exercise” under Section 10 (3) If the Holder has elected a Cash Exercise,
the Holder shall pay the sum of $____________ to the Company in accordance with the terms of the Warrant. (4) Pursuant to this Exercise Notice, the Company
shall deliver to the Holder
Warrant Shares in accordance with the terms of the Warrant. Dated
_____________ __, _____ Name of Holder: (Print) ____________________________________ By:_________________________________ Its:_________________________________ Warrant Shares Exercise Log Number of Warrant Shares Available to be Exercised Number of Warrant Shares Exercised Number of Warrant Shares Remaining to be Exercised FORM OF ASSIGNMENT [To be completed and signed
only upon transfer of Warrant] FOR VALUE RECEIVED, the
undersigned hereby sells, assigns and transfers unto
the right represented by the attached Warrant to purchase
shares of Common Stock to which such Warrant relates and appoints
attorney to transfer said right on the books of the Company with full power of substitution in the premises. Dated: __________ __, _______ ________________________________________ (Signature must
conform in all respects to name of holder as specified on the face of the Warrant) Address
of Transferee __________________________________________ __________________________________________ __________________________________________ Note:
Address for Delivery may not be a P.O. box and must be a physical address where stock certificates may be delivered in connection
with this purchase or any future stock issued through splits, warrant conversions or other circumstances. The delivery address
may be a personal residence, or a broker dealer where the certificate would be deposited 11 Exhibit 5.1 ROBINSON BROG LEINWAND GREENE GENOVESE &
GLUCK P.C. 875 THIRD AVENUE NEW YORK, NEW YORK 10022-0123 (212) 603-6300 FAX (212) 956-2164 August 13, 2014 Nxt-ID, Inc. One Reservoir Corporate Centre 4 Research Drive, Suite 402 Shelton, CT 06484 Re: Shares to be registered on Form
S-1 Gentlemen: We have acted
as counsel to you, Nxt-ID, Inc., a Delaware corporation, (the “Company”) in connection with the Company’s Registration
Statement on Form S-1 filed with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities
Act of 1933, as amended (the “Securities Act”) (File No. 333 –
197845) (the “Registration Statement”). The Registration Statement covers up to $8,050,000 (including the over-allotment
option) of: (a) shares of common stock, par value $0.0001 per share (the “Common Stock”) (each a “Share”
or in the aggregate, the “Shares”) and warrants to purchase shares of Common Stock (each a “Warrant” or
in the aggregate, the “Warrants”) and (b) shares issued in respect of the exercise of a Warrant (the “Warrant
Shares”). In connection
with this matter, we have examined the originals or copies certified or otherwise identified to our satisfaction of the following:
(a) Certificate of Incorporation of the Company, as amended to date, (b) By-laws of the Company, as amended to date, and (c) the
Registration Statement and all exhibits thereto. In addition to the foregoing, we also have relied as to matters of fact upon the
representations made by the Company and their representatives and we have assumed the genuineness of all signatures, the authenticity
of all documents submitted to us as originals, and the conformity to original documents of all documents submitted to us certified
or photostatic copies. We are members
of the Bar of the State of New York. We do not hold ourselves out as being conversant with, or expressing any opinion with respect
to, the laws of any jurisdiction other than the Federal laws of the United States of America, the laws of the State of New York,
and the Delaware General Corporation Law (the "DGCL"). Accordingly, the opinions expressed herein are expressly limited
to the Federal laws of the United States of America, the laws of the State of New York, and the DGCL. Based upon the foregoing and in reliance
thereon, and subject to the qualifications, limitations, exceptions and assumptions set forth herein, we are of the opinion that:
(i) the Shares, when and to the extent issued and sold in exchange for payment in full to the Company of all consideration required
therefor as applicable, and as described in the Registration Statement, will be validly issued, fully paid and non-assessable,
(ii) the Warrant Shares, when issued and delivered against payment therefor upon the exercise of the Warrants in accordance with
the terms therein, will be duly authorized, validly issued, fully paid and nonassessable, and (iii) the Warrants at issuance will
be duly executed and delivered to the purchasers thereof against payment of the purchase price therefor, and the Warrants will
constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. This opinion letter speaks
only as of the date hereof and we assume no obligation to update or supplement this opinion letter if any applicable laws change
after the date of this opinion letter or if we become aware after the date of this opinion letter of any facts, whether existing
before or arising after the date hereof, that might change the opinions expressed above. This opinion
letter is furnished in connection with the filing of the Registration Statement and may not be relied upon for any other purpose
without our prior written consent in each instance. Further, no portion of this letter may be quoted, circulated or referred to
in any other document for any other purpose without our prior written consent. We hereby consent to the
filing of this opinion with the Commission as an exhibit to the Registration Statement and to the use of our name as it appears
under the caption “Legal Representation” in the Prospectus included in the Registration Statement. In giving such consent,
we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities
Act or the rules and regulations of the Commission promulgated thereunder. This opinion is expressed as of the date hereof unless
otherwise expressly stated, and we disclaim any undertaking to advise you of any subsequent changes in the facts stated or assumed
herein or of any subsequent changes in applicable laws. Very truly yours, /s/ Robinson Brog Leinwand
Greene Genovese & Gluck P.C. Robinson Brog Leinwand
Greene Genovese & Gluck P.C.
Exhibit 23.1 Independent
Registered Public Accounting Firm’s Consent We
consent to the inclusion in this Registration Statement of Nxt-ID Inc. (the “Company”) on Amendment No. 1 of
Form S-1 (File No. 333-197845) of our report dated February 24, 2014, which includes an explanatory paragraph as to the Company’s
ability to continue as a going concern, with respect to our audits of the consolidated financial statements of Nxt-ID, Inc. and
Subsidiary as of December 31, 2013 and 2012 and for the years then ended, which report appears in the Prospectus, which is part
of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus. /s/ Marcum
llp Marcum
llp New York,
NY August
13, 2014
Assumed public offering price per share
$
As adjusted net tangible book value per share as of June 30, 2014
before giving effect to this offering
$
Increase in as adjusted net tangible book value per
share attributed to new investors purchasing shares and related warrants from us in this offering
$
As adjusted net tangible book value per share after giving
effect to this offering
$
Dilution in as adjusted net tangible book value per share
to new investors in this offering
$
Shares Purchased
Total Consideration
Average
Price Per
Number
Percent
Amount
Percent
Share
Existing stockholders
%
$
%
$
New investors
Total
100 %
$
100 %
$
●
exercise
of the underwriters’ over-allotment option; and
●
exercise
of any options, warrants or conversion rights outstanding as of June 30, 2014; and
●
any
securities, options, warrants or conversion rights issued subsequent to June 30, 2014. 18
●
on
an actual basis;
●
on
an as adjusted basis to give effect to the sale of shares
of the common stock and warrants to purchase shares of our common
stock we are offering based upon an assumed combined public offering price of $ per
share and related warrant, the closing price of our common stock as listed on OTC Bulletin Board on ,
2014, and after deducting underwriting discounts and approximately $ million
in other estimated offering expenses payable by us. The as adjusted column assumes no exercise by the underwriters of their
over-allotment option.
As of June 30, 2014
(Unaudited)
Actual
As Adjusted
Cash and cash equivalents
$ 592,331
$
Short-term debt
Convertible notes
-
Long-term debt
Warrant liability
-
Total debt and accrued interest
-
Equity
Preferred stock: 10,000,000 shares authorized, none issued and outstanding
—
—
Common stock: 100,000,000 shares authorized, 22,028,285
shares issued and outstanding; 100,000,000 shares authorized,
shares issued and outstanding, as adjusted
2,203
— *
Additional paid in capital
6,087,873
Accumulated deficit
(5,576,297 )
Treasury stock,
Total stockholders’ equity
513,779
Total capitalization
$ 513,779
$
19 20 21 22 23 24 25
Fiscal 2013
High
Low
First Quarter (January 1 - March 31)
$
N/A
$
N/A
Second Quarter (April 1 - June 30)
$
N/A
$
N/A
Third Quarter (July 1 - September 30)
$
3.75
(2)
$
2.75
(2)
Fourth Quarter (October 1 - December 31)
$
5.99
$
3.35
Fiscal 2014
High
Low
First Quarter (January 1 - March 31)
$ 5.10
$ 3.50
Second Quarter (April 1 - June 30)
$ 4.60
$ 3.15
Third Quarter (July 1 - September 30)
$ 4.25 (1)
$ 3.36 (1)
Fourth Quarter (October 1 - December 31)
$ –
$ –
(1)
Through August 12, 2014.
(2)
A public market for our common stock did
not exist prior to August 23, 2013. 26
Plan Category
Number of
Securities to
Be Issued upon
Exercise of
Outstanding
Options
Weighted Average
Exercise Price of
Outstanding
Options
Number of
Securities
Remaining
Available for
Future Issuance
under the Plan (2)
(a)
(b)
(c)
Equity compensation plans approved by security holders (1)
0
$ –
2,044,949
Equity compensation plans not approved by security holders
–
–
–
Total
0
$ –
2,044,949
(1)
Represents the
shares authorized for issuance under the Nxt-ID, Inc. 2013 Long-Term Stock Incentive Plan, which was approved by the Company’s
shareholders on January 3, 2013. The maximum aggregate number of shares of Common Stock that may be issued under the Plan,
including Stock Options, Stock Awards, and Stock Appreciation Rights is limited to 10% of the shares of Common Stock outstanding
on the first trading day of any fiscal year, less shares or awards previously issued under the Plan, or 2,044,949 for fiscal
2014.
(2)
As of January
1, 2014. 27 28 29 30 31 32 33 34
Patent
Title
Serial/Patent/
Registration Number
Method
and Apparatus for High
Resolution Three Dimensional Display
6,064,423
Omni-Directional
Cameras
D436,612
High
Speed Three Dimensional
Imaging Method
6,028,672
Method
and System for Three-Dimensional
Imaging Using Light Pattern Having
Multiple Sub-Patterns
6,700,669
Method
And Apparatus for Omnidirectional
Three Dimensional Imaging
6,744,569
Face
Recognition System and Method
7,221,809
A
System and a Method for Three-Dimensional Imaging Systems
7,349,104
Method
and Apparatus for an Interactive
Volumetric Three Dimensional Display
7,098,872
Face
Recognition System and Method
7,876,931
Method
and Apparatus for Omni-Directional
Video Surveillance System
7,940,299
A
System and a Method for a
Smart Surveillance System
7,358,498
A
High Speed Three Dimensional
Imaging Method
6,147,760
Method
And Apparatus for Modeling Via a
Three-Dimensional Image Mosaic System
6,819,318
Method
and System for a Three
Dimensional Facial Recognition System
7,804,997
Method
and Apparatus for Omni-Directional
Three-Dimensional Imaging
6,304,285
Method
and Apparatus for Generating Structural Pattern Illumination
6,937,348 35
Name
Age
Position
Gino
M. Pereira
56
Chief
Executive Officer, Chief Financial Officer and Director
David
Tunnell
48
Vice
President and Chief Technology Officer
Major
General David R. Gust, USA, Ret
69
Director
Michael
J. D’Almada-Remedios, Phd
51
Director
Daniel
Sharkey
57
Director 36 37
●
been
convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other
minor offenses);
●
had
any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or
business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or
within two years prior to that time;
●
been
subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction
or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement
in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities,
or to be associated with persons engaged in any such activity;
●
been
found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity
Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been
reversed, suspended, or vacated;
●
been
the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently
reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an
alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial
institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement
or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or
any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
●
been
the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory
organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of
the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority
over its members or persons associated with a member.
●
the
director is, or at any time during the past three years was, an employee of the company;
●
the
director or a family member of the director accepted any compensation from the company in excess of $120,000 during any period
of 12 consecutive months within the three years preceding the independence determination (subject to certain exclusions, including,
among other things, compensation for board or board committee service);
●
a
family member of the director is, or at any time during the past three years was, an executive officer of the company;
●
the
director or a family member of the director is a partner in, controlling stockholder of, or an executive officer of an entity
to which the company made, or from which the company received, payments in the current or any of the past three fiscal years
that exceed 5% of the recipient’s consolidated gross revenue for that year or $200,000, whichever is greater (subject
to certain exclusions);
●
the
director or a family member of the director is employed as an executive officer of an entity where, at any time during the
past three years, any of the executive officers of the company served on the compensation committee of such other entity;
or the director or a family member of the director is a current partner of the company’s outside auditor, or at any
time during the past three years was a partner or employee of the company’s outside auditor, and who worked on the company’s
audit. 38
Name and Principal Position
Year
Salary ($)
Bonus ($)
Stock
Awards ($)
Option Awards ($)
NonEquity Incentive Plan Compensation ($)
Nonqualified Deferred Compensation Earnings ($)
All Other Compensation ($)
Total ($)
Gino Pereira, Chief Executive Officer and Chief Financial Officer
–
–
–
–
–
–
–
–
–
–
David Tunnell, Chief Technology Officer
–
–
–
–
–
–
–
–
–
–
–
●
Payment of all necessary and reasonable out-of-pocket expenses incurred by the executive in the performance of his duties under the agreement.
●
Eligibility to participate in bonus or incentive compensation plans that may be established by the board of directors from time to time applicable to the executive's services.
●
Eligibility to receive equity awards as determined by the board of directors, or a committee of the board of directors, composed in compliance with the corporate governance standards of any applicable listing exchange. 39
Option Awards
Stock Awards
Name
Number
of
Securities
Underlying
Unexercised
Options
(# Exercisable)
Number of
Securities
Underlying
Unexercised
Option
(# Unexercisable)
Equity
Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned Options
(#)
Option
Exercise
Price
($)
Option
Expiration Date
Number of
Shares or
Units of
Stock
That
Have
Not
Vested
(#)
Market
Value of
Shares or
Units of
Stock
That
Have
Not
Vested
($)
Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights
That
Have
Not
Vested
(#)
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units Or
Other
Rights
That
Have
Not
Vested
($)
Gino Pereira
-
-
-
-
$
-
$
-
David Tunnell
-
-
-
-
$
-
$
-
Fees
Earned or
Paid in
Cash
($)
Stock
Awards
($)(1)(2)
Options
Awards
($)
Non-Equity
Incentive Plan
Compensation
($)
Nonqualified
Deferred
Compensation
Earnings
($)
All
Other
Compen-
sation
($)
Total
($)
Major General David R. Gust, USA, Ret.
-
20,000
-
-
-
-
20,000
Michael J. D’Almada-Remedios, PhD
-
5,000
-
-
-
-
5,000
(1)
Major
General David R. Gust, received 47,583 shares of common stock at an average price of $0.42 per share.
(2)
Michael
J. D’Almada-Remedios received 1,250 shares of common stock at an average price of $4.00 per share. 40
Name and address of beneficial owner
Amount and Nature of
Beneficial Ownership
Percent of class of
Common Stock (1)
5% Shareholders:
None
Directors and Officers:
Gino Pereira
Chief Executive Officer and Chief Financial Officer
11,018,922
50
%
David Tunnell
Chief Technology Officer
7,665,691
35
%
Major General David R. Gust, USA, Ret.
Director
50,125
*
Michael J. D’Almada-Remedios, PhD
Director
3,792
*
Daniel Sharkey
Director
-
-
Directors and Officers as a group (5 persons)
18,738,530
85
%
*
Less
than 1%
1)
Based
on 22,030,843 shares
of common stock issued and outstanding as of August 12, 2014. Shares of common stock subject to options or warrants currently
exercisable or exercisable within 60 days, are deemed outstanding for purposes of computing the percentage of the person holding
such options or warrants, but are not deemed outstanding for purposes of computing the percentage of any other person. 41 42 43 44
●
for
any breach of the director’s duty of loyalty to us or our stockholders;
●
for
acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;
●
for
unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL; and
●
for
any transaction from which the director derived an improper personal benefit. 45
●
increase
or decrease the aggregate number of authorized shares of such class;
●
increase
or decrease the par value of the shares of such class; or
●
alter
or change the powers, preferences or special rights of the shares of such class so as to affect them adversely. 46 47
●
1%
of the number of shares of common stock then outstanding, which will equal approximately shares immediately after this offering;
or
●
The
average weekly trading volume of the common stock during the four calendar weeks preceding the filing of a notice on Form
144 with respect to such sale. 48
Underwriters
Northland Securities, Inc.
The Benchmark Company, LLC
Newport Coast Securities Inc.
Total
Per Combined Share and Related Warrant
Total with No Exercise
Total With Exercise
Paid by us
$
$
$
49 50 51 F-1 F-2
June 30,
December 31,
2014
2013
(Unaudited)
Assets
Current Assets
Cash
$ 588,179
$ 303,626
Restricted cash
4,152
-
Inventory
30,167
6,533
Prepaid expenses
94,441
3,313
Total Current Assets
716,939
313,472
Property and equipment, net of accumulated depreciation of $1,944 and
$684
23,209
7,734
Total Assets
$ 740,148
$ 321,206
Liabilities and Stockholders' Equity ( Deficiency)
Current Liabilities
Accounts payable
$ 92,804
$ 244,094
Accrued expenses
53,547
135,017
Customer deposits
80,018
-
Convertible notes payable, net of discount of $0 and 26,755, respectively
-
123,245
Derivative liability - warrants
-
1,531,303
Conversion feature liability
-
118,940
Total Current Liabilities
226,369
2,152,599
Commitments and Contingencies
Stockholders' Equity (Deficiency)
Preferred stock, $0.0001 par value: 10,000,000 shares authorized; none
issued and outstanding
-
-
Common stock, $0.0001 par value: 100,000,000 shares
authorized; 22,028,285 and 21,937,822 issued and outstanding, respectively
2,203
2,194
Additional paid-in capital
6,087,873
(80,177 )
Accumulated deficit
(5,576,297 )
(1,753,410 )
Total Stockholders' Equity (Deficiency)
513,779
(1,831,393 )
Total Liabilities and Stockholders' Equity (Deficiency)
$ 740,148
$ 321,206 F-3
For the Six
Months Ended
June
30,
2014
2013
Revenues
$ -
$ -
Costs of goods sold
-
-
Gross Profit
-
-
Operating Expenses
General and administrative
758,077
326,004
Selling
377,603
5,489
Research and development
424,126
262,007
Total Operating Expenses
1,559,806
593,500
Operating Loss
(1,559,806 )
(593,500 )
Other Expense
Interest and other expenses, net
(30,744 )
(8,250 )
Inducement expense in connection with warrant exercise
(1,177,760 )
-
Unrealized loss on change in fair value of derivative liabilities
(1,054,577 )
-
Total Other Expense
(2,263,081 )
(8,250 )
Net Loss
$ (3,822,887 )
$ (601,750 )
Net Loss Per Share - Basic and Diluted
$ (0.18 )
$ (0.03 )
Weighted Average Number of Common
Shares Outstanding - Basic and Diluted
21,987,558
21,109,011 F-4
For the Three Months Ended
June 30,
2014
2013
Revenues
$ -
$ -
Costs of goods sold
-
-
Gross Profit
-
-
Operating Expenses
General and administrative
470,755
67,535
Selling
319,073
489
Research and development
259,847
84,225
Total Operating Expenses
1,049,675
152,249
Operating Loss
(1,049,675 )
(152,249 )
Other Expense
Interest and other expenses, net
-
(4,500 )
Inducement expense in connection with warrant exercise
(1,177,760 )
-
Total Other Expense
(1,177,760 )
(4,500 )
Net Loss
$ (2,227,435 )
$ (156,749 )
Net Loss Per Share - Basic and Diluted
$ (0.11 )
$ (0.01 )
Weighted Average Number of Common
Shares Outstanding - Basic and Diluted
22,007,979
21,242,244 F-5
For
the Six Months Ended
June 30,
2014
2013
Cash Flows from Operating
Activities
Net
loss
$ (3,822,887 )
$ (601,750 )
Adjustment to reconcile
net loss to net cash used in operating activities:
Depreciation
1,260
198
Stock based
compensation
144,000
80,000
Amortization
of debt discount
26,755
-
Unrealized
loss on change in fair value of derivative liabilities
1,054,577
-
Inducement
fee in connection with warrant exercise
1,177,760
-
Changes in operating
assets and liabilities:
Inventory
(23,634 )
(2,790 )
Prepaids
(91,128 )
-
Accounts
payable
(151,290 )
219,907
Accrued expenses
(59,985 )
-
Customer
deposits
80,018
-
Total Adjustments
2,158,333
297,315
Net
Cash Used in Operating Activities
(1,664,554 )
(304,435 )
Cash
flows from Investing Activities
Restricted Cash
(4,152 )
-
Purchase of equipment
(16,735 )
-
Net
Cash Used in Investing Activities
(20,887 )
-
Cash
flows from Financing Activities
Proceeds received
in connection with issuance of common stock and warrants, net
799,994
-
Proceeds received
in connection with issuance of common stock, net
-
246,435
Proceeds received
in connection with exercise of warrants
1,170,000
-
Proceeds from convertible
notes payable
-
75,000
Proceeds from advances
made by officer
-
64,000
Repayments
of advances made by officer
-
(60,000 )
Net
Cash Provided by Financing Activities
1,969,994
325,435
Net
Increase in Cash
284,553
21,000
Cash - Beginning
of Period
303,626
135,820
Cash - End of Period
$ 588,179
$ 156,820
Supplemental
Disclosures of Cash Flow Information:
Cash
paid during the periods for:
Interest
$ -
$ -
Taxes
$ -
$ -
Non-cash
financing activities:
Recognition of liability
in connection with warrant issuance
$ 3,431,541
$ -
Reclassification
of warrant liability to additional paid in capital in connection with warrant modification
$ 6,037,639
$ -
Issuance
of common stock in connection with conversion of note payable and accrued interest
$ 171,485
$ -
Reclassification of
conversion feature liability in connection with note conversion
$ 98,722
$ -
Retirement of common
stock by officers
$ 68
$ -
Accrual of common
shares to be issued for services
$ -
$ 35,000 F-6 F-7 F-8 F-9 F-10
June 30,
December 31,
2014
2013
Salaries
$ 20,861
$ 18,750
Reimbursable expenses
2,686
196
Investment banking fees
30,000
45,000
Consulting fees
-
18,574
Royalty fees
-
35,000
Interest expense - convertible note
-
17,497
Totals
$ 53,547
$ 135,017 F-11 F-12
Weighted
Weighted
Average
Average
Remaining
Number of
Exercise
Life
Intrinsic
Warrants
Price
In
Years
Value
Outstanding
at December 31, 2013
454,600
$ 3.25
-
-
Issued
1,341,539
3.00
-
-
Exercised
(400,000 )
3.00
-
-
Cancelled
-
-
-
-
Outstanding
at June 30, 2014
1,396,139
$ 3.00
4.65
$ 1,270,486
Exercisable
at June 30, 2014
1,396,139
$ 3.00
4.65
$ 1,270,486 F-13
February
21, 2014
February
18, 2014
January
13, 2014
December
31, 2013
Embedded Conversion Feature and
Warrant Liability:
Risk-free
interest rate
0.30 %
0.30 %
0.30 %
0.30 %
Expected volatility
124 %
123 %
123 %
123.54 %
Expected life (in
years)
4.9
0.75
5.00
4.59
Expected dividend
yield
-
-
-
-
Number of shares
1,391,539
55,497
941,539
500,000
Fair value
$ 6,037,639
$ 98,722
$ 3,431,541
$ 1,650,243 F-14
Fair
Value Measurements at June 30, 2014
Total
Carrying Value at June 30, 2014
Derivative
liabilities
$ -
$ -
$ -
$ -
For the six
months ended
For the three and
six months ended
June
30,
2014
June
30,
2013
Beginning balance
$ 1,650,243
$ -
Recognition of derivative liability
3,431,541
44,966
Net unrealized loss on derivative
liabilities
1,074,795
-
Net unrealized gain on conversion
feature liabilities
(20,218 )
(1,642 )
Adjustment
to additional paid in capital upon conversion and modification
(6,136,361 )
-
Ending balance
$ -
$ 43,324 F-15 F-16
Future Lease Obligation
2014
(remaining)
7,748
2015
15,496
2016
15,496
Total future lease obligation
38,740
·
An
initial term of 3 years beginning on October 1, 2012.
·
An
initial base salary of $150,000 per year. In January 2014, upon the successful completion of the MobileWocket prototype, the
salary was increased to $300,000 in accordance with the agreement.
·
Payment
of all necessary and reasonable out-of-pocket expenses incurred by the executive in the performance of his duties under the
agreement. F-17
·
Eligibility
to participate in bonus or incentive compensation plans that may be established by the board of directors from time to time
applicable to the executive's services.
·
F-18 F-19 F-20
December 31,
December 31,
2013
2012
Assets
Current Assets
Cash
$
303,626
$
135,820
Inventory
6,533
-
Prepaid expenses
3,313
-
Total Current Assets
313,472
135,820
Property and equipment, net of accumulated depreciation of $684 and $99
7,734
1,883
Total Assets
$
321,206
$
137,703
Liabilities and Stockholders' Deficiency
Current Liabilities
Accounts payable
$
244,094
$
-
Accrued expenses
135,017
69,279
Convertible notes payable, net of discount of $26,755 and $0, respectively
123,245
75,000
Derivative liability - warrants
1,531,303
-
Conversion feature liability
118,940
-
Total Current Liabilities
2,152,599
144,279
Commitments and Contingencies
Stockholders' Deficiency
Preferred stock, $0.0001 par value: 10,000,000 shares
authorized; none issued and outstanding
-
-
Common stock, $0.0001 par value: 100,000,000 shares
authorized; 21,937,822 and 20,752,000 issued and outstanding, respectively
2,194
2,076
Additional paid-in capital
(80,177
)
200,224
Accumulated deficit
(1,753,410
)
(208,876
)
Total Stockholders' Deficiency
(1,831,393
)
(6,576
)
Total Liabilities and Stockholders' Deficiency
$
321,206
$
137,703
F-21
For the Year Ended
December 31,
2013
For the Year Ended
December 31,
2012
Revenues
$
-
$
251,375
Costs of goods sold
-
48,455
Gross Profit
-
202,920
Operating Expenses
General and administrative
835,162
220,119
Selling
81,323
62,500
Research and development
518,614
114,269
Total Operating Expenses
1,435,099
396,888
Operating Loss
(1,435,099
)
(193,968
)
Other Expense
Interest expense
(35,461
)
(247
)
Unrealized loss on change in fair value of derivative liabilities
(73,974
)
-
Total Other Expense
(109,435
)
(247
)
Net Loss
$
(1,544,534
)
$
(194,215
)
Net Loss Per Share - Basic and Diluted
$
(0.07
)
$
(0.01
)
Weighted Average Number of Common Shares Outstanding
- Basic and Diluted
21,409,369
20,197,478
F-22
Common Stock
Additional
Paid-in
Accumulated
Shares
Amount
Capital
Deficit
Total
Balance - January 1, 2012
20,000,000
2,000
8,000
(14,661
)
(4,661
)
Capital contributions - founders
-
-
4,300
-
4,300
Issuance of common stock for cash
632,000
64
157,936
-
158,000
Issuance of common stock for services
120,000
12
29,988
-
30,000
Net loss
-
-
-
(194,215
)
(194,215
)
Balance - December 31, 2012
20,752,000
$
2,076
$
200,224
$
(208,876
)
$
(6,576
)
Exercise of common stock purchase warrants
300,000
30
299,970
-
300,000
Issuance of common stock and warrants for cash, net
of fees
443,063
44
588,736
-
588,780
Issuance of common stock for cash, net of fees
204,000
20
50,980
-
51,000
Issuance of common stock for services
377,222
38
311,202
-
311,240
Retirement of common stock by officers
(138,463
)
(14
)
14
-
-
Issuance of warrants in connection with offering
(Note 8)
-
-
(1,531,303
)
-
(1,531,303
)
Net loss
-
-
-
(1,544,534
)
(1,544,534
)
Balance - December 31, 2013
21,937,822
$
2,194
$
(80,177
)
$
(1,753,410
)
$
(1,831,393
) F-23
For the Years Ended
December 31,
2013
2012
Cash Flows from Operating Activities
Net loss
$
(1,544,534
)
$
(194,215
)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation
585
99
Stock based compensation
311,240
30,000
Amortization of debt discount
18,211
-
Unrealized loss on change in fair value of derivative
liabilities
73,974
-
Changes in operating assets and liabilities:
Inventory
(6,533
)
-
Accounts payable
244,094
64,279
Accrued expenses
65,738
-
Prepaid expenses
(3,313
)
-
Total Adjustments
703,996
94,378
Net Cash Used in Operating Activities
(840,538
)
(99,837
)
Cash flows from Investing Activities
Purchase of equipment
(6,436
)
(1,982
)
Net Cash Used in Investing Activities
(6,436
)
(1,982
)
Cash flows from Financing Activities
Proceeds received in connection with issuance of common stock and warrants, net
588,780
-
Proceeds received in connection with issuance of common stock, net
51,000
158,000
Proceeds from convertible notes payable
75,000
75,000
Proceeds from exercise of common stock warrants
300,000
-
Capital contributions-founders
-
4,300
Proceeds from advances made by officer
64,000
-
Repayments of advances made by officer
(64,000
)
-
Net Cash Provided by Financing Activities
1,014,780
237,300
Net Increase in Cash
167,806
135,481
Cash - Beginning of Year
135,820
339
Cash - End of Year
$
303,626
$
135,820
Supplemental Disclosures of Cash Flow Information:
Cash paid during the periods for:
Interest
$
-
$
-
Taxes
$
-
$
-
Non-cash financing activities:
Conversion feature in connection with note payable issuance
$
44,966
$
-
Retirement of common stock by officers
$
14
$
-
Issuance of warrants in connection with offering (Note 8)
$
1,531,303
$
-
F-24 F-25
Equipment
5 years
Furniture and fixtures
3 to 5 years F-26 F-27 F-28
December 31,
2013
2012
Salaries
$
18,750
$
16,000
Reimbursable expenses
196
27,334
Consulting fees
18,574
5,698
Royalty fees
35,000
20,000
Investment banking fees
45,000
-
Interest expense - convertible note
17,497
247
Totals
$
135,017
$
69,279
F-29
May 25,
2013
December 31,
2013
Embedded Conversion Feature and Warrant Liability:
Risk-free interest rate
0.30
%
0.30
%
Expected volatility
91.17
%
123.54
%
Expected life (in years)
1.60
4.59
Expected dividend yield
-
-
Number of shares
120,000
500,000
Fair value
$
44,966
$
1,650,243
Fair Value Measurements at
December 31, 2013
Total Carrying Value
at
December 31,
2013
Quoted prices in
active markets
(Level 1)
Significant other observable
inputs
(Level 2)
Significant unobservable
inputs
(Level 3)
Derivative liabilities
$
1,650,243
$
-
$
-
$
1,650,243
F-30
For the year ended
December 31, 2013
Beginning balance
$
-
Recognition of conversion feature liability
44,966
Recognition of derivative liability - warrants
1,531,303
Net unrealized loss on derivative liabilities
73,974
Ending balance
$
1,650,243
F-31
Number
of Warrants
Weighted
Average Exercise Price
Weighted
Average Remaining Life In Years
Intrinsic
Value
Outstanding at December 31, 2012
-
$
-
Issued
754,600
2.34
-
-
Exercised
(300,000
)
1.00
-
-
Cancelled
-
-
-
-
Outstanding at December 31, 2013
454,600
$
3.23
4.97
$
351,300
Exercisable at December 31, 2013
454,600
$
3.23
4.97
$
351,300
F-32
December 31,
2013
2012
Current
Federal
$
-
$
-
State
-
-
-
-
Deferred
Federal
(491,900
)
(66,000
)
State
(71,500
)
(9,700
)
(563,400
)
(75,700
)
Change in valuation allowance
563,400
75,700
Total income tax provision
$
-
$
-
December 31,
2013
2012
U.S. federal statutory rate
(34.00
)%
(34.00
)%
State income tax rate, net of federal benefit
(4.95
)
(5.00
)
Other permanent differences
2.47
-
Less: valuation allowance
36.48
39.00
Provision for income taxes
-
%
-
% F-33
December 31,
2013
2012
Deferred tax assets:
Net operating loss carryforward
$
639,100
$
75,700
Derivative liability
10,421
-
Total deferred tax assets before valuation allowance:
$
649,521
$
75,700
Valuation allowance
(639,100
)
(75,700
)
Deferred tax assets, net of valuation allowance
10,421
-
Deferred tax liabilities:
Convertible debt
(10,421
)
-
Total deferred tax liabilities
(10,421
)
-
Net deferred tax asset (liability)
$
-
$
-
F-34 F-35
●
An initial term of 3 years beginning on October 1, 2012.
●
A base salary of $150,000 per year, increasing to $300,000 per year
●
Payment of all necessary and reasonable out-of-pocket expenses incurred by the
executive in the performance of his duties under the agreement.
●
Eligibility to participate in bonus or incentive compensation plans that may be
established by the board of directors from time to time applicable to the executive's services.
●
Eligibility to receive equity awards as determined by the board of directors,
or a committee of the board of directors, composed in compliance with the corporate governance standards of any applicable
listing exchange. F-36
Northland
Capital Markets
The
Benchmark Company
Securities and Exchange Commission registration fee
$
2,342.87
FINRA fee
3,228.50
NASDAQ listing fee
55,000
Printing and mailing expenses
17,000
Accounting fees and expenses
60,000
Legal fees and expenses
240,000
Transfer agent fees and expenses
*
Miscellaneous
*
Total
$
377,571.37
II-1 II-2
Item 16. Exhibits.II-3
NXT-ID,
INC.
By:
/s/
Gino Pereira
Gino
Pereira
Chief
Executive Officer and Chief Financial Officer
Signature
Title
Date
/s/
Gino Pereira
Chief
Executive Officer, Chief Financial Officer and
August 14, 2014
Gino
Pereira
Director
(chief accounting officer)
/s/
Major General David R. Gust, USA, Ret.
Director
August 14,
2014
Major
General David R. Gust, USA, Ret.
/s/
Michael J. D’Almada-Remedios, PhD
Director
August 14,
2014
Michael
J. D’Almada-Remedios, PhD
/s/
Daniel Sharkey
Director
August 14,
2014
Daniel
Sharkey
II-4
Exhibit
No.
Description
of Exhibit
1.1
Form of Underwriting
Agreement
3.1(i)
Certificate
of Incorporation (1)
3.1(ii)
Bylaws
(1)
4.1
Form
of Warrant Agreement and Form of Warrant (1)
4.2
Form
of Warrant for January 2014 Offering (2)
4.3
Form
of Agent Warrant for January 2014 Offering (2)
4.4
Form
of Warrant for June 2014 Offering
4.5
Form
of Warrant for this Offering
4.6
Form
of Underwriter Warrant for this Offering
5.1
Opinion
of Robinson Brog Leinwand Greene Genovese & Gluck P.C.
10.
1†
Form
of Indemnification Agreement (1)
10.2
†
2013
Long Term Incentive Plan (1)
10.3
†
Forms
of Agreement Under 2013 Long Term Incentive Plan (1)
10.4
†
Employment
Agreement Between Nxt-ID and Gino Pereira (3)
10.5
License
Agreement between 3D-ID, LLC and Genex Technologies (1)
10.6
License
Agreement between 3D-ID, LLC and Aellipsys Holdings (1)
10.7
Purchase
Agreement between 3D-ID, LLC and Nxt-ID, Inc. (1)
10.8
††
Manufacturing
agreement with Identita Technologies, Inc., dated January 18, 2013 (4)
10.9
Form
of Securities Purchase Agreement for January 2014 Offering (2)
10.10
Form
of Registration Rights Agreement for January 2014 Offering (2)
10.11
Form
of Securities Purchase Agreement for June 2014 Offering
10.12
Form
of Registration Rights Agreement for June 2014 Offering
21.1
List
of Subsidiaries (1)
23.1
Consent
of Marcum LLP
23.2
Consent
of Robinson Brog Leinwand Greene Genovese & Gluck P.C. (Reference is made to Exhibit 5.1)
101.INS
*
XBRL
Instance Document
101.SCH
*
XBRL
Taxonomy Schema
101.CAL
*
XBRL
Taxonomy Calculation Linkbase
101.DEF
*
XBRL
Taxonomy Definition Linkbase
101.LAB
*
XBRL
Taxonomy Label Linkbase
101.PRE
*
XBRL
Taxonomy Presentation Linkbase
(1)
Filed
as an Exhibit to the Company’s Registration Statement on Form S-1 (File No. 333-184673) with the SEC on January 31,
2013.
(2)
Filed
as an Exhibit to the Company’s Current Report on Form 8-K with the SEC on January 17, 2014.
(3)
Filed
as an Exhibit to the Company’s Annual Report on Form 10-K with the SEC on February 24, 2014.
(4)
Filed
as an Exhibit to the Company’s Registration Statement on Form S-1/A (File No. 333-184673) with the SEC on March 25,
2013.
1 Plus an option to purchase up to [_______] additional
shares and warrants to purchase up to [_______] additional shares at an exercise price of [____] to cover over-allotments. 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Very
truly yours,
NXT-ID,
INC.
By
Name
Title
By
Managing Director
30
Underwriter
Number of Firm Shares (1)
Number of Firm Warrants (2)
Northland Securities, Inc.
[________]
[________]
The Benchmark Company, LLC
[________]
[________]
Newport Coast Securities Inc.
[________]
[________]
Total. . . . . . . . . . . . . . . . . . . . . . . . . .
[________]
[________]
(1) The
Underwriters may purchase up to an additional [●] Option Shares, to the extent the option
described in Section 3(b) of the Agreement is exercised, in the manner described
in the Agreement.
(2) The
Underwriters may purchase warrants to purchase up to [●]
additional shares to the extent the option described in Section 3(d) of the Agreement
is exercised, in the manner described in the Agreement.
1 2 3 4 5 6 7
NXT-ID
By:
Name:
Its:
[NAME OF WARRANT AGENT]
By:
Name:
Its:
8
Number
NXT-ID, INC.
Warrant
THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR
TO 5:30 P.M. NEW YORK CITY TIME, [_______], 2018
[____________________]
By:
President
Secretary
Transfer Agent and Registrar Authorized Officer 9
Dated ______________ __, _____
Name of Holder:
(Print)
By:
Its:
(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
10
Date
11
Note: Address for Delivery may not be a P.O. box and must be a physical address where stock certificates may be delivered in connection with this purchase or any future stock issued through splits, warrant conversions or other circumstances. The delivery address may be a personal residence, or a broker dealer where the certificate would be deposited
Attest:
1 2 3 4 5 6 7 8
(Signature
must conform in all respects to name of holder as specified on the face of the Warrant)9
Date
10